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Abstract
The development of in vitro cell culture models that investigate tissue-specific effects of the
extracellular matrix (ECM) on stem/progenitor cell lineage-commitment can contribute towards
the design of improved cell delivery strategies. This thesis developed processing methods that
conserved ECM bioactivity to generate well-characterized 2- and 3-D culture platforms that
facilitated the evaluation of ECM composition on the adipogenic and osteogenic differentiation of
human adipose-derived stromal cells (ASCs).
Initial work compared α-amylase and pepsin digestion as methods to fabricate ECM coatings. The
effects of enzyme processing and ECM composition were explored using human decellularized
adipose tissue (DAT) and bovine tendon collagen as matrix sources. The α-amylase-digested
coatings were softer and more stable, with a complex composition and fibrillar architecture. ASCs
cultured on α-amylase-digested ECM retained a spindle-shaped morphology, with enhanced
proliferation on the α-amylase-digested DAT. Further, the α-amylase-digested DAT enhanced
adipogenesis, based on adipogenic gene expression, glycerol-3-phosphate dehydrogenase (GPDH)
enzyme activity, and perilipin staining under differentiation conditions.
To further evaluate the effects of tissue-specific ECM composition on ASC differentiation, bovine
trabecular bone was explored as a compositionally distinct ECM source. A detergent-free protocol
was developed for obtaining decellularized trabecular bone (DTB). Immunohistochemical and
biochemical techniques were used to compare the composition of the DTB and DAT,
demonstrating higher levels of glycosaminoglycans in the DTB and enhanced expression of
basement membrane proteins (collagen IV, laminin, collagen VI) in the DAT.
To investigate the potential of applying a tissue-specific approach within a 3-D culture system,
cryo-milled DAT or DTB particles were incorporated within methacrylated chondroitin sulphate
(MCS) hydrogels. ASC viability, adipogenesis and osteogenesis were assessed in the MCS+DAT,
MCS+DTB and MCS alone. The findings indicated that the incorporation of DAT provided an
adipo-conductive microenvironment, as seen by enhanced adipogenic gene expression, GPDH
enzyme activity and intracellular lipid accumulation under differentiation conditions. The
preliminary osteogenic data suggested that the DTB may have osteo-inductive effects, as seen by
early stage osteogenic gene expression (OPN and ON) under proliferation conditions.
i

Overall, this thesis provided a body of evidence supporting that tissue-specific ECM composition
can be harnessed in biomaterials design to promote the lineage-specific differentiation of ASCs.
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Chapter 1

1

Literature review
1.1

Improving in vitro cell-culture models

Cell behavior is known to be mediated by the extracellular matrix (ECM), an intricate and
dynamic network of proteins and polysaccharides that is tissue-specific in terms of its
composition and ultrastructure1. The ECM of tissues is highly instrumental in directing
major cellular processes including survival, adhesion, migration, proliferation, and
differentiation2,3. Growing evidence has also indicated the ability of ECM from specific
tissues to direct stem/progenitor cell function in a tissue-specific manner4. Applying this
knowledge to the design of cell therapies, there is a need to develop high fidelity 2dimensional (2-D) and 3-dimensional (3-D) in vitro cell culture models that can reflect the
complexity of the ECM, in order to better understand and illustrate tissue-specific cellECM interactions.
The majority of 2-D in vitro culture studies are performed on either tissue culture plastic
(TCP) plates or on plates treated with purified ECM components such as collagens,
laminin, fibronectin, or vitronectin, which have been shown to mediate cell behavior when
used individually or in combination5–7. While the added dimension in 3-D in vitro models
involving cellular spheroids, single phase hydrogel constructs, electrospun bio-scaffolds
and more recently bio-printed constructs, provides a slightly better representation of the in
vivo microenvironment, these systems do not match its complexity8–11. ECM
decellularization, which conserves structural, biochemical and biomechanical cues, has
emerged as an attractive and versatile approach for the design of tissue-specific in vitro
cell culture models12,13. Intact and processed ECM in a range of formats such as
particulates, coatings and porous bio-scaffolds can be used individually or incorporated
with existing materials for the development of both 2 and 3-D in vitro cell culture models14–
17

. Using these models to discern stem cell-ECM interactions can provide valuable

information towards the design of delivery strategies that can help harness stem cell
therapeutic potential.
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1.2

Regenerative cell sources

In the development of in vitro cell culture models and cell-based therapies, the choice of
regenerative cell type is closely associated with and as important as the design of the
microenvironment. In the context of cell choice for therapies, a major requirement is the
accessibility to a high enough yield of cells for therapeutic efficacy18. Given the predicted
need for millions of therapeutic cells per kg of body weight for cell-based therapies in
humans (~108 – 109 cells/dose)19,20, cell sources should be readily isolated from abundant
and accessible tissues. If cell expansion is required, it is critical that the cells retain their
therapeutic potential18, given the possibility for cells to lose their beneficial properties over
population doublings and cell culture time21. While cell sources can be either autologous
(same donor) or allogenic (same species), autologous cell therapies minimize concerns
with immune rejection and deleterious side effects of immunosuppressive medications22.
Certain cell sources such as adipose-derived stromal cells (ASCs) have been shown to
exhibit immunomodulatory properties in vitro and are currently being studied further for
potential use as an allogenic cell source23.
Stem cells have the potential to differentiate into certain specialized cell types under
specific physiological or experimental conditions, thereby making them attractive for use
in a range of cell-based therapies24,25. Stem cell sources explored in the development of
cell-based therapies to date include embryonic stem cells (ESCs) and induced pluripotent
stem cells (iPSCs)26,27. Embryonic stem cells (ESCs) are pluripotent cells that are derived
from the inner cell mass of the blastocyst and their capability to differentiate into any cells
from the endoderm, mesoderm, or ectoderm makes them attractive for use in a wide range
of applications27,28. However, ESCs demonstrate immunological incompatibility, may
form teratomas, and are associated with ethical concerns 27,28. iPSCs on the other hand, are
an interesting alternative to ESCs, as they can be obtained through the genetic
reprogramming of adult somatic cells29. This process involves the de-differentiation of
cells such as fibroblasts to produce patient-specific pluripotent stem cells that exhibit
similar properties to ESCs29. With the original reprogramming procedure requiring the use
of viral transfection, new techniques are being developed that may have reduced risks (e.g.
synthetic messenger RNA), but still run the chance of developing teratomas30,31.
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Adult stem cells, found in almost every tissue in the body, serve to replenish the local
source of specialized cells in a given tissue during homeostasis and tissue repair32,33.
Mesenchymal stromal cells (MSCs) are multipotent adult stem cell populations that have
differentiation potential typically associated with their mesodermal lineage (adipogenic,
chondrogenic, osteogenic, myogenic)33,34. MSCs have also been shown to secrete a range
of beneficial paracrine factors that may facilitate angiogenesis and endogenous repair35,36.
The most commonly used MSCs and their respective characteristics will be discussed in
more detail in the following sections.

1.2.1

Mesenchymal stromal cell sources

MSCs, first reportedly isolated from the bone marrow37, constitute a heterogeneous
population of stromal cells which can be successfully harvested from several other adult
tissues such as adipose tissue38, synovial fluid39, dental pulp40 and peripheral blood41. The
International Society for Cellular Therapy (ISCT) has proposed minimum criteria to define
MSCs as cells that exhibit adherence to plastic, display a specific set of surface markers
(e.g. CD73, CD90, CD105), lack expression of CD14, CD31 and CD45 and demonstrate
the ability to differentiate in vitro into adipocytes, chondrocytes and osteoblasts42.
Accessible isolation, pro-regenerative functionality, and the ability to circumvent ethical
concerns associated with ESCs make MSCs a popular cell source for designing cell-based
regenerative therapies33. Recently, in vitro cultured MSCs have also been shown to possess
immunomodulatory properties, thereby expanding their utility in a clinical setting35.

1.2.2

Bone marrow derived mesenchymal stromal cells (bmMSCs)

Since their first description in 1976 by Friedenstein et al., bone marrow derived
mesenchymal stromal cells (bmMSCs) acquired from iliac crest bone marrow aspirates
have been the most extensively studied and established MSC type34. Typically, aspirates
are separated based on density, with mononuclear cells then plated to isolate the plastic
adherent population43. In addition to the advantage of applying established techniques for
their cultivation, separation and rapid proliferation in vitro, the immunomodulatory
properties of bmMSCs have shown promise for treatment of illnesses such as Crohn’s
disease44, graft-versus host disease45 and myocardial infarction46. However, the extraction
of bone marrow is painful and can be associated with a high risk of infection37,47. Further,
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it yields a low number (0.001-0.01% of the cell population) of regenerative cells, which
decreases with donor age37,47. This can significantly impact cellular therapies that typically
require a large number of MSCs.

1.2.3

Adipose-derived stromal cells (ASCs)

MSCs from fat have garnered significant attention since their identification in 2001 by Zuk
et al. from processed lipoaspirates48. Termed ASCs, the abundance and ease of access to
adipose tissue has rendered them a promising cell source, with a ~500 fold higher cell yield
from a gram of adipose tissue as compared to bone marrow aspirate49. ASCs can be
obtained at time of need from subcutaneous fat either through lipo-suction or lipo-reduction
surgeries, providing advantages for autologous cell therapy48,49. While still controversial,
several recent studies have suggested that ASCs are situated in proximity to the vasculature
of adipose tissue, known as the perivascular niche50. However, the variable levels of
expression reported for CD146 (a pericyte marker) in ASCs and the lack of expression of
other pericyte markers, makes this theory hotly contested50. To provide some clarity about
the identity of ASC populations, the International Federation for Adipose Therapeutics and
Science (IFATS) and ISCT in collaboration have defined a set of criteria to define ASCs51.
In general, ASCs should adhere to the following minimum criteria: (1) plastic-adherent;
(2) express the standard immunophenotypic profile (Table 1.1); (3) maintain multipotency
towards the adipogenic, osteogenic, and chondrogenic lineages51. In terms of the
immunophenotype profile, the general guideline involves including at least two primary
positive (> 90 %) and two primary negative markers (< 2 %), with additional markers
aimed at strengthening the characterization51. ASCs exhibit similar markers to bmMSCs
(e.g. CD29, CD44, CD73, and CD90) except CD34, whose expression in ASCs is high at
early passages and diminishes over time48,51. In spite of these clearly defined basic surface
antigens, ASC populations display heterogeneity in terms of morphologies52 and varying
ratios of uni-, bi-, and tri-potent stem cells, some of which are subsets of committed
progenitors53. This variation has been shown to be partially due to differences in isolation
and expansion techniques21,54,55.
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Table 1.1: Human ASC cell surface immunophenotype21,54.
Cell surface antigens
Primary positive markers (>80 %)

Secondary positive markers

Primary negative markers (<2 %)

Secondary negative markers

CD90 (Thy-1)
CD105 (endoglin)
CD73 (ecto-5’-nucleotidase)
CD44 (hyaluronic acid receptor)
CD29 (β1-integrin)
CD13 (aminopeptidase-N)
CD34 (progenitor associated marker)*
CD146 (melanoma cell adhesion
molecule, MCAM)*
CD10 (neprilysin)
CD26 (dipeptidyl peptidase-4)
CD49d (α4-integrin)*
CD49e (α5-integrin)
CD36 (fatty acid translocase)
CD31 (platelet endothelial cell adhesion
molecule, PECAM)
CD45 (leukocyte-common antigen, LCA)
CD235a (glycophorin A)
HLA-DR (human leukocyte antigenantigen D related)
CD3 (T-cell co-receptor)
CD11b (αM-integrin)
CD49f (α6-integrin)
CD106 (vascular cell adhesion molecule
1, VCAM-1)
PODXL (podocalyxin-like)

*variable levels of expression
Recently there has been a growing consensus that ASCs function by secreting a range of
paracrine factors that regulate angiogenesis and coordinate the immune response to
ultimately aid tissue regeneration36,56. In vivo data from investigating the therapeutic effects
of ASCs has shown a general improvement in terms of neovascularization and formation
of functional tissue (e.g. fat formation)57–59. However, low ASC engraftment, poor long
term survival and a lack of evidence to support in vivo differentiation coincide with the
overall improved tissue repair observed, which lends support to the hypothesis that the
ASCs could be acting in a paracrine fashion36,56,60,61.
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1.2.3.1

ASC isolation procedures

The predominant cell type within adipose tissue are adipocytes, which are unilocular cells
containing a single lipid droplet that comprises > 90 % of the total cell volume, surrounded
by a thin rim of cytoplasm that lies between the droplet and the plasma membrane62,63.
Adipose tissue is highly vascularized, with pericytes and endothelial cells associated with
the dense network of capillaries64,65. Pro-angiogenic factors (e.g. vascular endothelial
growth factor) secreted by adipocytes serve to promote on-going angiogenesis in order to
provide the adequate delivery of nutrients and oxygen to the tissues, and support the release
of hormones and cytokines into the systemic circulation66. Resident immune cells such as
macrophages, neutrophils and lymphocytes, perform a range of functions such as clearance
of apoptotic adipocytes, ECM remodelling, angiogenesis, and adipogenesis67. Finally, the
presence of multipotent stem cells and more committed progenitors serve to replenish the
pool of differentiated stromal vascular cell types and adipocytes to maintain adipose tissue
function68.
The initial methods to isolate stromal cells from adipose tissue were pioneered by Rodbell
and colleagues in the 1960s where lipoaspirate cells were isolated from rat fat pads69. A
modified version of this procedure is now utilized for the isolation of ASCs from human
adipose tissue68. Isolation procedures, growth conditions and site of isolation can differ
between laboratories, with cells expressing different surface markers, expansion rates and
differential potential70–73. For example, Boquest et al. used magnetic bead coupling and
sorting to remove CD45+ cells (leucocytic/haematopoietic lineages) and CD31+ cells
(endothelial lineage) from the isolated cells prior to differentiation experiments74.
However, the protocol described by Zuk et al. is still the most widely used method for
human ASC isolation48. This protocol involves the enzymatic digestion of collagenous
components and disruption of cell-cell junctions followed by centrifugation and filtration
steps to extract floating mature adipocytes and yield a heterogeneous stromal vascular
fraction (SVF) rich in cell types such as pre-adipocytes, erythrocytes, endothelial
progenitor cells, macrophages, fibroblasts, pericytes, and MSCs48,51,68. Following this, the
plastic-adherent ASC population can then be utilized.
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1.2.3.2

Differentiation potential

ASCs are capable of differentiation along the adipogenic, osteogenic, and chondrogenic
lineages and this has been confirmed using a combination of immunofluorescence, gene
expression analysis and specific functional assays to assess markers associated with each
lineage48. In general, the induction of ASC differentiation in vitro is mainly achieved by
culture in media supplemented with lineage-specific induction factors75.

1.2.3.2.1

Adipogenic differentiation

In order to promote adipogenic differentiation, ASCs can be seeded at high cell densities
to undergo growth arrest as a result of contact inhibition76. This initial growth arrest is
required to allow for subsequent terminal differentiation into adipocytes and is followed
by one or two additional rounds of mitotic clonal expansion, which then triggers the
expression of adipogenic transcriptional factors75. The addition of pro-differentiative
hormonal inducers and cytokines can aid in this initial growth arrest and trigger initial
commitment in cultured cell models. Glucocorticoid agonists such as hydrocortisone and
dexamethasone along with higher than physiological insulin concentrations, initiate this
signaling cascade77. The key transcriptional regulators, acting cooperatively and
sequentially to trigger adipogenic differentiation include members of the peroxisome
proliferator-activated receptor (PPAR) and the CCAAT/enhancer binding protein (C/EBP)
families75,76,78. The pro-adipogenic supplements provided activate the early transcription
factors CCAAT/enhancer binding protein-β (C/EBPβ) and CCAAT/enhancer binding
protein-δ (C/EBPδ) in pre-adipocytes which in turn stimulate the master transcription
factors of adipogenesis: the nuclear receptor peroxisome proliferator-activated receptor-γ
(PPARγ) and CCAAT/enhancer binding protein-α (C/EBPα)75,76,78. C/EBPα serves to
maintain growth arrest and inhibit proliferation, while both C/EBPα and PPARγ work in
collaboration to maintain a positive feedback loop, maintaining an elevated level of
expression in both genes75,76,79. Following this, an enhanced expression of genes that
characterize the adipocyte phenotype and enable triglyceride accumulation is observed,
including lipoprotein lipase (LPL), fatty acid binding protein-4 (FABP4 or aP2), glucose
transporter type 4 (GLUT4), fatty acid synthase (FAS), malic enzyme, acetyl CoA
carboxylase, insulin receptor, and glycerol-3-phosphate dehydrogenase (GPDH)75,76,79. A
summary of the cascade of transcription events in depicted in Fig. 1.1.
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Figure 1.1: Transcriptional control of adipogenesis in vitro.
Standard media supplements added to serum-free media formulations to induce in vitro
adipogenesis depend on the species of interest but often include insulin, 3-isobutyl-1methylxanthine (IBMX, a phosphodiesterase inhibitor), dexamethasone or hydrocortisone,
and troglitazone, which act to promote the upregulation of the key adipogenenic
transcription factors and genes80.

1.2.3.2.2

Osteogenic differentiation

Osteogenic differentiation of ASCs occurs in three stages starting with a proliferative phase
involving the formation of dense cell nodules, followed by matrix maturation involving the
synthesis and secretion of ECM (mainly collagen type I) and maturation into osteoblasts,
and finally matrix mineralization81. Several biochemical signaling systems are known to
play important roles during osteoblast development including the canonical Wnt and bone
morphogenic protein (BMP) signaling pathways81. Early in the differentiation process, the
commitment of ASCs into pre-osteoblasts is fulfilled by the runt-related transcription factor
2 (RUNX2), which functions as a master regulator81–83. A cocktail of hormones, growth
factors, and cytokines activates transcription of RUNX281–83. While the activation of
RUNX2 is critical, other genes, such as zinc finger-containing transcription factor osterix
(OSX), a transcription factor downstream of RUNX2, are important to sustain
differentiation towards the osteogenic lineage81–83. At this point, maturation of the preosteoblast ensues, along with the expression of osteogenic-specific genes such as bone
sialoprotein (BSP), osteopontin (OPN), alkaline phosphatase (ALP), osteonectin
(SPARC/ON), and osteocalcin (BGLAP/OCN), as well as the non-specific gene collagen I
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(COLL 1), which leads to immature matrix (osteoid) production and matrix mineralization
83

. It is important to note that mid-stage differentiation is characterised by the transcription

and protein expression of ALP, after which its level starts to decline before peaking again
prior to matrix mineralization84. A summary of the cascade of events is depicted in Fig.
1.2.

Figure 1.2: Transcriptional control of osteogenesis in vitro.
The differentiation of ASCs in vitro has been shown to depend significantly on the culture
conditions. Osteogenic differentiation of ASCs can be induced using a variety of media
supplements including beta-glycerophosphate, insulin, vitamin D, dexamethasone, and
ascorbate-2-phosphate in order to stimulate matrix deposition and mineralization. Each
supplement lends support at different stages along the osteogenic differentiation
pathway85,86.

1.2.3.2.3

The inverse relationship between osteogenesis and
adipogenesis

Given that adipocytes and osteoblasts are both derived from MSCs, differentiation
commitment between adipogenesis and osteogenesis is one that is delicately balanced87.
Substantial in vitro data points to an inverse relationship between adipogenesis and
osteogenesis, with adipo-inductive factors inhibiting osteogenesis and osteo-inductive
factors inhibiting adipogenesis87,88. This is also evident in the dysregulation of the adipoosteogenic balance being linked to several disease conditions such as obesity,
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osteopenia, osteopetrosis, and osteoporosis88–90. The maintenance of this balance can be
attributed to the tightly controlled intracellular signalling cascade with C/EBPs and
PPARγ regulating adipogenesis91 and RUNX2 regulating osteogenesis81. In vivo,
physical and biochemical cues from the ECM niche such as growth factors, matrix
stiffness, geometry and integrin-mediated adhesion and downstream signalling events
function to further maintain this balance87,88. Interestingly, the use of a growth factor,
bone morphogenic protein 2 (BMP2) at high concentrations promotes osteogenic
differentiation, while favoring adipogenic differentiation at low concentrations,
reiterating the presence of a delicate balance that is maintained when evaluating fatedecisions of differentiating MSCs87. In the context of designing tissue-specific MSC cell
delivery strategies, this inverse relationship can be exploited to understand the effects
of external factors (e.g. ECM composition) on MSC lineage-specific differentiation.

1.2.3.3

ASC donor variability

Recently, some studies have sought to examine the donor dependent behavior of ASCs,
which is important to assess if ASCs are to be considered for use as an autologous cell
source92–94. An increase in donor age has been shown to negatively impact the proliferation
of ASCs and cause cellular senescence95. Adipogenic differentiation potential has also been
shown to decline with age96. Interestingly, the osteogenic capacity of ASCs was reported
to be distinctly reduced in women aged above 37 years and was suggested as being linked
to a decline in estrogen levels in perimenopausal and menopausal women93. Estrogen is
known to regulate the differentiation of bone marrow-derived MSCs, and decreases in
circulating estrogen levels have been linked to a loss of stem cell osteogenic potential and
declined skeletal bone mass93. ASC donor health status and disease state are important and
increases in body mass index (BMI) have been shown to correlate with reduced
proliferation rates, and adipogenic differentiation capacity92,97. Given that these factors
could be working in synergy to affect ASC function, larger more defined studies are
necessary to draw tangible conclusions on the effects of donor variability on the proregenerative capacity of ASCs. In addition to intrinsic donor variability associated with
depot, age and disease state, outcome comparisons between several independent clinical
trials have indicated that the therapeutic efficacy of ASCs can be impacted by varying cell
isolation and culture methods of different research groups98. As such, standardization of
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the isolation techniques and expansion procedures is required in order to compare ASC
potency across experiments.

1.3

Design of cellular microenvironments

In order to successfully promote cell retention and function using a cell-based approach,
the carrier should fulfill some key design criteria99,100. Further, these criteria are also
important in the development of in vitro cell culture models for studying cell behavior.
First, the carrier microenvironment should ensure the maintenance of high cell viability
and long-term retention to stimulate a therapeutic response when administered101. Since
cell-environment interactions are instrumental in regulating cell behavior and function, it
is important that the carrier microenvironment provides structural and biological cues that
can regulate the cellular regenerative response1,102. For therapies aimed at regenerating
large defects in load bearing tissues such as cartilage and bone, carrier mechanical
properties (e.g. stiffness) are crucial to permit integration with surrounding tissue and
mitigate stress-shielding effects103. Further, ECM stiffness has been shown to play a crucial
role in modulating the lineage commitment of stem cells, when mimicked using hydrogels
with tunable mechanical properties104. For instance, in MSCs, softer substrates have been
shown to promote differentiation along the adipogenic lineage and stiffer substrates
towards the osteogenic lineage105,106. Other structural properties such as porosity and
topography can also mediate cell function by modulating cell-cell and cell-ECM
interactions that can influence adhesion, migration, proliferation and differentiation103,107.
Finally, it is important that the carrier microenvironment biodegrades into non-toxic byproducts, at a rate matched with the formation of new tissue, permitting remodeling over
time108. Apart from the aforementioned basic requirements, properties of cell carriers can
be further modified depending on the cell type, tissue type and application. This could
involve the design of vehicles that better represent the “niche” from which the cell type
originates. For example, in the context of strategies that are aimed at promoting in situ
differentiation of stem/progenitor cells, vehicles can be additionally designed to
incorporate cell instructive motifs such as purified or complex ECM proteins that could
potentially promote tissue-specific differentiation of transplanted cells and accelerate
regeneration109–112.
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Selected biomaterials and scaffold formats used for in vitro cell culture models and/or celltherapies will be described in detail in section 1.4.4. In general, materials used to design
microenvironments for cell culture and delivery can be classified as either naturallyderived (natural polymers and extracellular matrix (ECM) derived materials) or synthetic,
each having their own merits113. Synthetic polymers are attractive as they exhibit valuable
properties such as reproducibility in their scaled up preparation and the ability to be easily
modified and structurally tuned to suit specific application requirements114. However, some
synthetic polymers such as poly(ethylene glycol) (PEG) are limited in their
biodegradability and require the incorporation of additional constituents to promote cell
engraftment within the scaffold115,116. Due to their source, naturally-derived materials like
collagen, fibrin and hyaluronic acid (HA) can be degraded by cell-mediated proteases such
as matrix metalloproteinases (MMPs)117. Certain naturally-derived materials such as
chondroitin sulphate and HA have also been recently shown to exhibit ease in terms of
functionalization and modification to incorporate cross-linkable groups118. Hybrid bioscaffolds harnessing the strengths of synthetic and natural constituents represent promising
materials that can potentially combine the favorable physical properties and bioactivity of
each of these classes

116,119,120

. Amid increasing awareness of ECM properties and their

innate influence on cell behavior, there has been a growing emphasis on developing cellular
microenvironments that can replicate the complex milieu of the native tissue-specific
ECM9,121.

1.4
1.4.1

ECM and ECM-derived bio-scaffolds
Extracellular matrix

In vivo, cells are embedded within a protein- and polysaccharide-rich network known as
the extracellular matrix or ECM. The ECM also acts as a reserve of sequestered growth
factors that can be activated or released upon specific stimuli, interacting with cell-surface
receptors to modulate intracellular signaling1,102. While the ECM was initially considered
a passive network that provided structural support, it has been shown to be highly dynamic,
intricately organized in terms of structure and able to regulate a diverse range of cellular
processes such as attachment, survival, proliferation and differentiation in a reciprocal
manner122. In response to cues in the ECM, cells can secrete factors that alter or remodel the
environment, demonstrating this dynamic relationship between cells and their
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surroundings. In terms of composition and organization, the ECM of each tissue is unique
and is reflective of its specific functions1,102. The ECM is composed predominantly of (1)
structural proteins (e.g. collagen, elastin), (2) glycoproteins (e.g. laminin, fibronectin,
matricellular proteins), (3) glycosaminoglycans (GAGs) (e.g. chondroitin sulphate) and (4)
proteoglycans (e.g. biglycan, aggrecan)123,124. While ECM components are largely
conserved between tissue types and species, the amounts and organization of ECM
constituents determine the unique structure and function of each tissue.

1.4.1.1

Structural proteins

1.4.1.1.1

Collagens

Collagen is abundant (~30 % of total protein by mass in mammals) and the most ubiquitous
fibrous protein contained in every tissue of the body in varying amounts125,126. The primary
role of collagen is to provide structural integrity and tensile strength, but it is also able to
interact with cell-surface receptors regulating processes such as adhesion and migration125.
A total of 28 different types of collagen have been identified to date and can be classified
into (1) fibrillar (e.g. type I, II, III, V), (2) network forming or basement membrane (type
IV), (3) fibril-associated collagens with interruptions in their triple helices (FACIT) (e.g.
type IX, XII, XIV), (4) short chain collagens (e.g. type VIII, X), (5) anchoring fibrils (e.g.
type VII) and (6) other membrane-type collagens126,127. While each collagen classification
is unique in its composition, assembly and function within each specific tissue, all the
collagen types contain a common structural motif: the right-handed triple helical structure
comprised of three α-chain subunits125,128. Triple helix sequences in each α-chain are
comprised of glycine-X-Y amino acid repeats, with X and Y being frequently proline and
4-hydroxyproline, respectively and are stabilized by hydrogen bonds and electrostatic
interactions 129.
The structure of each type of collagen is unique to its purpose. For instance, the fibrillar
collagens, such as collagen I and II, are arranged in highly organized aggregates known as
fibrils crosslinked at the telopeptide regions by the enzyme lysyl oxidase126,129. Collagen
fibrils show a banding pattern with a periodicity (D-period) of 64–67 nm as a result of
individual collagen molecules staggered within the fibrils126. This fibril arrangement
imparts tensile strength to connective tissues that are required to withstand mechanical
stresses like tension, shear and pressure126,130. Collagen type I is the most abundant type
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found in adipose and bone tissue, while collagen type II is highly abundant in cartilage
tissue125,126,129. Type V collagen, which is a regulatory fibril forming collagen, occurs less
frequently in the ECM, but interacts with other fibrous collagens and structural proteins
conferring structural integrity. In adipose tissue, collagen type V is involved in regulating
matrix stiffness and adipocyte hypertrophy131. FACIT collagens do not form fibrils but are
associated with the surface of collagen fibrils. As the name suggests, they contain short
triple helical domains inter-dispersed with other non-triple helical and non-collagenous
domains132. Members of this collagen class associate strongly with collagen fibrils of different
types throughout the body, and are believed to have a regulatory role on fiber dimensions and
interactions132. Network-forming collagens (e.g. collagen type IV) form the most important
structural component of the basement membrane by assembling into mesh-works, as a
result of more flexible triple helix structures126,127. Additionally, the C-terminus contains
regions for dimers to form through disulfide linkages, causing collagen IV fibres to link
head-to-head at the C-terminus126,127. Collagen IV can be found in the lamina densa of skin,
as well as in the basement membrane surrounding adipocytes in adipose tissue125,127. Other
collagen types such as type VI, form a distinct network of beaded microfilaments that are
involved in bridging cell-ECM interactions and a broad range of cytoprotective effects
including regulating stemness and differentiation133. The importance of collagens as
structural reinforcements within the ECM can be appreciated by a range of disorders
associated with collagen absence or dysregulation 134,135.

1.4.1.1.2

Elastin

Elastin is a major component of tissues such as lung, skin and blood vessels, and endows
them with the long-range elasticity necessary (ability to stretch and recoil) for their
physiological functions136. The protein tropoelastin is the fundamental building component
of all elastins, and is produced intracellularly. Upon excretion into the extracellular space,
tropoelastin is crosslinked through the action of lysyl oxidase136,137. The newly-forming
elastin is introduced to existing microfibrils in the extracellular matrix by members of the
fibulin protein family and integrated into the network137,138. A microfibrillar glycoprotein
known as fibrillin interacts directly with elastin, forming a sheath and is important for its
assembly123. In articular cartilage, a network of elastin is contained in the interterritorial
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matrix of the surface zone and in the pericellular matrix139. In the intervertebral disc, elastin
fibers span the nucleus pulposus. A rich elastin network is also present in adipose tissue139.

1.4.1.2

Non-structural glycoproteins

Glycoproteins are involved in the cohesion of the ECM, functioning as adhesive
intermediaries that link components of the ECM to each other and promote cell attachment
to the matrix1. Two commonly studied glycoproteins are fibronectin and laminin, which
have been extensively used in biomaterial synthesis to enhance cell attachment and
survival123. Specific sequences on these glycoproteins are able to recognize and bind to
cell-surface adhesion molecules known as integrins to enable adhesion and regulate other
downstream processes140–142.

1.4.1.2.1

Fibronectin

Fibronectin is a large glycoprotein that is found in a wide variety of tissues and is involved
in directing the organization of ECM and plays a crucial role in mediating wound healing,
cellular adhesion and migration102,130. Within connective tissues, it is found as insoluble
fibers and exists as soluble molecules (plasma fibronectin) in body fluids, such as blood,
where fibril formation could be detrimental143. During healthy bone formation, osteoblasts
(cells that secrete bone ECM) produce both collagen type I and fibronectin144. In adipose
tissue, fibronectin assembly plays a key role in maintaining the fibrillar organization of
type I collagen145. Fibronectin is secreted primarily by fibroblasts in the form of a dimer
composed to two large subunits joined by disulphide bonds at the C-terminus130. Each
subunit contains multiple specific function domains and binding sites, with which different
cell types, cytokine and ECM components can interact simultaneously130,141. Each
polypeptide chain or subunit is composed of types I, II, and III repeat units146. Type I units
bind to fibrin, heparin or collagen. The type II units are collagen-binding domains and the
type III units bind to cell-surface receptors130. The tri-peptide arginine-glycine-aspartic
acid motif (RGD), an integrin-binding sequence derived from but not limited to fibronectin,
is located in the third module of fibronectin and functions as the site of cell attachment via
αvβ3 and α5β1 integrins on the cell surface147. Synthetic peptides with this sequence have
been successfully used to promote cell attachment, spreading and migration within a
variety biomaterial substrates for many different cell types, including ASCs115,148–151.
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1.4.1.2.2

Laminin

Laminin is a major component of the basement membrane, which is the thin sheets of
extracellular matrix that underlie epithelial and endothelial cells, surround cells in
muscle, adipose tissue, and nerve, and separate the dermis and epidermis in skin152,153.
The basement membrane fulfills a range of biological roles such as organogenesis, wound
healing and tissue repair, and it also functions as a growth factor reservoir152,153. Apart
from laminin, the basement membrane also contains proteins such as collagen type
IV, perlecan, agrin, and nidogens154. The structure of laminin is composed of three
polypepetide chains, consisting of one α, one β, and one γ chain in a cross- or T shape,
which self-assemble to form networks152,154. A total of 45 different laminin isoforms can
be assembled in principle123,155. Collagen type IV and laminin interact to form insoluble
networks that possess a primarily structural role, nidogens link the basement membrane
proteins together, and the glycosaminoglycan-containing perlecan and agrin contribute to
the matrix volume by attracting water and sequestering growth factors154,156. Similar to the
RGD sequence in fibronectin, the isoleucine-lysine-valine-alanine-valine motif (IKVAV),
derived from the laminin-α1 chain has been indicated to interact with integrins, modulating
cell attachment, proliferation and enabling the maintenance of cells in the differentiated
state154. Several studies have indicated the use of this and other laminin-derived motifs to
positively regulate MSC proliferation and differentiation157–160, with some also indicating
the ability for laminin isolates and laminin-derived sequences to promote attachment and
differentiation for adipogenesis159,161–163.

1.4.1.3

Glycosaminoglycans

Glycosaminoglycans (GAGs) are linear unbranched polysaccharides, with disaccharide
building blocks made of an amino sugar (glucosamine that is N-acetylated or N-sulfated
or N-acetylgalactosamine) that is linked by a glycosidic bond to a uronic acid (glucuronic
acid or iduronic acid) or galactose164,165. Being highly anionic, GAGs are able to attract
and trap water as well as sequester growth factors and cytokines, while maintaining a low
compressibility, functioning as lubricants and shock absorbers in the joints164–166. Apart
from their contribution to withstanding mechanical loading in the joints, GAGs are also
involved in modulating a range of cellular functions including adhesion, growth, differentiation
and even angiogenesis as a result of their affinity to cell adhesion molecules and matrix
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components165. Overall, GAGs can be classified into two main types: sulphated GAGs (e.g.
chondroitin sulphate (CS), dermatan sulphate (DS), keratan sulphate (KS), heparin and
heparan sulphate (HS)) and non-sulphated GAGs (e.g. hyaluronic acid)164–166. Further
distinctions can be noted with regards to the type of hexosamine or hexuronic acid unit
contained, as well as the geometry of the glycosidic linkage between the two units of the
disaccharide building block164,165. To illustrate the importance of GAGs in a range of
cellular processes, a study involving mice deficient in glycosyltransferases or
sulfotransferases involved in the biosynthesis of GAGs, showed defects in early
embryogenesis167. GAGs are abundantly expressed in bone tissue and evidence indicates
that osteoblasts rely on GAGs for cell attachment and mineralization, possibly through
GAG-sequestered growth factors168–170. A range of studies have also indicated the success
for GAGs used as coatings or as part of hydrogels to encourage the osteogenic
differentiation of seeded/encapsulated MSCs171–174.

1.4.1.4

Proteoglycans

Proteoglycans are a class of glycosylated proteins comprised of one or more sulphated
GAG chains that are covalently attached to a core protein1. While they are widespread in
most tissues, they are a predominant component of cartilage ECM175. Proteoglycan
structures are diverse with many core protein species and unique glycosylation
patterns176,177. Extracellular matrix proteoglycans can be divided into two major groups:
(1) hyaluronan- and lectin-binding proteoglycans (hyalectans) and (2) small leucine-rich
proteoglycans (SLRPs)176,177. The hyalectans contain a large protein core and are defined
by an N-terminal domain that binds hyaluronic acid, a central domain harboring the GAG
side chains, and a C-terminal region that binds lectins176–178. The most commonly studied
example is aggrecan, the major proteoglycan species present in cartilage tissue175. The
SLRPs designate a class of proteoglycans characterized by a relatively small protein core
(as compared to the larger aggregating proteoglycans) and encompass a central region
constituted by leucine-rich repeats (LRRs)179. SLRPs are localized in most skeletal regions
and play a major role during all phases of bone formation, including cell proliferation,
organic matrix deposition, remodeling, and mineral deposition179,180. Examples include
decorin and biglycan176–178. Given the vital role of GAGs and SLRPs in bone
morphogenesis and homeostasis, modifications in their expression have been implicated in
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diseases such as osteoarthritis180. The major biological function of proteoglycans derives
from the physicochemical characteristics of the GAG side chains, which provide hydration
and swell, enabling tissues to resist compression178. For example, loss of proteoglycans in
cartilage tissue is observed in various forms of arthritis, a sign of cartilage dysfunction178.

1.4.2

Adipose tissue function and ECM composition

Adipose tissue is a form of loose connective tissue which plays a central role in energy
homeostasis, maintaining a systemic equilibrium of energy intake and expenditure66,181. It
also functions to provide structural support and is an important regulator of body
temperature, providing insulation66,181. Adipose tissue is distributed within subcutaneous
regions and visceral depots, including in the epicardial and intramuscular regions, as well
as within the bone marrow. Two fundamental types of adipose tissue have been identified:
white adipose tissue (majority of adipose tissue in adults) and brown adipose tissue
(abundant in small mammals and neonates), which are distinct in terms of color, presence
in the body, and function, as well as cellular morphology and structure63. White adipose
tissue (WAT) stores energy reserves in the form of triglycerides, releasing fatty acids in
response to energy demands, while the metabolic function of brown adipose tissue (BAT)
is the oxidation of lipids to produce heat63. Recently, WAT has also been proven to be an
active endocrine organ secreting a wide array of hormones, referred to as adipokines to
maintain homeostasis182. As a result of its high prevalence and ease with which it can be
obtained, WAT has been the most studied and utilized source of ASCs and adipose-derived
extracellular matrix63,182.
As previously discussed, each tissue is unique in its ECM composition and arrangement,
giving rise to its specific function. It was first reported based on electron microscopy that
the adipose tissue ECM structure incorporated a dense network of collagen fibres183. The
improvement of immunohistochemical techniques and proteomic analyses have further
elucidated the components of adipose tissue ECM184,185. Adipose tissue ECM is enriched
with collagenous proteins (collagen types I-VI), with collagen type I and IV being the most
abundant66,186. In addition, adhesive glycoproteins such as laminin and fibronectin along
with GAGs and various proteoglycans (e.g. decorin) maintain adipose tissue integrity,
structure and function187,188. Mature adipocytes are surrounded by basement membrane
enriched in collagen IV and laminin. These proteins also line the supporting vascular
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structures187. Collagen type V and VI are known to associate with collagen type IV to
mediate anchoring of the basement membrane to the cells, serving to organize the ECM
and regulating adipocyte hypertrophy145,189. Adipose tissue ECM also sequesters growth
factors such as hepatocyte growth factor (HGF), fibroblast growth factor (FGF), insulin
like growth factor 1 (IGF-1) and vascular endothelial growth factor (VEGF) that are
released in response to stimuli to regulate angiogenesis, adipocyte differentiation and
overall adipose tissue homeostasis190–192.

1.4.3

Bone tissue function and ECM composition

Bone is mineralized connective tissue that plays a vital role in routine functions of the body
such as movement, locomotion and the protection of soft tissue and vital internal organs175.
In addition, it provides maintenance of mineral homeostasis (calcium and phosphate
regulation), serves as a reservoir of growth factors and provides an environment for bone
marrow storage and hematopoiesis175,193,194. Contrary to its inert appearance, bone is a
highly dynamic tissue that is constantly being remodeled in response to mechanical
loading175,193,194. Osteocytes or mature bone cells act as mechano-sensors and function in
combination with osteoblasts (“bone builders”) and osteoclasts (“bone destroyers”) to
facilitate the remodeling process195. Osteoblasts are derived from differentiated MSCs,
with MSC commitment requiring the expression of specific transcription factors such as
RUNX2 and aided by resident BMPs196–198. The predominant function of osteoblasts is to
secrete bone matrix, with the initial phase involving the deposition of collagen type I and
proteoglycans, followed by matrix mineralization195,199. Native bone tissue can be
classified as either cortical (compact) or cancellous (trabecular) bone and the adult human
skeleton is made up of 80% cortical bone and 20% cancellous bone175,200. Cortical and
cancellous bone are distinct in terms of their macromolecular structure, giving rise to their
unique functions. Cortical bone is dense with low-porosity, whereas cancellous bone
exhibits a honeycomb-like network interspersed in the bone marrow compartment175,200,201.
The ECM of bone is predominantly made up of inorganic material (~70%) consisting of
hydroxyapatite that provides bone with mechanical reinforcement and the ability to resist
compressive forces and loading175,193,202. The organic component of bone ECM (~20%) is
comprised of collagen type I, III, V, XII, as well as proteoglycans (e.g. aggrecan, decorin),
glycoproteins (e.g. fibronectin, vitronectin) and other matrix proteins such as osteocalcin,
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osteonectin and bone sialoproteins175,200,202. Collagen type I is the predominant protein in
bone ECM and non-collagenous proteins such as osteocalcin and osteonectin contribute to
the stabilization of amorphous calcium phosphate and the assembly of hydroxyapatite on
the freshly synthesized collagen type I (osteoid) to form mineralized matrix203,204. In both
cortical and trabecular bone, collagen fibrils are laid down in alternating orientations
known as a lamellar pattern, which is evident when visualized under a polarized light
microscope as a result of birefringence203. This lamellar pattern and nano-composite
structure (tough and flexible collagen fibers reinforced by hydroxyapatite crystals) is
integral to the requisite compressive strength and high fracture toughness of bone199. Bone
matrix also comprises a reservoir of growth factors, such as transforming growth factor-β
(TGF-β), insulin-like growth factor-1 (IGF-1), bone morphogenetic proteins (BMPs),
platelet-derived growth factors (PDGFs), and cytokines such as interleukin-1 (IL-1), IL-6
and colony-stimulating factors205. The structural components of the ECM serve to regulate
the bioavailability of these growth factors, maintaining bone homeostasis175,206.

1.4.4

ECM-derived bio-scaffolds

As mentioned previously, the ECM is a structurally and functionally specialized
environment for each tissue type, providing a mechanical framework facilitating processes
like cell adhesion and migration, as well as a bioactive substrate for cell signalling and
mediating intracellular processes such as proliferation and differentiation1. Recognising
the intricacy of the ECM in mediating cell function, the contemporary strategy employed
for the design of cellular microenvironments for in vitro cell culture and delivery is to
identify and reconstruct vital elements of the ECM in order to promote a regenerative
response115,158,160,207,208. For this purpose, various bottom-up strategies using materials
modified with mechanical reinforcements, growth factors, cell adhesive peptides and
ECM-derived molecules have been meticulously designed9,209–211. As this approach has
proven to be challenging, the use of decellularized tissue bio-scaffolds has emerged as a
promising option to exploit the innate functions of the ECM13,212.
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1.4.4.1

Tissue decellularization

Decellularization of tissues involves the selective removal of immunogenic cellular
components, while preserving the tissue-specific ECM ultrastructure and biochemical
composition as much as possible212,213. A range of tissue types including small intestinal
submucosa (SIS), urinary bladder, dermal tissue, adipose tissue, bone tissue and blood
vessels, have been decellularized using protocols that are specifically and carefully tailored
to the tissue of interest184,207,213–216. In addition, more than 30 off-the-shelf bio-scaffolds
have been commercialized and received FDA approval for clinical use such as
decellularized human dermis (Alloderm®, LifeCell), porcine heart valves (Synergraft®,
Cryolife) and porcine urinary bladder (Urinary bladder matrix, ACell)217,218. A growing
body of research has been focused on evaluating the in vitro and in vivo cell and functional
responses to the resulting bio-scaffolds enriched in structural and functional proteins. For
instance, utilizing decellularized porcine urinary bladder for esophageal repair in a
preclinical dog model facilitated a constructive, non-stenotic healing response with the
formation of all layers of the esophageal wall that were functional and innervated219. A
recent study demonstrated xenogeneic porcine SIS bio-scaffolds used to treat volumetric
muscle loss in mice and human patients promoted de novo blood vessel and skeletal muscle
formation accompanied by overall improved function220. In assessing cell-seeded
decellularized bio-scaffolds in a murine excisional wound model, decellularized porcine
SIS bio-scaffolds significantly improved ASC survival and proliferation relative to cell
delivery without a scaffold based on bioluminescence imaging of seeded donor murine
ASCs221. These studies collectively suggest the potential of using ECM-derived bioscaffolds as a design element within cell culture models and cell delivery platforms.

1.4.4.2

Decellularization methods

The methods for decellularization can be tailored depending on the properties of the tissue
of interest and its constituents (e.g. cellularity, ECM density and lipid content,
morphology), as well as the downstream requirements for scaffold design and final
application217. Depending on the requirements, decellularization can either be performed
on whole organs via perfusion through an existing vascular network of the tissue/organ, or
by dissecting tissues into smaller sections and agitating in the respective reagents212,217.
Decellularization of tissue sources typically involves mechanical, chemical, and enzymatic
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strategies used either separately or in combination to remove the cellular components while
striving to maintain the general molecular composition and ultrastructure of the
ECM13,217,222. It is important to recognize that each method will invariably alter ECM
composition and cause some degree of ultrastructure disruption, depending on the tissue
type and decellularization method utilized.
Mechanical and physical methods of decellularization involve the use of either (1)
temperature in terms of freeze-thaw cycles that are able to lyse cells or (2) physical pressure
and force, such as using hydrostatic pressure in combination with enzymes and/or
hypotonic saline solutions that ultimately aid in the breakdown of cells and the elimination
of cellular debris13,217,222. Enzymatic methods used in protocols typically include trypsin,
lipase, and nucleases that are effective due their specificity towards components that
require

disruption

respectively13,217,222.
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as
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ethylenediaminetetraacetic acid (EDTA), help to cleave cell-cell and cell-ECM receptors,
while nucleases (e.g. DNAse and RNAse) cleave trapped nucleic acids resulting from cell
lysis 13,217,222. Chemical methods of decellularization involve the use of acids or bases, as
well as detergents that can disrupt cell membranes and dissociate nucleic acids from
proteins13,217,222. The use of acids and bases, while effective, can cause disruption of
collagen structure and eliminate sequestered growth factors from the ECM213. However,
certain tissue types such as bone contain mineral components that necessitate the use of
acids223. Detergents such as sodium dodecyl sulphate (SDS) and Triton X-100 are
commonly used for the decellularization of dense tissues such as heart, cartilage and
dermis, in which enzymatic and osmotic methods are insufficient to extract the majority of
cells and cellular components224–226. However, losses in soluble proteins like GAGs,
fibronectin, and laminin, as well as changes in ultrastructure have been reported with the
use of detergents224,225,227. In addition, another important concern is the possible
cytotoxicity caused by residual detergents trapped within the tissues225,228.
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1.4.4.3

Assessment of decellularization

Although the goal in decellularization is to remove nuclear content while retaining the
structural, biochemical and biomechanical cues to the best possible extent, the choice of
extraction method can cause modifications in the ECM microstructure, composition and/or
mechanical properties13,228–230. This emphasizes the need for detailed evaluation of the
tissues post-decellularization for not just nuclear content, but also key structural and
bioactive components when developing a protocol for decellularization. Since
decellularization techniques cannot remove 100 % of nuclear content, it is important to
both qualitatively and quantitatively evaluate intracellular molecules such as double
stranded DNA (dsDNA)231. Remnant cellular materials, depending on the concentration
and tissue type can elicit a negative immune response when implanted in vivo, and based
on adverse cell and host response investigations, the minimal criteria suggested for
decellularized materials includes (1) <50 ng dsDNA per mg ECM dry weight and (2) lack
of visible nuclear material in tissue sections stained with 4’,6-diamidino-2-phenylindole
(DAPI)217,232. To assess the presence of cell remnants, DAPI staining is often coupled with
DNA quantification with the Quant-iTTM PicoGreen® dsDNA kit231. In assessing the
structural and compositional integrity of the resulting ECM, immunohistochemical
techniques, enzyme-linked immunosorbent assays (ELISAs) and Western blotting
techniques are helpful to visualize and identify key ECM constituents (e.g. collagen I, IV,
laminin, fibronectin) and growth factors184,194,214. The emergence of proteomic techniques
have further allowed for the in-depth characterization of decellularized ECM185,233.
Biochemical quantification of collagen and GAG content using the hydroxyproline and
dimethyl methylene blue (DMMB) assays further help to characterize the resulting ECM.
Scanning electron microscopy techniques and mechanical testing enable visualization of
collagen ultrastructure and assessment of ECM mechanical properties respectively184,234–
236

. The final decellularized ECM is highly dependent upon the choice of reagents,

treatment methods and time frame over which the decellularization is performed.

1.4.4.4

Adipose tissue decellularization

Recently, several groups have examined the use of decellularized adipose tissue as a
bioactive template for treating soft tissue defects, both as a construct that promotes fat
regeneration and in combination with cells such as ASCs184,232,234,237. Since human adipose
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tissue is routinely discarded as surgical waste, it provides a convenient alternative to
xenogenically-sourced and synthetic materials. The resulting adipose tissue ECM postdecellularization is enriched with collagen types I-VI, laminin, fibronectin, elastin, GAGs,
and proteoglycans, in addition to other soluble growth factors and matricellular proteins
that may contribute to its bioactivity185,238,239.
Adipose tissue decellularization protocols mostly involve the combined use of physical,
chemical and biological treatment stages. The Flynn lab pioneered adipose tissue
decellularization, developing a novel detergent-free method184. More specifically, the
method uses a combination of freeze/thaw cycles, washes in hypotonic solutions, trypsinEDTA, and isopropanol, as well as DNase and RNase treatments to yield an intact bioscaffold with preserved extracellular matrix architecture184. The resulting decellularized
adipose tissue (DAT) included conserved basement membrane proteins and was recently
shown to contain a range of growth factors and matricellular proteins associated with
adipogenesis185,239. In vivo implantation of DAT and ASCs within Wistar rats showed
enhanced angiogenesis and adipogenesis, with ASCs modulating the pro-regenerative
immune response57. Most other groups investigating adipose decellularization use
detergents such as SDS, Triton X-100 or sodium deoxycholate to ensure sufficient removal
of cellular components by destabilizing the cell membrane and enabling cell lysis234,237.
Choi et al. homogenized human adipose tissue lipoaspirate samples prior to
decellularization, increasing its surface area before subjecting the slurry to SDS treatment,
followed by nucleic acid elimination using DNAse and RNAse237. Wang et al. subjected
adipose tissue to freeze-thaw cycles to aid cell lysis, followed by a series of incubations in
trypsin/EDTA to release cells, isopropanol to extract lipid and finally 1% TritonX-100 as
a means to remove cellular content from subcutaneous human adipose tissue234. Although
decellularized ECM obtained from these protocols promoted host cell infiltration and fat
formation when implanted in mice, the use of a detergent-free protocol may be superior as
it avoids potential cytotoxicity due to residual detergent that may be difficult to extract at
the end of processing234.
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1.4.4.5

Bone tissue decellularization

Following pioneering work in 1984, demineralized bone matrix (DBM) is now a medically
approved alternative used successfully in treating bone defects194. In general, the bone
demineralization process also leads to its decellularization and removal of cellular
content194,240. Typically, the decellularization process for bone comprises the extraction of
bone marrow using chemical detergents to solubilize the cellular membrane, blood and
lipids, followed by optional antibiotic soaks, acid demineralization and freeze-drying241.
The resulting product is a composite of predominantly type I collagen, non-collagenous
proteins and growth factors, such as bone morphogenetic proteins (BMPs), IGF-1 and
growth factors from the TGF-β family240,242,243. This makes the DBM not only osteoconductive, but also osteo-inductive for potential use in a clinical setting. More than 15
commercially-available and FDA-approved DBM products are available in the market,
each in a variety of forms including powders, sponges, strips, injectable putty and pastes244.
The most popular DBM format is a flexible putty consisting of powdered DBM within a
water soluble polymer or water miscible solvent. The putty form allows for the filling of
irregular defects245. Several in vivo studies (pre-clinical and clinical) have demonstrated
enhanced revascularization, bone formation, integration and healing due to the use of DBM
separately and also within autologous bone grafts243,246–248.
Inspired by the commercial DBM, several groups have focused on examining the role of
decellularized bone tissue in mediating cellular processes such as attachment, proliferation,
differentiation, immunomodulation and overall tissue repair and regeneration215,247,249–251.
In order to do this, customized bone decellularization protocols have been developed and
processed accordingly to suit the application of each group, with the majority of groups
focused on decellularizing cancellous (trabecular) bone due to its ease of procurement and
osteo-inductivity194,241. For example, in a patented process, porcine femoral trabecular
bone was delipidated in pure acetone, followed by a decellularization step using trypsin
and finally a rinse in acetone before being crosslinked and used as a scaffold coated with
bioactive glass252. Constructs implanted within Sprague–Dawley rats showed enhanced
cell infiltration, neovascularization and newly formed tissue within 8 weeks252. Sawkins et
al. demineralized bovine cancellous bone in hydrochloric acid, followed by a lipid
extraction in chloroform and methanol and finally decellularized in trypsin and EDTA215.
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The resulting decellularized bone fragments were pepsin-digested into hydrogels and
supported mouse primary calvarial cell survival and proliferation215. Other methods have
recently emerged including the use of hydrostatic pressure to decellularize porcine bone
developed and utilized by Hashimoto et al.253 The scaffolds enhanced the osteogenic
differentiation of rat MSCs in the absence of exogenous factors in vitro and exhibited
cytocompatibility when subcutaneously implanted within Wistar rats253. A non-exhaustive
list of bone decellularization protocols explored in the literature can be found in Table 1.2.
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Table 1.2: Trabecular bone decellularization protocols.
Reference

Detergent

Species

Key steps

Gardin et al.254

Bovine

Chen et al.255

Porcine

1. Four freeze thaw cycles (-196 °C to 121 °C) in
deionized water (dH2O); freeze cycles lasted
16 h and thaw cycles 20 min
2. Incubate blocks in 1% Triton X-100 for a total
of 24 h
3. Rinse in dH2O twice for 24 hr each to extract
detergent
1. Bone disks were soaked in dH2O at 4 °C
overnight
2. Incubate disks in 1% Triton X-100 for 48 h
3. Extract lipid in a mixture of methanol/methane
for 24 h
4. Incubate in DNase for 2 h and ethanol for 4 h
1. Bone digested in 0.5% SDS and 0.1%
ammonium hydroxide at room temperature
for 3 weeks and replaced every 36 hr
2. Repeatedly wash in dH2O to extract residual
SDS
1. High pressure water jet to extract bone marrow
2. Incubation in 0.1 % w/v EDTA and 10 mM
Tris at 4 °C overnight
3. Incubation in 10 mM Tris and 0.5% sodium
dodecyl sulfate for 24 hr
4. Extensive rinses in PBS and digest for 5 h in
DNase and RNase
1. Mineral extraction in 0.5 N HCl for 24 hours
2. Lipid extraction in chloroform/methanol (1:1)
for 1 h
3. Trypsin (0.05 %) /EDTA (0.02 %) incubation
for 24 h
1. Bone was hydrostatic pressurized at 980 MPa
at 30 °C for 10 min using propylene glycol as
a fluid
2. Samples were then rinsed in DNase for 3
weeks
3. Samples were rinsed at 80 % ethanol for 3 d
1. Ground into particles and sieved to obtain
particles < 710 µm in size
2. Mineral extraction in 0.5 N HCl (50 mL/g of
powder) for 3 h
3. Rinsed multiple times in PBS and dH2O

Lee et al.223

Rat

Hung et al.256

Bovine

Sawkins at al.215

Bovine

Hashimoto et al.253

Porcine

Pietrzak et al.257,258

Human

Detergent
-free
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1.4.4.6

Decellularized ECM processing

Several studies have demonstrated the potential of intact decellularized ECM bio-scaffolds
to provide physiologically relevant ultrastructural features (e.g. intact basement
membrane) and composition that aid tissue repair. However, this also results in challenges
pertaining to the defined geometry and natural heterogeneity of the tissue that may cause
variability in cell attachment and distribution during cell seeding259,260. Further, intact
decellularized ECM presents limitations in terms of its in vivo delivery and the inability to
tailor scaffold properties such as porosity, shape and configuration narrows their utility10.
Aimed at increasing versatility, several groups have developed methods to fabricate
powders, pastes, hydrogels, foams, microcarriers, and sheets using decellularized ECM as
a base16,58,261–264.
The most common methods of ECM processing involve mechanical (e.g. mincing, milling)
and enzymatic (e.g. pepsin) means to obtain processed ECM that can be utilized in an
injectable form or incorporated within other biomaterials as a cell-instructive
component15,234,262. The mechanical modification of decellularized tissues into micronized
particles represents a simple technique where decellularized ECM is flash frozen and
micronized using a cryo-milling apparatus. Modifying parameters such as speed, time and
sieving after milling, can produce particles of a range of sizes, with different size ranges
shown to affect downstream cellular processes262. This technique allows for micronized
particles to be used directly as a paste, or incorporated as a cell-instructive component
within composite bio-scaffolds265,266. Cryomilled decellularized ECM from human adipose
tissue in a suspension along with hASCs when injected into Fischer 344 rats
subcutaneously, contributed to fat formation within 4 weeks with cell tracking indicating
the retention of transplanted cells and their contribution to the regenerative response234. In
the context of bone regeneration, the injection of commercial demineralized bone matrix
in the form of a putty enhanced neo-bone formation through endochondral ossification as
seen by higher bone mineral density and larger trabecular bone volume as compared to
untreated controls in a rabbit tibial model of distraction osteogenesis267.
Enzymatic digestion is a highly versatile method by which ECM can be processed into a
wide range of formats such as coatings, injectable hydrogels, foams, microcarriers and
bioinks16,17,215,268. Common enzymatic digestion methods involve acid-assisted digestion
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with pepsin as well as acetic acid-assisted dispersion of ECM using a-amylase. Pepsin is
the most common enzyme used to digest ECM, resulting in soluble peptide fragments that
can be used to create hydrogels through thermally-induced gelation or crosslinked into
stable constructs264,269,270. Pepsin-digested ECM hydrogels from various tissues have been
shown to promote in vitro cell survival and differentiation in some cases, as well as
enhanced tissue repair in vivo15,215,270,271. A substantial amount of work in the Flynn lab has
focused on the decellularization of various tissue types such as adipose, cartilage, bone,
myocardial and dermal tissue. Some of these tissue types have been processed with aamylase to fabricate porous foams and microcarriers16,58,272,273. In our approach, collagen
fibrils are preserved following a glycosidic cleavage of carbohydrate groups within the
telopeptide regions, rather than the non-specific proteolytic cleavage that occurs when
using pepsin274. DAT processed with a-amylase and processed into foams has been shown
to demonstrate adipo-inductive properties for human ASCs and promote adipogenesis both
in vitro and in vivo58. Most recently, DAT microcarriers fabricated with a-amylasedigested DAT successfully enhanced the initial attachment and subsequent expansion of
human ASCs compared to commercially obtained Cultisphere-S microcarriers and tissue
culture plastic, with ASCs retaining their immunophenotype and differential potential272.
While processing can increase overall ECM utility, some forms of processing can damage
or destroy the complex structural components and alter the biomechanical properties of the
ECM to varying degrees. However, the varied effects of processing on resulting ECM
bioactivity and subsequent cellular responses remains unclear and relatively unexplored.

1.5

Hydrogel bio-scaffolds

In addition to being used to fabricate standalone scaffold formats as mentioned in section
1.4.4.6, processed decellularized ECM has also been incorporated within a range of
materials to serve as cell-instructive components, the most common being
hydrogels15,262,266,275,276. Hydrogels are three-dimensional (3-D) hydrophilic materials of
either synthetic or natural origin that can absorb and retain large amounts of water277,278.
They are able to maintain their structural integrity as a result of either physical interactions
(chain entanglement, ionic interactions, hydrophobic interactions and hydrogen bonding)
or chemical bonds277,278. Hydrogels in their hydrated state resemble natural soft tissues and

30

allow for the permeability of oxygen, nutrients and other water-soluble metabolites,
making them effective vehicles for cell delivery9. Further, when chemically modified they
allow for the manipulation of physical and mechanical properties to suit the application279.
Specifically, for irregular tissue defects, hydrogels can be cross-linked outside the body
into a variety of shapes depending on the topography, size and shape of the tissue defect or
designed to allow for the clinician to inject the pre-polymer/cell suspension directly at the
site through minimally invasive means, followed by in situ crosslinking277,280–282. The latter
is particularly beneficial in terms of the homogenous dispersion of cells throughout the
defect, as well as cell encapsulation in situ under physiological conditions262,266.
Most synthetic polymers for use as hydrogel building blocks offer advantages in terms of
their controllable and reproducible chemistries, which can be harnessed to tailor the
mechanism of gelation279,283. For instance, PEG can be crosslinked by incorporating
acrylate and methacrylate groups that can be photo-polymerized using an appropriate
photo-initiator and UV source149,284. PEG-based and other synthetic hydrogels such as
poly(vinyl alcohol) (PVA) have also shown their versatility by allowing the easy bioactive
modification with adhesive peptides (e.g. RGD and IKVAV motifs) and incorporation of
enzyme-cleavable domains to tailor scaffold degradation116,285,286. Naturally-derived
hydrogels on the other hand, can represent the ECM at a simplistic level, with hydrogels
made of collagen, gelatin and polysaccharides like chondroitin sulphate and hyaluronic
acid that are key compositional elements of the native ECM210,287–289. As compared to
certain synthetic materials, they provide enhanced bioactivity, and degrade into byproducts that may be more easily metabolized by the body and have bioactive
effects117,279,283. For example, collagen hydrogels have gained popularity chiefly due to the
abundance of collagen in the ECM of all tissues. They are able to provide naturally
occurring adhesive peptides (e.g. Arg–Gly–Asp sequences) for integrin-mediated adhesion
and signaling, and can be degraded by MMPs in vivo290. Polysaccharides such as chitosan,
chondroitin sulphate and hyaluronic acid are particularly suitable due to their biochemical
resemblance to GAGs in the ECM291 and reactive functional groups (e.g. amine, carboxylic
and hydroxyl groups) that can be utilized as sites to attach functional groups that induce
crosslinking upon response to specific stimuli (e.g. pH, temperature, light)289,291. Selected
polysaccharide and glycosaminoglycan-based hydrogels will be discussed in detail in the
subsequent sections.
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Owing to the plethora of biochemical, structural and biomechanical factors in the ECM
that work in synergy to maintain tissue homeostasis, the design of in vitro cell culture
models that apply hydrogels has been recently extended towards trying to replicate this
complexity, with a large focus on improving bioactivity through the addition of naturallyderived cell-instructive components. For instance, hydrogel phases have been decorated
with one or many matrix-derived molecules such as ECM-derived proteins (e.g. collagen,
laminin, elastin, fibronectin, vitronectin), adhesive peptide sequences and growth factors
that have been shown to potentially aid attachment and differentiation for a range of
applications7,292–294. With the advent of decellularization, the incorporation of
decellularized ECM (e.g. adipose, cartilage, meniscus and tendon tissue) in a particulate or
variably processed liquid format within base hydrogel materials has been explored to
recapitulate the cocktail of ECM cues in the native ECM111,266. These methods have yielded
promising results with ECM from tissue-specific sources promoting stem/progenitor cell
proliferation and differentiation261,266,295–297. Previous work in our lab has shown the ability
of decellularized ECM particles within methacrylated chondroitin sulphate and
methacrylated glycol chitosan to promote adipogenesis in encapsulated human ASCs261,262.
Interestingly, some focus has shifted towards assessing effects of ECM processing on the
retention of bioactivity and consequent cell response within these hydrogel formats due to
some types of ECM processing preserving the structural and bioactive cues more than
others264,297.

1.5.1
1.5.1.1

Polysaccharide/Glycosaminoglycan hydrogels
Chondroitin sulphate

Chondroitin sulphate (CS) is a sulphated GAG, consisting of repeating D-glucuronic acid
and N-acetyl galactosamine disaccharide units, sulphated at either the 4- or 6-position298.
In the human body, CS is an important structural component of cartilage ECM,
predominantly enabling the accumulation of water and resisting compressive stresses175. It
also plays a role in maintaining chondrocyte phenotype and general ECM homeostasis299.
From a biological perspective, CS and CS disaccharides exhibit pro-angiogenic and antiinflammatory properties300,301, as well as water and nutrient absorption298. For tissue
engineering applications, CS and CS derivatives are commonly used to form biocompatible
hydrogels through various chemical or photo-crosslinking methods302. The pendant
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hydroxyl groups function as sites to conjugate polymerizable moieties such as methacrylate
groups and aldehydes302. These polymerizable moieties can be either crosslinked using
stimuli such as light, or change in temperature or pH when used with appropriate initiator
systems302. For example, Li et al. reported the functionalization of CS with
photopolymerizable methacrylate groups, forming methacrylated chondroitin sulphate
(MCS) that enabled the encapsulation of chondrocytes within UV-crosslinked MCS
hydrogels289. Evaluating the efficacy of MCS for use in cartilage tissue engineering,
photopolymerized MCS was implanted subcutaneously within athymic mice, in a rabbit
articular chondral defect model and a larger femoral condyle model in goats302. After 5
weeks, MCS hydrogels integrated well with the surrounding tissue in the mouse model,
with the accumulation of functional cartilage tissue. In the larger goat model, MCS
hydrogels enhanced tissue repair and ECM remodelling over a period of 6 months as
compared to untreated defects302. Our laboratory has focused on harnessing the innate
biological and functional potential of MCS to develop multifunctional platforms that
support ASC viability and adipogenic differentiation. Photopolymerized MCS hydrogels
with and without DAT ECM particles, have been shown to promote adipogenic
differentiation of encapsulated human ASCs, which may be related in part to promoting a
rounded ASC phenotype that is conducive for adipogenic differentiation261,262. Further, this
MCS based platform has been used to explore parameters such as cell density, DAT particle
size and DAT concentration on the viability, proliferation and adipogenic differentiation
of ASCs262. Finally, it has been proven a versatile hydrogel platform with the ability to
encapsulate other ECM derivatives such as decellularized cartilage using both thermal and
UV-mediated crosslinking mechanisms265.

1.5.1.2

Chitosan

Chitosan is a linear polysaccharide of N-acetyl-glucosamine and N-glucosamine obtained
from the partial deacetylation of chitin, which is derived from the shells of crustaceans303–
305

. Chitin by itself is not readily applicable for use as a hydrogel base material due to its

high level of acetylation, rigid structure and poor solubility in aqueous solutions303.
Chitosan-derived materials have been widely studied over the past two decades due to their
intrinsic antimicrobial properties304 and ability to promote cell viability303, and to have byproducts of degradation which are recognized by human enzymes305. The amine and

33

hydroxyl groups on chitosan chains can be harnessed for chemical and photo-induced
cross-linking by introducing azide and methacrylate moieties306. Composite hydrogels
fabricated from chitosan derivatives have been integrated with bio-instructive constituents
such as collagen and gelatin to improve cell adhesion and viability for a range of
applications such as bone, cartilage and adipose tissue engineering109,307–309. Previously,
Cheng et al. developed a thermosensitive composite chitosan-gelatin hydrogel to
encapsulate human ASCs that maintained high cell viability, with ASC laden hydrogels
showing enhanced cell retention and neovascularization in a murine model of cutaneous
wound healing310. In another study, thermally crosslinked chitosan-glycerol phosphate
hydrogels incorporating decellularized human adipose tissue supported human ASC
viability over 14 d and promoted angiogenesis when implanted within a subcutaneous
mouse model311.

1.5.1.3

Hyaluronic Acid

Hyaluronic acid (HA) is a high molecular weight non-sulphated GAG in the extracellular
matrix (ECM) of many soft connective tissues, composed of alternating units of Dglucuronic acid and N-acetyl-D-glucosamine312,313. In most tissues, HA contributes to the
mechanical integrity and viscoelasticity of the ECM network by absorbing large amounts
of water, facilitating expansion of up to 1000 times in volume313. Apart from this, HA also
functions as a lubricant, osmotic buffer and regulates many cellular processes through its
binding with cell surface receptors (e.g. CD 44), activating signaling pathways that direct
cell functions like adhesion, migration and differentiation314. The principal target sites for
chemical modification in HA are the carboxylic, hydroxyl and the N-acetyl groups
(following deamidation), that allow for hydrogel formation through either chemical or
initiator-based crosslinking methods312,313. HA derivatives have been extensively studied
for use in cartilage and bone tissue engineering, as well as for sustained drug
delivery119,315,316. HA supplemented within poly(lactic-co-glycolic acid) (PLGA) fibrous
mats enhanced the attachment, proliferation and “re-differentiation” of bovine
chondrocytes in vitro, with the secretion of new cartilage-specific matrix (collagen type II
and glycosaminoglycan) over a period of 1 month119. An in vivo study of HA in a rabbit
calvarial defect model showed that the addition of HA within hydroxyapatite/betatricalcium phosphate (HA-βTCP) particles resulted in an enhanced bone density as
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evaluated by computed tomography, and accelerated healing at 2 and 4 weeks post
implantation317.

1.6
1.6.1

Tissue-specific approach to scaffold design
Factors influencing stem cell behavior in ECM-derived bioscaffolds

The ECM, as highlighted in Section 1.3, is a highly organized microenvironment with
molecular components that are intricately organized, working in concert to provide tissuespecific properties. This tissue-specificity in terms of compositional, structural and
biomechanical properties helps to regulate tissue-specific cell phenotypes and other
cellular processes for the overall function of a given tissue. Key elements in the ECM that
directly mediate cell behavior are schematically represented in Fig. 1.3.

Figure 1.3: Proposed mechanisms by which the ECM compositional and
biomechanical properties could direct stem/progenitor cell behaviour and responses.
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In designing microenvironments for in vitro cell culture models and cell-based therapies
using intact or processed decellularized ECM bio-scaffolds, it is important to first
understand the mechanisms through which they are able to modulate cell behavior. It is
pertinent to acknowledge that the individual effects of compositional, structural and
biomechanical properties can be challenging to decouple since they work in an interrelated
manner in vivo318. Further, as a result of dynamic reciprocity, cell populations sense and
respond to their microenvironment and remodel bio-scaffolds through the synthesis of new
ECM and the action of matrix degrading enzymes (e.g. MMPs and disintegrin and
metalloproteinase with thrombospondin motifs (ADAMTs))318. Obtaining a better
understanding of these properties would require tailored strategies to suit the type of
decellularized tissue, cell and application.

1.6.1.1

Compositional/Biochemical properties

Decellularized ECM-derived bio-scaffolds are enriched in structural and functional
proteins that play a central role in regulating cell behavior217. ELISA, mass spectrometry
and immunohistochemical analyses on several decellularized tissues have illustrated the
retention of ECM proteins (both structural and functional), cytokines and growth
factors185,319–321. A recent proteomic analysis in the Flynn laboratory demonstrated a
compositionally distinct profile of proteins in human DAT and human decellularized
trabecular bone (DTB), with a higher amount of adipogenic proteins present in the DAT as
compared to the DTB185. Retained structural and functional proteins may act via the
binding of cells to adhesive sites on structural ECM components via integrins, through the
activity of sequestered growth factors, and/or by the action of small molecular weight
“cryptic peptides” or fragments from degraded ECM that have been shown to possess
immunomodulatory, angiogenic, mitogenic, and chemotactic properties4,322.
Several in vitro and in vivo studies have highlighted the ability of subtle differences in
ECM composition to influence a range of cellular processes such as survival, proliferation
and differentiation297,323,324. For example, Rothrauff et al. recently showed that the urea
extraction of ECM proteins from tendon and cartilage better promoted the tissue-specific
differentiation of bmMSCs as compared to pepsin-digested materials both in 2D and 3D
environments, potentially due to the greater abundance of non-collagenous low to moderate
molecular weight proteins and growth factors in the former as compared to the latter297.
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Similarly, a recent study using decellularized skeletal muscle ECM as a hydrogel improved
murine myoblast maturation in vitro and cell survival, engraftment and vascularization in
vivo when compared to collagen type I hydrogels323. They hypothesized this was related to
skeletal muscle-specific ECM proteins, as well as growth factor binding sites present
within the decellularized skeletal muscle, previously characterized using mass
spectrometry analysis323. Matrix degradation products, or matrikines, have been
documented to recruit resident stem/progenitor cells in vivo, and to modulate cell adhesion,
migration

and

differentiation325.

Finally,

specific

components

in

the

ECM

(glycosaminoglycans) are able to sequester growth factors and regulate their
bioavailability326. Enzyme degradation enzymes such as ones from the MMP and ADAM
families may selectively degrade the ECM, triggering the release of growth factors,
allowing for dynamic regulation of stem/progenitor cell behaviour327.

1.6.1.2

Biomechanical and structural properties

Cells embedded within the ECM are able to sense and respond to properties such as ECM
stiffness and forces through a process known as mechano-transduction, whereby integrin
mediated focal adhesion complexes activate downstream intracellular signalling cascades
that lead to an intricate regulation of cell behavior328. Cellular responses can range from a
simple altering of cell shape, stem cell renewal and differentiation, to the alteration of the
surrounding ECM as seen in disease states327,329. A comprehensive study by Engler et al.
showed that soft collagen-coated polyacrylamide gels resulted in increasingly branched
MSC morphology and neuronal marker expression at stiffness values of ~0.1–1 kPa
simulating the brain, while stiffer matrices of ~ 25–40 kPa resulted in polygonal shaped
MSCs and promoted osteogenic differentiation105. Furthermore, the 3-D structural
assembly of tissues and decellularized bio-scaffolds is unique to each tissue, with
differences in fibre alignment, ligand presence and organization, porosity, topography and
certain defining structural features such as the basement membrane330. These properties
can influence cell shape, organization and density that are well recognized mediators of
cell phenotype maintenance and lineage commitment159,331.
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1.6.2

Tissue-specific cell instructive effects of ECM

Various studies have indicated that ECM-derived scaffold microenvironments, in different
formats (intact, processed and as part of composites) have potential to enhance tissue
regeneration. A growing amount of evidence also indicates the synergistic effect of seeded
regenerative cell populations within these environments in aiding tissue regeneration
through direct and indirect mechanisms such as engraftment, differentiation and/or
paracrine effects318. More specifically, stem/progenitor cells within ECM-derived bioscaffolds of tissue-specific origin have been shown to exhibit lineage-specific
differentiation in vitro. This section will discuss key findings in terms of tissue-specific
effects of ECM-derived scaffolds on stem/progenitor cell populations, with a focus on
lineage-specific differentiation.

1.6.2.1

Cell attachment and proliferation

In general ECM-derived scaffolds have been able to improve cell retention and survival
both in vitro and in vivo, as a result of their intrinsic structural and biochemical properties.
Decellularized ECM-derived hydrogels from lung332,333, liver334 and cardiac tissues335 have
been documented to promote the proliferation of seeded stem/progenitor cells as compared
to commonly used collagen type I and Matrigel bio-scaffolds in vitro. Interestingly, in some
cases processed tissue-specific ECM has been shown to enable the retention of
stem/progenitor cell phenotype when used to fabricate coatings, and to enhance initial
attachment and proliferation in vitro as compared to uncoated tissue culture plastic, with
processing strategies that avoid or minimize proteolytic digestion providing better
proliferative capacities264,335–337.

1.6.2.2

Lineage-specific differentiation

ECM-derived bio-scaffolds can also provide an inductive substrate that may help to direct
differentiation and/or processes such as paracrine factor production318. A lot of focus has
been placed on investigating the tissue-specific effects of ECM-derived bio-scaffolds in
vitro and their ability to direct the lineage-specific differentiation of seeded stem/progenitor
cells, with numerous studies suggesting possible tissue- and region-specific differentiation
effects334,338–340. Our laboratory specifically has spent the last few years elucidating the
tissue-specific effects of DAT on human ASCs. We have demonstrated that the adipo-
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inductive environment induces the expression of the key transcription factors PPARγ and
C/EBPα in human ASCs cultured on intact DAT bio-scaffolds in the absence of exogenous
differentiation factors184. Further, we have successfully shown the ability for DAT-based
bio-scaffolds such as foams, microcarriers and composite hydrogels to display conductive
and inductive effects by enhancing in vitro adipogenic differentiation of human ASCs both
in adipogenic medium and proliferation medium that would normally suppress
adipogenesis58,261,262,296.
In the context of bone regeneration, Datta et al. cultured rat bone marrow-derived MSCs
on bio-scaffolds comprised of autologous cell-secreted ECM within a titanium mesh14.
Osteogenic differentiation in terms of ALP activity was augmented in bio-scaffolds
containing the ECM under induced conditions compared to groups without ECM and in
the absence of induction media, suggesting a synergistic effect of the two components on
differentiation14. Additionally, Hung et al. have shown that 3-D printed polycaprolactone
(PCL) bio-scaffolds incorporating decellularized bovine trabecular bone particulates
enhanced osteogenesis in vitro as compared to PCL bio-scaffolds alone as seen by
osteogenic gene (RUNX2, SPARC, and BGLAP) expression in human ASCs, and improved
bone regeneration in a murine calvarial defect model256. Recently, a comprehensive study
by Beachley et al. investigated the effects of 7 different ECM sources in a particulate form,
incorporated within chondroitin sulphate hydrogels, on the in vitro osteogenic
differentiation of mouse ESCs and in vivo bone regeneration266. Their results indicated that
bone ECM particles promoted the strongest osteogenic response in vitro and accelerated
full thickness regeneration as compared to ECM particles from other tissue types in a rat
femur bone defect model266.
Similar effects have been shown with decellularized ECM from other tissues.
Decellularized cardiac ECM in forms such as whole organs, composite hydrogels and
coatings was able to promote the differentiation and/or maturation of a range of
stem/progenitor cells (e.g. hESCs, hESC derived cardiomyocytes, rat cardiac progenitor
cells) towards a cardiac cell fate335,341,342. In a study by O’Neill et al., three different ECMderived scaffold formats (sheets, hydrogels and pepsin digested ECM) were developed
from three morphologically and biochemically distinct regions of porcine kidney (renal
cortex, medulla, and papilla)339. Interestingly, they found that kidney stem cells seeded
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within the bio-scaffolds demonstrated differences in cell proliferation and morphology,
with structure formation resembling the native renal ECM339.

1.7
1.7.1

Project Overview, hypothesis and specific aims
Project Overview

Most recent efforts in the design of cell-instructive microenvironments for cell culture and
delivery involve the replication of the “niche” from which the desired cell types
originate213. This stems from the notion that cell behavior in vivo is regulated by its physical
and chemical interactions with the surrounding microenvironment and their respective
tissue-specific ECM could provide distinct biomechanical, biochemical, and biophysical
cues to help direct cell function3. Recognizing this, decellularization provides a method for
exploiting the native ECM composition from an assortment of tissues217,218.
Decellularization is aimed at extracting immunogenic cellular components, while
preserving the complex ECM constituents as much as possible217,218. While the exact
mechanisms remain unclear, decellularized ECM bio-scaffolds in a variety of formats have
demonstrated the ability to mediate cell functions ranging from attachment to tissuespecific differentiation218. Therefore, an increasingly applied approach to bio-scaffold
design comprises composite hydrogels incorporating decellularized ECM as a cellinstructive element, to modulate the biological responses of the chosen regenerative cell
population9,277,283. Typically, the decellularized ECM is either physically processed into
micronized particulates or enzyme digested into a solution or suspension that can be
fabricated into hydrogels or incorporated within other biomaterials343. While complex
ECM sourced from decellularized tissues has demonstrated potential advantages over
purified ECM components and single phase hydrogel systems, there is a need to investigate
the effects of ECM processing and sourcing on the cell-instructive properties of the
resultant bio-scaffolds to design high fidelity cell-culture and delivery platforms. Further,
a growing body of evidence has suggested the capacity of the unique ECM constituents in
a particular tissue to promote the differentiation of stem/progenitor cells towards that
specific lineage344. However, many of these studies lack the usage of appropriate tissuetype controls as well as systematic comparisons between ECM sources to be able to
interpret whether there are tissue-specific compositional effects on the cells. Inherent intraand inter-ECM heterogeneity in terms of structural and biomechanical properties pose
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some challenges. For applications focused on promoting in situ differentiation, this
motivates the development of tunable platforms that incorporate tissue-specific ECM as a
cell-instructive component to allow for the lineage-specific differentiation of the delivered
cells, ultimately facilitating regeneration.
In previous studies in the Flynn lab, pepsin- and α-amylase-digested DAT have been used
to synthesize 3-D bio-scaffold formats that enhanced the adipogenic differentiation of
human ASCs58,272,296. Acknowledging that proteolytic ECM processing can modify the
ECM properties to varying degrees, I developed a method to fabricate robust ECM-derived
coatings using enzymatic digestion with α-amylase in place of conventionally-employed
pepsin for use in cell culture studies. Further, I performed a systematic comparison between
two different ECM sources (human DAT versus commercially-sourced bovine tendon
collagen) with similar structural and biomechanical properties, in order to elucidate the
potential benefits of applying a tissue-specific approach for ASC expansion and adipogenic
differentiation. Details of this work are found in Chapter 2.
Due to the observed differences in bioactivity of commercial DBM products, several
research groups have focused on developing reproducible protocols for decellularizing
bone that can retain its osteo-inductive and osteo-conductive properties241. In Chapter 3, I
highlight the development and assessment of an effective detergent-free method to obtain
decellularized trabecular bone (DTB), along with a rigorous characterization of DTB
relative to DAT.
Building from the results in my first two chapters, I subsequently explored the effects of
tissue-specific ECM on the lineage-specific differentiation of ASCs towards the adipogenic
and osteogenic lineages within a 3-D environment. More specifically, cryo-milled DTB or
DAT was incorporated, along with human ASCs within MCS hydrogels using a UVinitiated crosslinking approach. The response of the encapsulated ASCs was characterized
in terms of functional assays for adipogenic and osteogenic differentiation under both
induced and non-induced conditions, complemented by the assessment of lineage-specific
gene expression and staining techniques. Details of this work are found in Chapter 4.
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1.7.2

Hypothesis

Hypothesis: Tissue-specific ECM can direct the lineage-specific differentiation of human
ASCs when incorporated within 2-D and 3-D in vitro cell culture models and cell delivery
platforms.

1.7.3

Specific Aims

Objective 1: To develop an alternative method to pepsin, for the fabrication of robust
ECM-derived coatings from decellularized adipose tissue and collagen, and investigate
their use as in vitro cell culture platforms for the adipogenic differentiation of human ASCs.
Objective 2: To develop an effective protocol for the decellularization of bovine trabecular
bone, and evaluate the structural and compositional differences between decellularized
adipose and bone matrix.
Objective 3: To develop an in situ encapsulation strategy to combine human ASCs and
decellularized ECM from (i) adipose and (iii) bone tissue within bulk methacrylated
chondroitin sulphate (MCS) hydrogels, and evaluate the ability of tissue-specific ECM to
promote lineage-specific ASC differentiation under both induced (i.e. differentiation
media) and non-induced (i.e. proliferation media) conditions.
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Chapter 2

2

Probing the effects of tissue-specific matrix-derived
coatings on the proliferation and adipogenic
differentiation of human adipose-derived stromal cells
2.1

Introduction

The cells in our body reside within the extracellular matrix (ECM), an intricate and
dynamic network of proteins, glycoproteins, and polysaccharides, with tissue-specific
composition and ultrastructure1. Cell-ECM interactions are reciprocal, with cells
remodeling the surrounding ECM in the microenvironment in response to stimuli and these
modifications in turn directing major cellular processes including survival, adhesion,
migration, proliferation, and differentiation2,3. Despite the recognized importance of the
ECM in mediating cell function, the majority of basic in vitro cell biology studies are
performed on rigid two-dimensional (2-D) tissue culture plastic (TCP) plates, flasks or
dishes345,346. Although lacking the complexity of the native cellular milieu, these systems
readily support the attachment and proliferation of many adherent cell types, and are
convenient for downstream analyses using well-established biological characterization
assays347. To incorporate cell-ECM interactions within these platforms, tissue culture
plasticware is often coated with purified ECM components such as collagens, laminin,
fibronectin, or vitronectin, which have been shown to mediate cell behavior when used
individually or in combination5–7. However, these simplified models do not closely
recapitulate the complex biochemical composition or biomechanical properties of the
native ECM, which may limit the translatability of the findings from in vitro to in vivo
systems.
In general, there is a need to develop higher fidelity culture models that better reflect the
complex ECM microenvironment within tissues, while maintaining the convenience and
flexibility of standard TCP formats. To address this challenge, strategies have focused on
applying knowledge gained from the field of tissue engineering in the design of scaffolds
that mimic the biochemical, biomechanical, and biophysical features of the native ECM108.
In particular, the approach of tissue decellularization holds promise for the development of
tissue-specific culture models. Decellularized ECM has been extracted from virtually every
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tissue in the body using tailored protocols involving a combination of chemical, enzymatic,
and/or mechanical processing to extract cellular components, while striving to conserve
the characteristics of the native ECM184,223,263,338,348. To generate coatings incorporating the
complex and tissue-specific composition of the ECM, decellularized tissues are typically
digested using the proteolytic enzyme pepsin270,297,334,341. However, pepsin digestion is
highly non-specific, with digestion times influencing the profile of resulting peptides270.
Further, it is unclear whether pepsin digestion is the best approach for generating coatings
that retain the tissue-specific bioactivity of the ECM. Some studies have shown that pepsindigested ECM coatings can promote cell proliferation and/or differentiation compared to
collagen type I334, gelatin341, Matrigel349 and uncoated substrates334. In contrast, other
studies have suggested that proliferation and lineage-specific differentiation can be
enhanced with urea-extracted ECM, while pepsin-digested ECM coatings provided no
benefit relative to collagen type I coated and uncoated TCP269,297. Taken together, these
findings suggest that the bioactivity of coatings synthesized with pepsin-digested ECM
may be highly context dependent in terms of the specific ECM sources used as starting
materials, as well as the cell types under investigation and culture conditions.
As an alternative to pepsin, our lab group has established protocols using enzymatic
digestion with α-amylase to generate porous foams and microcarriers derived from
decellularized tissues16,58,272,273. Digestion with α-amylase enhances collagen dispersion in
acetic acid by cleaving carbohydrate groups rather than peptide bonds, thereby better
preserving the native structure of the proteins found within the ECM274. Previous studies
have demonstrated that 3-D bioscaffolds fabricated from α-amylase-digested ECM can
modulate the proliferation and differentiation of human adipose-derived stromal cells
(ASCs) in culture58,272,273 , but the bioactivity relative to substrates prepared with pepsindigested ECM has not yet been explored.
With a focus on developing culture models for studying adipogenic processes, the current
study compared the proliferation and adipogenic differentiation of human ASCs cultured
in 2-D on coatings prepared using ECM digested with α-amylase versus pepsin relative to
uncoated TCP controls. More specifically, human decellularized adipose tissue (DAT) and
commercially-available bovine tendon collagen (COL) were explored as contrasting ECM
sources to assess potential tissue-specific effects on the cellular response. We hypothesized
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that ASC attachment, proliferation, and adipogenesis would be enhanced on the coatings
derived from tissue-specific ECM (i.e. DAT), and that the bioactivity of the ECM would
be more highly conserved through digestion with the glycolytic enzyme α-amylase as
compared to the proteolytic enzyme pepsin.

2.2 Methods
2.2.1

Materials

Unless otherwise specified, all chemicals and reagents were purchased from Sigma Aldrich
and used as received.

2.2.2

Adipose tissue procurement and processing

Subcutaneous adipose tissue was collected from patients undergoing lipo-reduction
surgeries at the University Hospital and St. Joseph’s Health Care Hospital in London, ON
(HREB# 105426). Samples were transported in sterile phosphate buffered saline (PBS)
supplemented with 20 mg/mL bovine serum albumin (BSA). The tissue was processed
using published methods for ASC isolation350 or decellularization184 within 2 h. Isolated
ASCs were seeded on T-75 flasks in proliferation medium (DMEM:Ham’s F-12
supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin and
0.1 mg/mL streptomycin (pen-strep)), and washed with sterile PBS after 24 h (37°C, 5%
CO2) to remove unattached cells and debris. Proliferation media was replaced every 2-3 d
and the cells were passaged at 80% confluence. Passage 2 (P2) ASCs were used for all
seeding and characterization experiments. The immunophenotype of the P2 ASCs was
confirmed prior to seeding using a Guava easyCyte 8HT flow cytometer (Millipore,
Billerica, MA, USA), as described previously94 (Appendix A, Table A.1).

2.2.3

Enzyme digestion and coating preparation

Human DAT pooled from 5 donors and bovine tendon collagen (COL) (Sigma, Cat #:
9007345 were cryo-milled separately using previously reported methods and stored in a
desiccator until further use262. Prior to enzyme processing, ECM particles were
decontaminated in 70 % ethanol overnight, followed by 3 successive 1 h rinses in PBS. αamylase-digested DAT and COL suspensions were synthesized using established protocols
and stored at 4°C58. To prepare the pepsin-digested ECM solutions, milled DAT and COL
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were added at a concentration of 25 mg/mL to 10 % (w/w) porcine pepsin (Sigma-Aldrich,
Activity: 3200-4500 mU/mg protein) in 0.2 M acetic acid and digested for 48 h under
agitation (100 RPM) at room temperature. The solutions were neutralized with 5.7 N NaOH
to inactivate the enzyme, centrifuged at 12,000 xg to extract undigested components and
filtered through a 0.22 µm syringe filter (Millipore). The resulting ECM solutions were
stored at 4°C, with a maximum storage time of 2 months.
For scanning electron microscopy (SEM) and coating thickness measurement studies, 8
mm round glass coverslips were positioned at the bottom of 12-well TCP plates before
coating preparation. For mechanical testing and immunohistochemical characterization of
ASC attachment/proliferation and intracellular lipid accumulation, 25 mm square glass
coverslips were placed at the bottom of 6-well TCP plates prior to coating preparation. For
all other studies, 12-well TCP plates were coated directly. To generate the coatings,
individual wells of the 12-well or 6-well TCP plates were coated with 0.6 mL or 1.2 mL of
enzyme-digested ECM respectively and the plates were left to dry overnight in a biological
safety cabinet.

2.2.4
2.2.4.1

Physical characterization of coatings
SDS Page analysis of ECM digests

For SDS-PAGE analysis, 20 µL volumes of the α-amylase- and pepsin-digested DAT and
COL samples (diluted to 1 mg/mL in 0.2 M acetic acid based on starting ECM mass) were
run on Tris-HCl, 6-20% gradient polyacrylamide gels in running buffer comprised of 25
mM Tris, 1% glycine, and 0.1% SDS. Gel electrophoresis (Bio-Rad, USA, MiniPROTEAN Tetra vertical electrophoresis cell) was performed in comparison to a BLUeye
pre-stained broad size range protein standard (Cat #:PM0070500) with visualization with
Gel Code Blue Protein Stain (Thermo Scientific).

2.2.4.2

SEM analysis of coating ultrastructure

SEM was used to visualize the initial ultrastructure of the DAT and COL coatings prior to
seeding. Coatings prepared on 8 mm round glass coverslips in 12-well TCP plates were
rinsed twice in PBS and stored in 80 % ethanol. Critical point drying was performed, and
the samples were coated with 10 nm of osmium (OPC 80 T, SPI Supplies) before
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visualization with a LEO1530 scanning electron microscope (Nanofabrication facility,
Western University). The α-amylase DAT and COL samples were scratched through the
centre with a scalpel blade to enable visualization of the coating interior and all samples
were imaged at 5 kX magnification with an accelerating voltage of 1.00 kV and a 6 mm
working distance.

2.2.4.3

Toludine blue staining

Toluidine blue staining was performed to provide a qualitative assessment of the DAT and
COL coatings before and after 2 rinses with proliferation medium used in preparation for
the cell culture studies. Uncoated wells were included as a control. The coatings were
stained at a concentration of 0.15 mg/mL in 50 mM sodium acetate for 10 min at room
temperature, and then gently rinsed in PBS to remove excess dye. The samples were
visualized at 10X magnification using an EVOS® XL CORE bright field microscope (Life
Technologies).

2.2.4.4

Hydroxyproline assay

The hydroxyproline assay was performed to provide a quantitative assessment of coating
stability following rinsing. DAT and COL coating samples before and after 2 rinses in
proliferation medium (n=3/group) were processed and evaluated using previously
published methods239.

2.2.4.5

Coating thickness

To assess the thickness of the α-amylase-digested coatings, the DAT and COL coatings
were prepared on 8 mm round glass coverslips and rinsed twice in PBS. The coatings
(n=3/group) were then scratched through the centre with a scalpel blade and imaged from
the side using a stereomicroscope. Roughly 6 non-overlapping images were obtained
across the scratched coating and the surface thickness was measured and analyzed using
ImageJ software.
For the pepsin-digested DAT and COL coatings, a scratch test was performed in samples
both before and after two rinses in proliferation medium, followed by surface thickness
evaluation using a mechanical stylus surface profiler (KLA Tencor P-10 Surface Profiler,
Surface Science Western) (n=3/group). More specifically, the scratch was made at the
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center of the coating, and three line scans at different regions were taken with 6-7 randomly
chosen readings within each scan used to estimate the average thickness of the coatings.

2.2.4.6

Mechanical characterization using atomic force microscopy

Young’s moduli (E) of the DAT and COL coatings after the rinse step were estimated and
evaluated in their hydrated states using an atomic force microscope (Bioscope Catalyst,
Bruker). A nanoindentation method using a pyramidal silicon nitride AFM tip (Bruker,
MSNL-10D) with a 5 µm polystyrene bead on a cantilever with spring constant 0.037 N/m
in the contact mode was employed. Prior to use, the spring constant of the tip was checked
and calibrated against glass using the thermal fluctuation method351. Force-extension
indentation curves were sampled to estimate Young’s Moduli with a force trigger of 4 nN
prescribing the point at which the cantilever approach was stopped and then retracted351.
Three replicates for the pepsin-digested samples and 6 replicates for the α-amylase digested
samples were evaluated, with a total of six experimental points per replicate to account for
regional variability. The Hertz linear contact model (below) for a spherical tip was applied
to fit the rising slopes of the approach curve before relaxation using the Bruker NanoScope
software, with conditions kept consistent between all samples and groups351. The Poisson’s
ratio (n) was assumed to be 0.5. To ensure that the stiffness of the underlying substrate was
not affecting the measurements, the indentation depth of each run was extrapolated and
ensured to be £10 % of the sample thickness using the software during post-processing 352.
F=
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ASC proliferation studies
ASC seeding and culture

The coatings were rinsed twice in proliferation medium, and P2 ASCs were seeded at a
density of 5,000 cells/cm2 on DAT and COL coated glass coverslips in 6-well plates for
proliferation studies (37°C, 5% CO2) over a period of 14 d, with uncoated coverslips
included as controls. Fresh proliferation medium was provided to all samples every 2-3 d.
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2.2.5.2

Immunocytochemical assessment of cell morphology and
proliferation

To assess cell attachment, morphology and proliferation over time, immunocytochemical
staining of vimentin with DAPI counter-staining was performed at 4 h, 24 h, 72 h, 7 d and
14 d (n=3 samples per group/trial, N=2 trials with different ASC donors). At each
timepoint, triplicate samples were fixed overnight in buffered 4% paraformaldehyde
solution (pH 7.4) at 4 °C and rinsed in PBS. Prior to staining, the samples were blocked
with tris buffered saline (TBS, pH 7.4) containing 1% BSA and 0.01% Triton X-100 for 1
h, followed by an overnight incubation at 4 °C with rabbit polyclonal anti-vimentin
(ab92547, Abcam) at 1:200 dilution in the blocking buffer. The coatings were then rinsed
extensively with TBS before incubation with an Alexa Fluor® 594 conjugated goat antirabbit IgG secondary antibody (ab150080, Abcam) at a 1:200 dilution in the blocking
buffer for 1 h at room temperature. Finally, the coatings were rinsed in PBS and mounted
with

Fluoroshield™

mounting

medium

(Abcam)

containing

4',6-diamidino-2-

phenylindole (DAPI) for the visualization of cell nuclei. Approximately 10 nonoverlapping images were captured across the entire coating in each of the triplicate samples
using an EVOS® FL fluorescence imaging system (Life Technologies) at 10X and 20X
magnification. Nuclei were counted under a single blind setup using ImageJ software and
were represented as the number of nuclei per mm2 in each group.

2.2.6
2.2.6.1

ASC differentiation studies
ASC seeding and culture

The coatings were rinsed twice in proliferation medium and P2 ASCs were seeded at a
density of 50,000 cells/cm2 on the various substrates in proliferation medium in preparation
for the adipogenic differentiation studies (37°C, 5% CO2)262, with uncoated
wells/coverslips included as controls. Following 24 h incubation to facilitate cell
attachment, the samples were rinsed with PBS and the medium was replaced with serumfree adipogenic differentiation medium comprised of DMEM:Ham’s F12 nutrient mixture
supplemented with 33 μM biotin, 17 μM pantothenate, 66 nM human insulin, 1 nM
triiodothyronine (T3), 10 μg/mL transferrin, 100 nM hydrocortisone, 100 U/mL penicillin
and 0.1 mg/mL streptomycin353. The differentiation medium was supplemented with 1
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μg/mL of troglitazone and 0.25 mM isobutylmethylxanthine (IBMX) for the first 72 h.
Fresh medium was provided to all samples every 2-3 d for up to 14 days.

2.2.6.2

RT-qPCR analysis of adipogenic gene expression

Quantitative RT-PCR analysis was performed to evaluate the expression of key adipogenic
markers in the cells cultured on the various substrates in 12-well plates at 7 and 14 d postinduction of differentiation (n=3 samples per group/trial, N=3 trials with different ASC
donors) as per previously published protocols 272. The TaqMan® Gene Expression Assay
human gene-specific primers conjugated with FAM-MGB probes (Invitrogen) used in this
study are presented in Table 2.1. A comparative Ct method was used to calculate the
relative fold change in gene expression relative to the uncoated TCP group at 7 d. No RT
and no template controls were included on every plate.
Table 2.1: Human gene-specific primers used for quantitative RT-PCR.
Gene
PPARγ
LPL
ADIPOQ
PLIN1
GAPDH
IPO8

2.2.6.3

Description
Peroxisome proliferator-activated receptor gamma
Lipoprotein lipase
Adiponectin
Perilipin
Glyceraldehyde-3-phosphate dehydrogenase
Importin 8

Product code
Hs00234592_m1
Hs00173425_m1
Hs00605917_m1
Hs00160173_m1
Hs02758991_g1
Hs00183533_m1

Glycerol-3-phosphate dehydrogenase (GPDH) Activity

To assess the adipogenic response at the protein level, intracellular GPDH enzyme activity
was measured using a GPDH Activity Measurement Kit (Kamiya Biomedical Corporation,
Cat. # KT-010, Seattle, WA, USA) in the samples prepared in 12-well plates at 7 and 14 d
post-induction of adipogenic differentiation (n=3 samples per group/trial, N=3 trials with
different ASC donors) using previously published methods 261,262. For each cell donor, the
data was normalized to the uncoated TCP group at 7 d for comparative purposes.

50

2.2.6.4

Immunocytochemical assessment of perilipin expression

To qualitatively assess ASC adipogenesis on the various substrates, immunocytochemical
analysis of perilipin expression was performed at 7 and 14 d post-induction of adipogenic
differentiation (n=3 wells per group/trial, N=2 trials with different ASC donors). The
coatings were fixed, rinsed and blocked, as previously described. The samples were then
incubated overnight at 4 °C with rabbit polyclonal anti-perilipin A (ab3526, Abcam) at
1:200 dilution in the blocking buffer. Following this, the samples were rinsed extensively
with TBS before incubation with Alexa Fluor® 680 conjugated goat anti-rabbit IgG
secondary antibody (ab175773, Abcam) at a 1:200 dilution in the blocking buffer for 1 h
at room temperature. Finally, the samples were rinsed in PBS and mounted with
Fluoroshield™ mounting medium (Abcam) containing DAPI for the visualization of cell
nuclei. Multiple non-overlapping images were captured across the entire coating in the
triplicate samples using an EVOS® FL fluorescence imaging system (Life Technologies)
at 10X and 20X magnification.

2.2.7

Statistical analysis

All numerical data are expressed as mean ± standard deviation (SD). All statistical analyses
were performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA) by oneway or two-way ANOVA with a Tukey’s post-hoc comparison of the means. Differences
were considered statistically significant at p < 0.05 unless otherwise noted.

2.3 Results
2.3.1
2.3.1.1

Physical characterization of coatings
SDS PAGE

Using the same starting mass of ECM, α–amylase digestion of the DAT and COL produced
off-white viscous and cloudy ECM suspensions, while pepsin digestion generated
transparent yellow solutions with qualitatively lower viscosity (Appendix A, Fig. A.1A).
A concentration of 25 mg/mL was selected for the studies, as it was the highest
concentration of ECM that could be incorporated in the α–amylase-digested samples to
produce a workable suspension that evenly coated the surface of the well plates. Molecular
weight analysis of the ECM digests by SDS-PAGE showed that α–amylase-digested DAT
and COL displayed distinct bands at a wide range of molecular weights (Appendix A,
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Fig. A.1C). In contrast, the pepsin-digested DAT and COL displayed only faint bands of
smaller molecular weight.

2.3.1.2

SEM analysis

Macroscopically, the α–amylase-digested ECM coatings were visually apparent on the
surface of the well plates and could be carefully extracted from the TCP as an intact sheet
using forceps (Appendix A, Fig. A.1B). Thickness measurements obtained using a
stereomicroscope indicated that the α-amylase-digested DAT coatings were 160 ± 10 µm
thick and the α-amylase-digested COL coatings were 150 ± 10 µm thick. In contrast, the
pepsin-digested coatings appeared as thin yellow films that could not be removed from the
plastic. SEM imaging demonstrated that the α-amylase-digested DAT and COL coatings
had a fibrous interior ultrastructure, consistent with the preservation of high-molecular
weight collagen fibers (Fig. 2.1). Higher magnification analysis of these samples
demonstrated that the characteristic D-banding pattern of collagen was retained in the
samples digested with α-amylase (Appendix A, Fig. A.1D). In contrast, the coatings
generated with pepsin-digested DAT or COL showed no fibrous ultrastructure, consistent
with the proteolytic degradation of the collagen fibers within the source materials.
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Figure 2.1: α-amylase digestion produces coatings with a fibrous ultrastructure.
Representative SEM images of coatings generated with (A) α-amylase-digested DAT, (B)
α-amylase-digested COL, (C) pepsin-digested DAT and (D) pepsin-digested COL. The
coatings prepared from α-amylase-digested ECM had a fibrous interior ultrastructure,
while the samples prepared with pepsin-digested ECM had a macroscopically smooth
appearance. Scale: 100 μm.

2.3.1.3

Toluidine blue staining and hydroxyproline assay

Toluidine blue staining qualitatively supported that there was at least partial retention of
the coatings in all of the samples after two rinses in the proliferation medium that was used
in preparing the coatings for ASC culture (Fig. 2.2A). The visualization of the staining in
the α–amylase-digested samples was more challenging due to their non-transparent nature,
but the patterns appeared qualitatively similar both before and after rinsing for both the α–
amylase-digested DAT and COL coatings. To complement the staining results, the
hydroxyproline assay was used as a measure of protein content to quantitatively assess
whether there was protein loss from the collagen-rich coatings during the rinses in
proliferation medium (Fig. 2.2B). Interestingly, there was significantly higher
hydroxyproline content in the samples prepared with DAT relative to COL for both the α–
amylase-digested and pepsin-digested groups, potentially attributed to the more complex
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ECM source. While no significant difference was noted in the hydroxyproline content
before and after rinsing in the coatings prepared with α–amylase-digested ECM, a
significant decrease in hydroxyproline content was observed for both the pepsin-digested
DAT and COL coatings following rinsing (Fig. 2.2B).

Figure 2.2: Coatings fabricated with α-amylase-digested ECM show enhanced
stability in culture. (A) Toluidine blue staining was performed to qualitatively assess the
coatings before and after 2 rinses in proliferation medium. The staining patterns relative to
uncoated controls support that coating materials remained on the TCP following rinsing in
all of the groups. Scale: 10 μm. (B) Quantitative assessment of coating stability via the
hydroxyproline assay suggested that there was a significant loss in protein content from
the pepsin-digested DAT and COL coatings following rinsing, while no change was
observed in the α–amylase-digested samples (n=3,*p<0.01).
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2.3.2

Coating thickness and atomic force microscopy

Profilometry analyses corroborated that the proliferation medium rinses resulted in
substantial protein loss in the coatings prepared with the pepsin-digested ECM, with the
thickness of the pepsin-digested DAT coatings decreasing from 20 ± 4 µm to 4 ± 3 µm,
and the pepsin-digested COL coatings decreasing from 15 ± 4 µm to 2 ± 1 µm. Regional
and sample variability within the coatings was observed after rinsing, indicating that
coating retention was not consistent across the samples. SEM images of the pepsin-digested
coatings obtained before and after rinsing further confirmed that coating materials
remained on the TCP prior to cell seeding (Appendix A, Fig. A.2).
Recognizing that substrate stiffness can modulate cell function, including MSC
differentiation329, AFM studies were performed to compare the mechanical properties of
the various coatings. The thickness measurements were used to ensure that the Buckle’s
indentation depth limit was maintained at each measurement to avoid sensing the stiffness
of the underlying substrate354. AFM analysis of coatings generated with the α-amylasedigested ECM revealed an estimated Young’s modulus of 36 ± 16 kPa for the DAT
coatings and 24 ± 10 kPa for the COL coatings respectively, with no significant differences
between the two groups (Fig. 2.3). The corresponding indentation depths were 180 ± 74
nm for the DAT coatings and 210 ± 47 nm for the COL coatings, which were both well
below the Buckle’s indentation depth limit. In contrast, the coatings fabricated with pepsindigested ECM were substantially stiffer, with an estimated Young’s modulus of 1060 ±
390 kPa for the DAT coatings and 505 ± 320 kPa for the COL coatings (Fig 2.3). The
pepsin-digested ECM coatings showed notable sample-to-sample and regional variability,
potentially consistent with their reduced stability and variable protein loss over time. The
corresponding indentation depths were 100 ± 7 nm for the DAT coatings and 129 ± 47 nm
for the COL coatings, which was close to the Buckle’s indentation depth limit352. Hence,
the underlying TCP substrate may have contributed in part to the measured values.
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Figure 2.3: Atomic force microscopy analysis indicated that the coatings fabricated
with α-amylase-digested ECM had significantly lower Young’s moduli than the
coatings fabricated with pepsin-digested ECM. No statistically significant differences
were observed between the tissue types for each digestion method. (n=3 for pepsin-digested
coatings, n=6 for α-amylase-digested coatings, *p<0.05)

2.3.3

ASC morphology and proliferation

Based on assessment of cell attachment to the coatings through quantification of DAPI
staining, the human ASCs were observed to readily attach to all of the substrates, with
enhanced cell densities observed on the α–amylase-digested DAT coatings at all timepoints
from 24 h to 14 d relative to all other groups (Fig. 2.4). Moreover, a significant increase
in cell density was observed on the α–amylase-digested DAT group between each
timepoint from 24 h to 14 d. In addition, staining for vimentin indicated that the ASCs
cultured on the coatings fabricated with α-amylase-digested DAT and COL had a more
spindle-shaped cellular morphology as compared to the ASCs cultured on the pepsindigested ECM coatings or uncoated controls, which showed greater cell spreading
(Appendix A, Fig. A.3).
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Figure 2.4: Human ASCs cultured on α-amylase-digested DAT coatings showed
enhanced proliferation and a more spindle-shaped morphology. (A) Representative
immunocytochemical staining for vimentin (green) with DAPI (blue) of ASCs cultured on
the various substrates at 24 h, 72 h and 7 d. Scale: 100 μm. (B) Quantification of cell
density over 14 d via DAPI nuclear counting. A significant increase in cell density was
observed over the 14 day culture period for the ASCs on the α-amylase-digested DAT
coatings, with a significantly higher cell density observed at 24 h, 72 h, 7 d and 14 d as
compared to all other groups (**p<0.05). (Pooled results; n=3 samples per group/trial, N=2
trials with different ASC donors)
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2.3.4
2.3.4.1

Adipogenic differentiation
RT-qPCR

RT-qPCR analysis of adipogenic gene expression indicated that adipogenesis was
enhanced in the ASCs cultured on the α-amylase digested DAT coatings relative to all other
groups (Fig. 2.5). More specifically, while no difference was observed in the expression
levels of the transcription factor PPARg between any of the groups, the expression of LPL,
ADIPOQ and PLIN were enhanced in the α-amylase-digested DAT group as compared to
all other substrate conditions at both 7 and 14 d, with no significant changes in expression
levels over time.

Figure 2.5: The expression of adipogenic genes was enhanced in the ASCs cultured
on the α-amylase-digested DAT coatings. Relative gene expression levels of (A) PPARg,
(B) LPL, (C) ADIPOQ, and (D) PLIN after 7 and 14 d of culture in adipogenic
differentiation medium, with GAPDH and IPO8 as the housekeeping genes. (*p<0.05)
(Pooled results; n=3 samples per group/trial, N=3 trials with different ASC donors)
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2.3.4.2

Glycerol-3-phosphate dehydrogenase (GPDH)
quantification

To corroborate the gene expression findings, adipogenic differentiation was assessed at the
protein level through quantitative analysis of GPDH enzyme activity. Similar to the gene
expression data, significantly higher GPDH activity was observed in the ASCs cultured on
the α-amylase-digested DAT coatings as compared to all other groups at 7 d (Fig. 2.6). At
14 d, the GPDH activity levels were higher in the ASCs cultured on the α-amylase-digested
DAT coatings relative to all other substrate conditions with the exception of the pepsindigested DAT coatings. There were no significant differences in the GPDH activity levels
between the two timepoints for any of the groups.

Figure 2.6: Glycerol-3-phosphate dehydrogenase enzyme activity levels were
enhanced in human ASCs cultured on the α-amylase-digested DAT coatings. Relative
GPDH activity levels support that adipogenic differentiation was enhanced when the cells
were cultured on the α-amylase-digested DAT substrates relative to all other groups at 7 d
and relative to all other groups with the exception of the pepsin-digested DAT coatings at
14 d. (*,**p<0.05). (Pooled results; n=3 samples per group/trial, N=3 trials with different
ASC donors)
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2.3.4.3

Immunocytochemistry staining for perilipin

To provide a complementary qualitative assessment of adipogenic differentiation,
immunocytochemical staining for perilipin was performed to assess intracellular lipid
accumulation in the ASCs cultured on the various substrates in adipogenic differentiation
medium for 7 and 14 d (Fig. 2.7). Consistent with the adipogenic gene expression and
GPDH enzyme activity data, perilipin expression was qualitatively enhanced in the ASCs
cultured on the α–amylase-digested DAT coatings as compared to all other groups at both
timepoints. Notably, there was a qualitative increase in perilipin expression in the α–
amylase-digested DAT group from 7 to 14 days, with a uniform cellular response observed
across the entire coating, consistent with a progression in adipogenic differentiation and
the assumption of a more mature phenotype associated with enhanced lipid accumulation
and larger intracellular lipid droplets.

Figure 2.7: Intracellular lipid accumulation was enhanced in human ASCs cultured
on the α-amylase-digested DAT coatings. Representative perilipin (red) staining with
DAPI counterstaining (blue) of ASCs cultured on the various substrates in adipogenic
differentiation medium for 7 or 14 d. At 14 d, selected regions (white boxes) of the 10X
images were visualized at higher magnification, as shown in the bottom row. Scale:100
μm.
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2.4 Discussion
There is a compelling need for cell culture models that more closely recapitulate the
complex composition, structure, and biomechanics of the native extracellular milieu346,355.
Consequently, there has been increasing interest in the development of ECM-derived
coatings sourced from decellularized tissues. Recent studies have suggested that these
substrates can be harnessed to guide cell attachment and proliferation, as well as to promote
the lineage-specific differentiation of stem cells in culture334,336,349,356. However, further
research on the effects of enzymatic digestion on ECM bioactivity is warranted, as well as
more systematic comparisons between ECM sources to assess the benefits of applying a
tissue-specific approach.
To date, the most prevalent strategy for generating coatings from decellularized tissues
has involved digestion with pepsin isolated from porcine gastric mucosa357. Proteolytic
digestion with pepsin yields a solution of peptide fragments of varying sizes, which can be
dependent on factors including the enzyme activity, processing conditions, and digestion
time268. The resulting solution can be used to fabricate 2-D coatings334,336,341 or 3-D
hydrogels215,358, or incorporated as a cell-instructive component in composite
biomaterials334,340,359. However, there have been conflicting reports on the bioactivity of
pepsin-digested ECM substrates269,336,360. Moreover, in our experience, biomaterials
fabricated with pepsin-digested ECM are difficult to handle and show low stability unless
chemically crosslinked361, likely due to the highly fragmented nature of the digested ECM.
In the present study, enzymatic digestion with the glycosidic enzyme a-amylase was
investigated as an alternative approach for generating ECM-derived coatings. In previous
studies, our group has used a-amylase-digested ECM to fabricate 3-D foams and
microcarriers from human DAT58,272, porcine decellularized myocardium273, and porcine
decellularized dermis16. However, to the best of our knowledge, this approach has not yet
been applied to synthesize coatings for use in 2-D cell culture studies. In addition to
exploring this new method of ECM processing, a secondary goal was to probe the effects
of the ECM source to develop a deeper understanding of the potential benefits of applying
adipose-derived ECM as a tissue-specific substrate for ASC expansion and adipogenic
differentiation. Many studies assessing ECM-derived biomaterials lack appropriate tissuetype controls that have similar structural and biomechanical properties to be able to
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interpret whether there are tissue-specific compositional effects on the cells318.
Commercially-sourced bovine tendon collagen was selected as a tissue-type control based
on our previous studies characterizing the protein composition of this specific source185, as
well as our previous success in applying it with a-amylase digestion to generate 3-D foams
that were compositionally distinct from the DAT239.
The ECM provides a bioactive substrate for cells that can modulate cell function through
integrin-mediated binding, as well as through the action of sequestered growth factors,
matricellular proteins, and matrikines268,362. Based on our characterization studies,
digestion with a-amylase better preserved the fibrillar structure of the collagen-rich ECM
sources and retained a range of higher molecular weight proteins. Our findings are similar
to a recent study that compared pepsin digestion, urea extraction, and homogenization in
acetic acid as processing methods for generating coatings from decellularized ECM
produced by placental MSCs, which demonstrated that pepsin digestion produced clear
solutions comprising low molecular weight (< 50 kDa) proteins, while acetic acid
homogenization generated the most complex mixture of proteins of varying sizes264.
Interestingly, the coatings generated from their pepsin-digested ECM were shown to
enhance the metabolic activity of the placental MSCs relative to the other coatings, while
those generated from urea extracts enhanced osteogenesis under differentiation conditions.
Notably, the acetic acid-homogenized ECM showed no bioactive effects relative to the
uncoated TCP in their studies, which was postulated to be due to the heterogeneous nature
of the coatings generated with the ECM suspension, as well as potentially the concentration
employed (25 µg/mL).
Homogeneity and stability are important considerations when designing ECM coatings for
use in long-term culture studies. From our analyses, the coatings generated with α–
amylase-digested ECM were structurally robust and macroscopically homogeneous, with
enhanced stability compared to the coatings generated with the pepsin-digested DAT and
COL. Rinsing twice in media was demonstrated to reduce the thickness and uniformity of
the pepsin-digested coatings used in the current study. As such, it is highly likely that there
was further loss in protein content over time in culture from these substrates, which may
have contributed to the lack of observable bioactive effects in these groups. In contrast, the
α–amylase-digested coatings were qualitatively retained over the course of the 14-day
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culture studies, consistent with our previous work showing the long-term stability of 3-D
microcarriers and foams generated with α–amylase-digested DAT58,272.
In addition to showing enhanced stability, AFM analysis indicated that the α–amylasedigested coatings were significantly softer than the pepsin-digested substrates. The use of
the 5 µm polystyrene bead on the AFM tip enabled indentation testing of a larger region of
the coatings, providing an analysis of the properties on the scale of individual cells.
Notably, the α–amylase-digested DAT coatings were stiffer than the previous values
measured through bulk compression testing for the intact DAT and porous foams generated
with α–amylase-digested DAT, which were in the range of ~ 2 – 4 kPa and similar to the
values reported for native human fat58,236. The increased stiffness of the coatings may be
related in part to the marked difference in the scale of the testing methods employed, as
well as structural differences in the materials and their processing to form coatings. While
the underlying TCP substrate may have contributed to the higher stiffness values measured
in the pepsin-digested substrates, previous studies have suggested that cells cultured on
thin coatings (< 10 µm) are able to sense underlying stiff substrates363,364, and therefore
these values may reflect the properties experienced by the cells. Notably, the similarity of
the structure and moduli between the α–amylase-digested DAT and COL coatings suggests
that the ECM composition was the predominant factor contributing to the enhanced
proliferation and adipogenic differentiation of the human ASCs cultured on the α–amylasedigested DAT.
There is a growing body of evidence to support that strategies that avoid or minimize
proteolytic digestion may be favourable for conserving bioactivity in ECM-derived
substrates. For example, a study comparing the bioactivity of solubilized decellularized
cartilage and tendon ECM prepared through urea extraction versus pepsin digestion found
that only the urea-extracted samples could promote the lineage-specific differentiation of
human bone marrow-derived MSCs297. Another study demonstrated that reducing the
amount of time that decellularized cardiac ECM was digested with pepsin enhanced the
capacity of the coatings to promote cardiomyocyte proliferation, which was postulated to
be due to changes in the composition of the substrates270. Building from this, we
hypothesize that the enhanced proliferation of the human ASCs observed on the α–
amylase-digested DAT was attributed to the complex tissue-specific ECM composition in

63

these substrates. Our findings are supported by other studies that have indicated that ECM
coatings derived from other tissue sources can enhance cell attachment, survival and
proliferation in a tissue-specific manner297,336,356.
ASCs cultured on TCP are expected to have a spindle-shaped morphology, with cell
spreading and flattening serving as markers of senescence in long-term culture365. In
general, cell spreading correlates with properties of the underlying substrate such as
stiffness, ligand density and arrangement, through the regulation of focal adhesions363,364.
As such, the spindle-shaped morphology observed on the a-amylase-digested coatings may
be related to the lower stiffness, more fibrous ultrastructure, and thicker nature of these
samples363. Our findings are consistent with other studies that have shown that MSCs
seeded on fibrous ECM-derived coatings were more elongated and had a more spindleshaped morphology, as compared to cells cultured on TCP and other purified ECM
components (e.g. fibronectin)366–370.
Consistent with previous studies of other DAT scaffold formats58,237,261,262,271,272, the
current study supports that adipose-derived ECM can provide a pro-adipogenic
microenvironment for human ASCs. Notably, enhanced differentiation was only observed
with the coatings synthesized with α–amylase-digested DAT, suggesting that the
proteolytic digestion methods employed were not favourable for conserving the bioactivity
of the ECM. In contrast to our findings, other groups have reported that hydrogels
synthesized with pepsin-digested DAT can promote the adipogenic differentiation of
human ASCs in culture and in vivo adipose tissue formation 232,371,372. The differences in
the cellular response may be due to a combination of factors including both the scaffold
composition and format, which may impact other properties including biomechanics, cellECM interactions, and substrate stability. Regardless, our findings support that our new α–
amylase-digested DAT coatings are a highly promising substrate for adipogenic cell culture
studies. The uniformity of the differentiation response on the α–amylase-digested DAT
was particularly notable, with a much higher fraction of the ASCs accumulating
intracellular lipid based on perilipin expression as compared to the other substrates, in
addition to the cells having a more mature phenotype associated with larger intracellular
lipid droplets.
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The straightforward and scalable methods described enable the production of soft,
compliant, and robust tissue-specific coatings that have demonstrated cell-instructive
effects. One challenge when working with the α–amylase-digested substrates is that they
are not transparent, which interferes with routine visualization of the cells in culture using
standard brightfield microscopy. However, the cells cultured on the coatings can be readily
characterized using numerous standard biological assays including immunofluorescence,
RT-PCR, and protein assays, supporting the utility of the platform for fundamental and
applied cell biology research.

2.5

Conclusion

In the current study, methods were successfully developed for generating coatings for use
in cell culture studies using ECM digested with the glycosidic enzyme α–amylase in place
of the standard proteolytic enzyme pepsin. The α–amylase-digested DAT and COL were
easily applied to produce soft, compliant, robust, and cell-supportive substrates, which had
conserved fibrillar ECM structure and complex composition including high molecular
weight proteins. The α–amylase-digested coatings were thicker, softer, and more stable
than those prepared with pepsin-digested ECM, while remaining amenable to standard
analysis using a range of cell-based assays. Notably, the coatings generated with α–
amylase-digested DAT demonstrated tissue-specific cell-instructive effects, promoting
human ASC proliferation and adipogenic differentiation. Overall, the α–amylase-digested
DAT coatings may have broad utility as platforms for ASC expansion, as well as in tissuespecific culture models for applications in adipose tissue regeneration, obesity, diabetes,
and metabolic research. Further, the methods developed here could easily be extended to
other decellularized tissue sources to create a wide-range of tissue-specific
microenvironments that enable probing the effects of the ECM on cellular responses in the
context of both health and disease.
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Chapter 3

3

Development and characterization of decellularized
trabecular bone
3.1

Introduction

In vivo, cells reside within an active extracellular matrix (ECM), a protein and
polysaccharide rich network with tissue-specific composition and architecture1,3. The ECM
functions as a structural and bioactive framework that modulates cell signaling and cell
fate373. Recognizing the importance of this environment in mediating cell function, there
has been growing interest in designing naturally-derived cell-instructive biomaterials that
can be used within cell culture models and cell delivery strategies. Tissue decellularization
is an approach that has been shown to selectively remove immunogenic cellular
components while retaining the ECM unique to the tissue of interest13,212. A range of
decellularized tissues exhibit retained tissue-specific structural proteins, growth factors and
matricellular

proteins,

as

shown

by

immunohistochemical

and

proteomic

analyses185,233,320,335. Notably, several recent studies have demonstrated the potential of
decellularized ECM-derived bio-scaffolds to enhance the viability, proliferation and
lineage commitment of stem/progenitor cells when used in a tissue-specific
manner260,359,367,371. These studies have provided a rationale to further investigate the
effects of tissue-specific ECM and validate its use as an instructive component for cellbased strategies.
In the context of developing ECM-derived bio-scaffolds for bone regeneration, bone graft
substitutes such as commercially available demineralized bone matrix (DBM) have been
developed that have shown osteo-inductive potential in a range of in vitro and in vivo
studies242,243,267,374. DBM is typically produced via the acid extraction of mineral content
from allogenic bone and has been shown to retain collagen type I, non-collagenous proteins
(e.g. osteopontin) and growth factors (e.g. bone morphogenic proteins (BMPs))194.
However, differences in osteogenic activity of commercial DBM products have been
observed due to variation in donor age, health status, DBM processing and carriers375,376,
with some negative inflammatory effects also documented377. This has prompted the
scientific community to investigate the development of effective and reproducible
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protocols for decellularizing bone that retain its osteo-inductivity and osteo-conductivity.
In surveying the literature, several groups have developed methods to decellularize
trabecular bone, with most groups predominantly using detergents that can prove to be
cytotoxic if not completely eliminated after the decellularization process223,249,254.
Trabecular bone is commonly utilized in these approaches rather than cortical bone due to
its porous ultrastructure that facilitates decellularization and inherent osteo-inductivity
possibly due to high concentrations of resident osteoblast progenitors that help maintain
the osteogenic potential prior to decellularization194,241,378,379. While some researchers have
developed detergent-free protocols215,253, these methods have involved the use of harsh
organic solvents to remove bone marrow constituents that could potentially disrupt the
ECM ultrastructure and release growth factors212,213. In addition, they typically require
prolonged periods of incubation time in decellularization reagents253. Furthermore,
although the ability for these resulting decellularized bone bio-scaffolds to modulate
osteogenic differentiation has been documented266,380,381, to the best of our knowledge, no
group has performed a rigorous characterization of the decellularized bone ECM
composition using immunohistochemical and biochemical assays.
Addressing these limitations, the goal of the work described in this chapter was to develop
a reproducible detergent-free method to obtain bovine decellularized trabecular bone
(DTB), with the elimination of nuclear content but retention of complex ECM composition.
Bovine bone was selected as the source due to its ease of procurement in addition to its
physiochemical and structural resemblance to human bone382–385. Following the
development of the decellularization protocol, the biochemical composition of the DTB
was characterized with decellularized adipose tissue (DAT) as a comparator, using
immunohistochemical techniques and biochemical assays. It was hypothesized that while
there might be similarities in terms of the major structural components between the two
tissue types, differences would be present in terms of the relative abundance and
distribution of some ECM constituents between the two tissue sources. These studies form
the basis for the future comparison of the DAT and DTB as cell-instructive components
for the lineage-specific differentiation of human adipose-derived stromal (ASCs)
encapsulated within 3-dimensional hydrogel systems in Chapter 4.
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3.2 Methods
3.2.1 Bovine trabecular bone decellularization
3.2.1.1

Bovine bone procurement

Bovine trabecular bone was sourced from the intervertebral bodies in the tail region of 30month old cows obtained from the Mount Brydges Abattoir using a chisel and mallet. The
trabecular bone was extracted within one hour of procurement and cut into pieces (~ 2 mm
x 2 mm x 2 mm) to increase the surface area in contact with the decellularization reagents.
The bone fragments were then rinsed in phosphate buffered saline (PBS) for 20 min to
remove blood, prior to treatment with the various decellularization protocols. The bone
was either subjected to the first step of each decellularization protocol or stored at -80 ºC
until further processing.

3.2.1.2

Trabecular bone decellularization

For initial screening, two protocols (Protocol 1215 and 2 254) from the literature were adapted
and slightly modified in an effort to eliminate the use of detergents. Protocol 1 was chosen
due to its resemblance with methods used to produce commercially-available DBM and
the ability to avoid the use of any detergents. Protocol 2 was chosen due to its use of freezethaw cycles that have been deemed effective in the removal of cellular contents, when used
alone or in combination with other chemical and enzymatic agents. However, the detergent
step using Triton X-100 originally included in the protocol was omitted and the freezethaw cycles were performed between -80°C and 37°C instead of -196°C and 121°C to
circumvent any temperature associated denaturing of proteins. Both the initial two
protocols were also selected as they avoided the need for expensive equipment (e.g.
isostatic pressurization machines) and extended processing times. The third and final
protocol (Protocol 3) was developed with elements adapted from methods used for
producing commercially-available DBM240, as well as methods for adipose
decellularization developed in the Flynn lab184. Each protocol was tested on three different
animal donors to validate protocol consistency. A summary of the bovine bone
decellularization protocols tested is shown in Table 3.1, and detailed protocols are provided
below.
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Table 3.1: Protocols tested to obtain decellularized trabecular bone.
Decellularization
Protocol
Protocol 1:
Sawkins et al.215

Protocol 2: Adapted and
modified from Gardin et
al.254

Protocol 3: Shridhar et al.

Methodology
1. All steps performed at 25 mL/g of tissue
2. Mineral extraction in 0.5 N hydrochloric acid for 24 h
at room temperature
3. Lipid extraction in chloroform/methanol (1:1) for 1 h
at room temperature
4. Trypsin (0.05 %) / ethylenediaminetetraacetic acid
(0.02 %) incubation for 24 h at 37 °C
1. All steps performed at 25 mL/g of tissue
2. 3 Freeze/Thaw cycles in PBS from -80 °C to 37 °C
3. Mineral extraction in 0.5 N HCl for 24 h at room
temperature
4. Lipid extraction in absolute ethanol for 24 h at 37 °C
1. All steps performed at 25 mL/g of tissue unless stated
2. 3 Freeze/Thaw cycles in hypotonic buffer (12 mL/g
of tissue) from -80 °C to 37 °C
3. Mineral extraction in Formical 2000 for 8 h at room
temperature
4. Lipid extraction in isopropanol overnight at 37 °C
5. DNAse (36 µg/mL of solution), RNAse (125 µg/mL
of solution) and lipase (2 µg/mL of solution)
incubation overnight

Protocol 1
Protocol 1 was adapted from Sawkins et al.215 and was performed over a timeframe of 2.5
d. All the steps were performed at a reagent versus tissue ratio of 25 mL/g of tissue. The
bone fragments were first subjected to an acid extraction of the inorganic component of the
bone in 0.5 N hydrochloric acid (HCl) for 24 h at room temperature. The bone fragments
were maintained in suspension by stirring at 300 rpm to ensure their interaction with the
decellularization reagents. Following this, the tissue was incubated in a 1:1 ratio of
chloroform/methanol supplemented with 1% antibiotic/antimycotic (ABAM) (Gibco®,
Thermo-

Fisher

Scientific,

Oakville,

ON,

Canada)

and

0.014

mM

phenylmethylsulfonylfluoride (PMSF) for 1 h at room temperature to extract the lipid-rich
bone marrow constituents. Following lipid extraction, the tissue was rinsed in PBS three
times for 30 min each at 37 °C to remove the organic solvents before incubation in trypsin
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(0.05 %) / ethylenediaminetetraacetic acid (EDTA) (0.02 %) for 24 h at 37 °C
supplemented with 1% ABAM and 0.014 mM PMSF. Finally, the bone was rinsed twice
in PBS for 15 min each at room temperature, followed by a single 15 min rinse in deionized
water (dH2O), prior to freezing at -80 °C and lyophilization.
Protocol 2
Protocol 2, adapted and modified from Gardin et al. 254 included demineralization in 0.5 N
HCl, which is a consistently implemented step in bone decellularization, but involved the
use of freeze-thaw cycles with agitation to promote cell lysis. This protocol spanned a total
of 3.5 d. All the steps were performed at a reagent versus tissue ratios of 25 mL/g of tissue.
First, the bone fragments were submerged in freezing solution consisting of PBS with 1%
ABAM and 0.014 mM PMSF. The tissue was subjected to 3 freeze-thaw cycles from -80
°C to 37 °C, with replacement of the freezing solution between each cycle. During the thaw
step, samples were agitated at 200 rpm to aid decellularization. Next, the tissue was
incubated at room temperature in 0.5 M HCl for 24 h at room temperature under agitation
at 300 rpm, similar to Protocol 1. The tissue was then incubated in absolute ethanol
supplemented with 1% ABAM and 0.014 mM PMSF under agitation at 200 rpm and 37°C
for 24 h to extract lipid. Finally, the bone was rinsed twice in PBS at room temperature for
15 min, followed by a single 15 min rinse in dH2O, prior to freezing at -80°C and
lyophilization.
Protocol 3
Protocol 3 spanned a total of 3 d and also involved freeze-thaw cycles in a hypotonic
freezing solution in place of PBS to help promote cell lysis184. All the steps were performed
at a reagent versus tissue ratio of 25 mL/g of tissue unless otherwise stated. More
specifically, the bone fragments were processed in a hypotonic freezing solution consisting
of 10 mM Tris and 5 mM EDTA solutions supplemented with 1% ABAM and 0.014 mM
PMSF at a ratio of 15 mL of solution per gram of tissue. The tissue was subjected to 3
freeze-thaw cycles from -80 °C to 37° C, with replacement of the freezing solution between
each cycle. During the thawing step, the samples were agitated at 200 rpm to aid
decellularization. Next, the tissue was incubated at room temperature in Formical 2000
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(StatLab, Texas) consisting of 23% (w/w) formic acid for 8 h at room temperature under
agitation at 300 rpm. Formic acid is a weak acid and common decalcification reagent
utilized to process calcified tissue such as bone for histology386,387. It was selected as an
alternative to HCl as it was anticipated to demineralize the bone tissue as effectively, in a
less harsh manner. The processed bone was then rinsed with absolute isopropanol
supplemented with 1% ABAM and 0.014 mM PMSF under agitation at 200 rpm and 37°C
overnight to extract lipids. Next, the tissue was rinsed in Sorensen’s phosphate buffer
(SPB) rinse solution (8 g/L NaCl, 200 mg/L KCl, 1 g/L Na2HPO4, and 200 mg/L
KH2PO4 (pH 8.0)) three times, 30 min each, at room temperature and incubated in SPB
digest solution (55 mM Na2HPO4, 17 mM KH2PO4, 4.9 mM MgSO4.7H2O) supplemented
with 12.5 mg RNase Type III (from bovine pancreas), 15,000 U DNase Type II (from
bovine pancreas) and 2,000 U Lipase type VI-S (from porcine pancreas) overnight at 37°C
under agitation. Finally, the tissue was rinsed in the SPB rinse solution three times for 30
min each at room temperature, followed by two 30 min rinses in dH2O and freezing at 80°C and lyophilization.

3.2.2 Evaluation of decellularization
3.2.2.1

4′,6-diamidino-2-phenylindole (DAPI) and Masson’s
trichrome staining

Decellularized bone samples from the three different decellularization protocols were fixed
overnight in 4 % paraformaldehyde (PFA). Native tissue control samples were
demineralized in formic acid overnight, and then similarly fixed and processed for
sectioning. The following day, the samples were rinsed in PBS, transferred into 70 %
ethanol, and sent for processing at the Robarts Molecular Pathology Laboratory in London,
ON. The samples were subsequently embedded in paraffin and sectioned (5 µm sections)
using a Leica RM2235 microtome (Leica Biosystems, Concord, ON, Canada). Finally, the
sections were deparaffinized by incubation in xylene twice for 10 min each, followed by
rehydration in an ethanol series from 100 % ethanol to 70% ethanol, followed by two rinses
in dH2O for 5 min each. Three separate animal donors obtained on different days were
assessed with triplicate technical samples to account for any variability and confirm the
consistency of the decellularization protocols. The sections were stained with DAPI to
identify residual nuclear content and Masson’s trichrome staining was performed using the
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manufacturer’s protocol to further confirm residual nuclear content and assess collagen
distribution. Images were taken at both 10X and 20X magnification with an EVOS XL
CORE light microscope (Life Technologies).

3.2.2.2

dsDNA quantification

To corroborate the qualitative staining results, the residual DNA content in the
decellularized tissue was quantified. The decellularized tissue samples from the three
different DTB protocols (n = 3 samples, N = 3 tissue donors), were frozen, lyophilized and
cryo-milled into micron-sized particles using established methods262. Purified double
stranded DNA (dsDNA) was extracted from decellularized bone samples from all three
decellularization protocols and native bone tissue controls using the DNeasy Blood and
Tissue Kit (Qiagen, Germany), according to the manufacturer’s protocols. The purity of
the extracted dsDNA was confirmed using the Nanodrop spectrophotometer (ND1000,
Fisher Scientific), and then quantified using the PicoGreen® dsDNA quantification assay
(Life technologies) according to the manufacturer’s protocol. The resulting data was
normalized to the dry mass of initial cryo-milled tissue.

3.2.2.3

Hydroxyproline content

The hydroxyproline assay (Abcam) was used to assess the total hydroxyproline content in
the samples from the three different protocols, as a measure of the total collagen content388.
The decellularized tissue samples from the three different DTB protocols (n = 3 samples,
N = 3 tissue donors) were frozen, lyophilized and cryo-milled into micron-sized particles
using established methods. The samples were then digested with 60 mU/mL of proteinase
K enzyme in Tris-EDTA buffer (200 nM Tris-HCl, 200 nM EDTA, pH 7.5) under agitation
at 300 rpm and 65 °C for 1 h, followed by a 10 min incubation at 95 °C to inactivate
the enzyme. Following this, the digested samples were hydrolyzed in 12 N HCl at 110 °C
for 24 h, neutralized with 6 N sodium hydroxide and filtered using activated charcoal.
Finally, 50 µL volumes of 0.05 N chloramine-T/20% 2-methoxyethanol (20 min
incubation), 3.15 N perchloric acid (5 min incubation) and Ehrlich’s reagent (20 min
incubation at 60 °C) were added sequentially into a 96-well plate containing the 50 µL
sample volumes (1:20 dilution in water). Before measurement, the plate was incubated at
4 °C and absorbance was measured at 560 nm using a CLARIOstar spectrophotometer
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(BMG LABTECH Inc) against a hydroxyproline standard curve. The resulting data was
normalized to the dry mass of initial cryo-milled tissue.

3.2.2.4

Glycosaminoglycan content

The glycosaminoglycan content was evaluated using the dimethyl methylene (DMMB)
blue assay, which detects sulphated glycosaminoglycans. The decellularized tissue samples
from the three different DTB protocols (n = 3 samples, N = 3 tissue donors) were frozen,
lyophilized and cryo-milled into micron-sized particles using established methods262. The
milled DTB samples from the three different protocols were digested in proteinase K as
described in section 3.2.2.3. Next, 10 µL volumes of the ECM digests were pipetted into
96-well plates followed by 200 µL of a 1.6% solution of DMMB dye dissolved in 1%
ethanol and 0.2% formic acid in dH2O. The measurements were made using a CLARIOstar
spectrophotometer (BMG LABTECH Inc) against a chondroitin sulphate standard curve at
525 nm. The resulting data was normalized to the dry mass of initial cryo-milled tissue.

3.2.3 Comparative Evaluation of DTB vs DAT
The ECM composition of the DTB generated with Protocol 3 was characterized in
comparison to human decellularized adipose tissue (DAT), in preparation for future cell
culture studies comparing the cellular response to the two tissue sources.

3.2.3.1

Adipose tissue procurement and decellularization

Subcutaneous adipose tissue was collected from patients undergoing lipo-reduction
surgeries at the University Hospital and St. Joseph’s Health Care Hospital in London, ON
(HREB# 105426). Samples were transported in sterile PBS supplemented with 20 mg/mL
bovine serum albumin (BSA) and decellularized using published methods to obtain
DAT184.

3.2.3.2

Hydroxyproline content

The DTB (Protocol 3) and DAT samples (n = 3 samples, N = 3 tissue donors pooled prior
to the trial) were frozen, lyophilized and cryo-milled into micron-sized particles using
established methods262. Hydroxyproline content was assessed using the hydroxyproline
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assay based on methods described in section 3.2.2.3. The resulting data was normalized to
the dry mass of initial cryo-milled tissue.

3.2.3.3

Glycosaminoglycan content

The glycosaminoglycan content of DAT and DTB (Protocol 3) samples (n = 3 samples,
N = 3 tissue donors pooled prior to the trial) was compared using the DMMB assay based
on methods described in sections 3.2.2.4. The resulting data was normalized to the dry
mass of initial cryo-milled tissue.

3.2.3.4

Immunohistochemical staining and semi-quantitative
analysis of ECM constituents

DTB and DAT samples (n = 3 samples, N = 2 tissue donors) were embedded in Tissue-Tek
OCT compound (Sakura Finetek, Torrance, CA, USA), and snap frozen in liquid nitrogen
prior to cryosectioning (7-µm transverse sections). The sections were first fixed in acetone
and blocked with 10 % goat serum in Tris buffered saline (TBS) and 1% Triton-100X for
1 h. The sections were then stained overnight at 4 °C with rabbit polyclonal antibodies
against collagen type I (dilution 1:100 in TBS with 1% BSA, ab34710, Abcam, Toronto,
ON, Canada), collagen type IV (dilution 1:100, ab6586, Abcam), collagen type V (dilution
1:300, ab7046, Abcam), collagen type VI (dilution 1:300, ab6588, Abcam), fibronectin
(dilution 1:150, ab23750, Abcam), or laminin (dilution 1:200, ab11575, Abcam).
Following primary antibody incubation, the slides were rinsed extensively with TBS before
incubation with an Alexa Fluor® 594 conjugated goat anti-rabbit IgG secondary antibody
(ab150080, Abcam) at 1:200 dilution in the blocking buffer for 1 h at room temperature.
Finally, the slides were rinsed in PBS and mounted with Fluoroshield™ mounting medium
(Abcam) containing DAPI for the visualization of cell nuclei. Positive tissue controls and
controls with no added primary antibody were included during all experiments
(Appendix A, Fig. A.4). Mouse skin was used as a positive control for collagen type I, IV,
laminin and fibronectin, while human adipose tissue was used as a positive control for
collagen type V and VI. Images were acquired with a Zeiss Imager M2 microscope (Zeiss
Canada, Toronto, ON, Canada) from 4-5 fields of view on each sample. Semi-quantitative
analysis of the relative expression levels was performed using ImageJ and results reported
as a percentage of the positive signal area normalized to total tissue area.
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3.2.3.5

Picrosirius red staining

DTB and DAT samples (n = 3 samples, N = 2 tissue donors) were processed, embedded
and sectioned in paraffin as described in section 3.2.2.1. To prepare sections for the
staining, they were deparaffinized by incubation in xylene twice for 5 min each, followed
by rehydration in an ethanol series from 100 % ethanol to 70% ethanol and an incubation
in acetone at -20 °C for 10 min. Finally the slides were rinsed in PBS for 2 min each, with
a final rinse in dH2O for 10 min. The sections were then placed in a Coplin jar and stained
with 90 mL of Picrosirius Red solution (1 mg/mL) made of Direct red 80 dye (Sigma
Aldrich) in 1 % picric acid and incubated at room temperature for 60 min followed by two
rinses in 100 % ethanol for 2 min each and a final incubation in xylene for 5 min before
being mounted with Permount® mounting media (Thermo Scientific) and left to air dry.
Slides were visualized using a Nikon Optiphot-pol polarizing microscope (Nikon, Tokyo)
under circularly polarized light and images captured with an Infinity 2-3 CCD camera
(Lumenera, Ottawa, Canada) at 10X magnification.

3.2.4

Statistical analysis

All numerical data are expressed as mean ± standard deviation (SD). All statistical analyses
were performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA) by oneway ANOVA with a Tukey’s post-hoc comparison of the means. Differences were
considered statistically significant at p < 0.05 unless otherwise noted.

3.3

Results

3.3.1 Bovine bone decellularization
3.3.1.1

Macroscopic evaluation

A macroscopic evaluation of bone decellularized with the three different protocols showed
differences at each step of the decellularization (Fig. 3.1). Upon acid extraction, the
samples from Protocol 1 appeared red (Fig. 3.1A), suggestive of the presence of residual
blood and bone marrow, specifically in the centers of the samples. However, the samples
exhibited a spongy texture that was consistent with the extraction of the inorganic phase.
While the lipid extraction stage did aid in eliminating the red colour, the resulting DTB
appeared off-white (Fig. 3.1B). Bone samples decellularized using Protocol 2 displayed a
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mild brown tinge following the freeze-thaw cycles in PBS, with no further change in colour
observed during processing. This suggested that the freeze-thaw procedure enhanced the
extraction of bone marrow constituents compared to solely agitation steps (Fig. 3.1C and
D). As in Protocol 1, the acid extraction stage appeared to be effective in removing mineral
content from the bone, with the samples exhibiting a soft and spongy texture at the end of
treatment. In Protocol 3, the freeze/thaw cycles in hypotonic solution qualitatively
appeared to be effective in removing the bone marrow, with the samples appearing offwhite at the end of processing (Fig. 3.1E and F). Upon mineral and lipid extraction, the
samples appeared consistently white, with no visible retention of bone marrow. Following
formic acid treatment, a similar texture was observed to the samples subjected to Protocol
1 and 2, suggestive of effective demineralization. Overall, for all three protocols,
approximately 90% loss of mass was observed by the end of processing.

Figure 3.1: Macroscopic evaluation of bone decellularized using the three different
protocols. (A) Protocol 1 bone samples still appeared red after the first demineralization
step, while Protocols (C) 2 and (E) 3 that involved freeze/thaw cycles has a lighter
colouration consistent with enhanced removal of the bone marrow constituents. Post
processing, the samples from Protocols (B) 1 and (D) 2 appeared off-white with some
darker regions, while the samples from (F) Protocol 3 had a more uniform white
appearance.
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3.3.1.2

DAPI and Masson’s Trichrome staining

DAPI (Fig. 3.2) and Masson’s Trichrome (Fig. 3.3) staining of paraffin sections
corroborated each other and supported the macroscopic observations in section 3.2.1.1,
with Protocol 1 ineffective in removing most of the nuclear content particularly in the bone
marrow (20X image), as well as osteocytes in their lacunae within the trabeculae. Although
the absence of nuclear content in the marrow region on bone sections from Protocol 2
indicated that the freeze-thaw cycles were successful in eliminating cells associated with
the bone marrow, visible nuclei from osteocytes were observed within the lacunae. Bone
sections from Protocol 3 indicated the complete loss of nuclei in both the bone marrow and
within lacunae, demonstrating the efficacy of the approach in decellularizing the bone
tissue. Further, there was no evidence of residual cell debris at the end of the processing.
Sections stained with Masson’s Trichrome stain confirmed that Protocols 2 and 3
eliminated the bone marrow constituents more effectively than Protocol 1.
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Figure 3.2: DAPI staining of paraffin sections to identify remaining nuclei. Protocol 3
was the most efficient in removing both nuclear material in the bone marrow, as well as
from lacunae embedded within the collagenous region of the bone. Boxed regions in 10X
images (left panels) are magnified at 20X (right panels). Scale: 100 µm.
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Figure 3.3:Masson’s trichrome staining evaluated the ability for the protocols to
eliminate cellular contents within the bone marrow regions. Consistent with the DAPI
staining results, Protocols 2 and 3 were the most efficient in removing nuclear content in
the bone marrow region. Boxed regions in 10X images (left panels) are magnified at 20X
(right panels). Scale: 100 µm.
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3.3.1.3

dsDNA Quantification

dsDNA content quantified using the PicoGreen® assay (Fig. 3.4) supported the qualitative
assessments from the DAPI and Masson’s trichrome staining. While all of the protocols
significantly reduced the dsDNA content in the decellularized tissue compared to native
bone tissue (205.1 ± 18.1 ng/mg of tissue), a significantly lower dsDNA content was
observed in samples using Protocols 2 (3.2 ± 0.6 ng/mg of tissue) and 3 (1.6 ± 0.3 ng/mg
of tissue) as compared to residual dsDNA content in Protocol 1 (26.7 ± 3.8 ng/mg of tissue).
Overall, Protocol 3 was the most effective at eliminating nuclear content in the bone tissue
samples, with the shortest processing time and using the most gentle processing methods.
It was also noticed that the bone samples subjected to decellularization Protocol 3 exhibited
the least variability between individual samples and animal donors.

Figure 3.4: PicoGreen® quantification of double stranded DNA content in
decellularized samples. All of the protocols significantly reduced the dsDNA content
compared to native tissue with Protocol 2 and 3 retaining the lowest residual dsDNA
(*,**p<0.05) (n=3, N=3 tissue donors’ dry weight)
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3.3.1.4

Hydroxyproline and GAG content

An analysis of the DTB samples subjected to the three protocols in terms of their collagen
and GAG content indicated that DTB obtained from Protocols 1(120.2 ± 2.0 µg/ mg tissue),
2 (107.2 ± 14.4 µg/ mg tissue) and 3 (124.2 ± 1.3 µg/ mg tissue) exhibited similar amounts
of collagen after the decellularization process (Fig. 3.5A). In addition, the DTB samples
also did not differ in terms of their GAG content (Fig. 3.5B). DTB samples from Protocols
1, 2 and 3 contained 10.4 ± 2.2 µg/ mg tissue, 10.2 ± 1.4 µg/ mg tissue and 10.1 ± 0.4 µg/
mg tissue respectively.

Figure 3.5: Biochemical evaluation of the DTB obtained from the three different
decellularization protocols. The results indicated that there were no observed significant
differences in (A) hydroxyproline content and (B) GAG content between bone samples
subjected to the three different protocols. (*p<0.05) (n=3, N=3 tissue donors’ dry weight)

3.3.2
3.3.2.1

Comparative Evaluation of DTB vs DAT
Biochemical Composition of DTB vs DAT

A comparative evaluation of collagen and GAG content using the hydroxyproline assay
and DMMB assay suggested that the DTB and DAT were distinct in terms of their
biochemical composition (Fig. 3.6). More specifically, the hydroxyproline assay indicated
a higher collagen content in the DTB (120.2 ± 2.2 µg/ mg tissue) than the DAT (97.9 ± 0.9
µg/ mg tissue). Further, the DTB samples showed a significantly higher (~5-fold) GAG
content (10.1 ± 0.4 µg/ mg tissue) as compared to the DAT (2.4 ± 0.3 µg/ mg tissue).
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Figure 3.6: Biochemical evaluation of DTB as compared to DAT. The two ECM types
indicated that the DTB had significantly higher collagen and GAG content than the DAT.
(*p<0.05, n=3, N=3 tissue donors’ dry weight pooled)

3.3.2.2

Immunohistochemical staining of DTB vs DAT

The qualitative (Fig. 3.7A) and semi-quantitative (Fig. 3.7B) immunohistochemical
evaluation indicated that both ECM types contained similar relative amounts and
distribution of collagen type I and collagen type V. Notably, collagen type I (DTB: 35 ±
13 %, DAT: 25 ± 5 %) was abundant in both tissues, while collagen type V (DTB: 3.4 ± 2
%, DAT: 4 ± 1 %) was relatively less expressed. Fibronectin levels (DTB: 9.5 ± 6.2 %,
DAT: 35.4 ± 15.9 %) were qualitatively more expressed in the DAT. However, the semiquantitative analysis indicated that the levels were not statistically different between the
two groups, likely due to the large sample-to-sample and regional variability observed in
the DAT samples. Further, the DAT contained ~4-fold higher collagen type IV, ~6-fold
higher collagen type VI, and ~5-fold higher laminin expression compared to DTB. Both
tissues displayed minimal expression and distribution of laminin with some regions and
samples lacking laminin expression.
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Figure 3.7: Immunohistochemical staining (A) and semi-quantitative comparative
analyses (B) of the DTB and DAT to identify key ECM constituents. Data indicated
that there was no statistical difference in the levels of collagen type I, V and fibronectin
between the groups. The DAT however, contained a significantly higher amount of
collagen IV, VI and laminin. (n=3, N=2 tissue donors, 4-5 images per sample) (*p<0.05)
Scale: 100 µm.
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3.3.2.3

Picrosirius Red staining of DAT vs DTB

Picrosirius red staining (Fig. 3.8) indicated that the DTB and DAT were distinct in the type,
distribution and organization of fibrillar collagens present. DTB sections mostly appeared
red/orange, indicating the predominant presence of thicker fibrillar collagen types. In
contrast, sections of the DAT showed the presence of thin fibers, as seen by the
green/yellow birefringence. The DTB samples also maintained the characteristic weave
pattern seen in bone tissue.

Figure 3.8: Picrosirius red staining of DTB and DAT sections. Birefringence indicated
that while DTB contained predominantly thicker fibrillar collagen types as seen by the
red/orange appearance, DAT contained thinner fibers as seen by the green and orange
colours under polarized light microscopy. Scale: 100 µm.

3.4 Discussion
First described by Urist et al389, several commercial human DBM products including
GraftonTM

(Osteotech

Inc),

DynaGraftTM

(Regeneration

Sciences

Inc)

and

OsteofilTM(Medtronic) are now available in a variety of forms such as gels, sheets, chips
and pastes194,243,390. While these products have been shown to generally promote
osteointegration and accelerate tissue repair in vivo242,243,267,374, the inconsistencies in
osteo-inductivity and subsequent regenerative responses have motivated the development
of reproducible protocols for decellularizing bone tissue with minimal modification to
ECM composition and bioactivity267,391,392. Further, to facilitate the use of decellularized
bone as a cell-instructive substrate within cell culture models to study the effects of ECM
composition on stem/progenitor cell differentiation, more complete characterization of the
ECM constituents within the processed tissues is necessary.
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With this in mind, this study focused on the development of a detergent-free and
reproducible method to extract decellularized ECM from bovine trabecular bone. In
contrast to commonly implemented protocols, this approach avoided the use of potentially
cytotoxic detergents such as SDS and Triton-100X223,247,254. While some groups have
developed detergent-free decellularization protocols to obtain DTB, some of these
processes require expensive equipment (e.g. isostatic pressurization machines) and longer
processing times to eliminate harsh organic solvents that could be problematic for scaleup253. As an added objective, the resulting bone matrix was compared with the DAT in
terms of its biochemical composition to identify differences that could potentially impact
the lineage-specific differentiation of ASCs when used as a cell-instructive component
within in vitro cell culture models.
Based on the results of this study, the finalized detergent-free protocol was highly effective
and consistent at eliminating nuclear content compared to the other protocols studied. The
freeze-thaw steps adopted extracted the bone marrow constituents within a short timeframe, without the need for harsh chemical or enzymatic digestion steps that have been
shown to alter ECM biochemical and biomechanical properties227,393. Notably, the
hypotonic solution used in the finalized protocol compared to PBS in Protocol 2, was
slightly more effective at extracting the bone marrow constituents, in addition to improving
the extraction of nuclear content within the trabeculae. Indeed, the decellularization of
other dense tissues such as tendon and cartilage have demonstrated similar results, with
freeze-thaw cycles alone or in combination with other chemical and enzymatic agents
resulting in the effective removal of cells394–397. It is hypothesized that freeze-thawing
increases tissue porosity and induces cell lysis through the formation of ice crystals, while
imparting only minor modifications to the ECM structural and biomechanical properties394–
397

. While the use of polar solvents is common in extracting lipids from fatty tissues, the

new protocol was developed to exclude the use of harsh organic solvents such as methanol
and chloroform used in Protocol 1, which are also frequently used as tissue fixatives217.
The finalized decellularization protocol resulted in the qualitatively effective
demineralization of the bone samples with the use of a milder acid, in one third of the
treatment time, without compromising the efficacy of decellularization. A more in-depth
assessment of demineralization would be beneficial to corroborate this, and could be
performed using calcium colorimetric assays or X-ray diffraction methods398,399. Formic
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acid is a well-known decalcifying agent for histology, with its use documented in the
decellularization of other tissues such as menisci400,401. Chen et al. showed that the formic
acid decellularization of porcine meniscus ensured the effective elimination of cells and
debris, while showing little to no adverse effect on GAG and type II collagen content400.
Interestingly, a study by Pietrzak et al. recently indicated that increased concentrations and
incubation times in HCl resulted in the decline of growth factors of the BMP family
possibly due to the hydrolysis of amide bonds, supporting the value of investigating a
milder acid with a shorter incubation time257. All three decellularization protocols retained
similar amounts of collagen and GAG post decellularization as seen by the hydroxyproline
and DMMB assays.
Acknowledging the role of tissue-specific ECM composition in mediating a range of
cellular processes, several in vitro cell culture models that assess stem/progenitor cell
lineage-commitment involve the systematic incorporation of one or many tissue-specific
structural constituents7,294,367. Many of these studies have enabled the identification of key
components that potentially mediate osteogenesis121,402–404 and adipogenesis162,163,405,406.
With this in mind, a group of ECM constituents were selected for comparative analyses
that

have

been

previously

shown

to

promote

osteogenesis121,402–404

and

adipogenesis162,163,405,406.
Biochemical characterization of DTB and DAT indicated that although no significant
difference in hydroxyproline content was observed between the two tissue types, sulphated
GAG content was more prevalent in the DTB samples, which is expected given its
significant role in bone homeostasis and morphogenesis180,407,408. GAGs in the bone also
serve to modulate the bioavailability and bioactivity of various osteogenic factors180,407,408.
A number of studies have also indicated the ability for GAG-modified substrates to
downregulate proliferation and activate osteoblast differentiation in a range of
stem/progenitor cell types172,407,409. Picrosirius staining and visualization also indicated that
the DTB and DAT were starkly different in terms of overall collagen structure and
organization. Our immunohistochemical data indicated that the DTB and DAT were
abundant in collagen type I, which was anticipated given that over 90 % of the organic
portion of bone comprises collagen type I, with its expression also evident in the connective
tissue component of adipose tissue410,411. A similar trend was observed with fibronectin,
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consistent with the fibronectin-collagen type I interaction in ECM secreted by osteoblasts
during bone formation144,412. In bone, fibronectin also serves to bind and regulate growth
factors from the BMP family413,414. The presence of collagen type I and fibronectin in DAT
supports data obtained from previously characterized DAT scaffolds both in their intact
and processed formats184,185,272.
Given that basement membrane proteins line the rich vascular network in native adipose
tissue, and surround mature adipocytes184, higher levels of basement membrane proteins
(collagen type IV and laminin) were anticipated in the DAT. This premise was supported
by the analyses from the current study, and previously published data has similarly
identified these components in intact DAT239,272. However, the protocols to decellularize
trabecular bone involved the removal of the bone marrow containing the vasculature and
adipocytes, resulting in the conceivable loss of these proteins240. Given that basement
membrane proteins play a fundamental role in mediating wound healing and potentiating
adipogenesis163,415,416, the relative abundance of these proteins within DAT could
potentially encourage the adipogenic differentiation of ASCs when incorporated within cell
culture models. Similarly, collagen type VI found along the periphery of mature
adipocytes, and serving to regulate adipocyte hypertrophy in vivo, was also more prevalent
in the DAT than the DTB64,292.
Overall, the data supported that the DTB and DAT generated with the decellularization
approaches developed in the Flynn lab were distinct, with tissue-specific ECM
composition. Although the bovine DTB has not been previously characterized using
proteomic and/or western-blotting techniques, previous proteomic data comparing human
DTB extracted with the finalized protocol and human DAT similarly indicated marked
differences in the protein composition between those two sources185. More specifically, the
DAT contained elevated levels of adipogenic proteins, while the DTB showed elevated
levels of osteogenic proteins185. These fundamental differences can potentially be
harnessed in future studies to investigate the effects of tissue-specific ECM composition
on the osteogenesis and adipogenesis of ASCs.
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3.5

Conclusion

In the current study, a detergent-free method was successfully developed to decellularize
bovine trabecular bone without the need for excessive physical processing or prolonged
incubation times. The resulting DTB showed the effective and consistent removal of cells,
including those embedded within their lacunae. Characterization of the DTB in comparison
to DAT indicated distinct structural and compositional differences, with higher levels of
sulphated GAGs observed in the DTB, which may help to promote osteogenesis, and higher
levels of basement membrane proteins in the DAT, which may be favourable for
adipogenesis. The data implies that the two ECM types are distinct and can be potentially
harnessed to investigate lineage-commitment in ASCs when used as cell-instructive
constituents within in vitro cell culture models.
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Chapter 4

4

The effect of tissue-specific extracellular matrix on the
adipogenic and osteogenic differentiation of human
adipose-derived stromal cells within methacrylated
chondroitin sulphate hydrogels
4.1

Introduction

In order to better represent the 3-dimensional (3D) in vivo cellular microenvironment in
culture, there is interest in the development of advanced cell culture models using
biomaterials including hydrogels, electrospun bio-scaffolds and more recently, bioprinting8–11. These platforms represent promising tools for investigating the role of
extracellular matrix (ECM) composition on stem/progenitor cell behavior8–11. In particular,
hydrogel systems are widely applied in these approaches as they offer versatility, and can
enable cell encapsulation within a highly hydrated microenvironment that can be tuned to
support long-term cell viability and function279,345.
The ECM is a highly complex microenvironment that has tissue-specific biochemical,
structural and biomechanical properties that play critical roles in directing cell function
during homeostasis and repair32. Recognizing the importance of the ECM, there is a
growing body of work on the design of hydrogels that replicate features of the native
cellular milieu, with a large focus on improving bioactivity through the addition of
naturally-derived cell-instructive components9,277,417. For example, the incorporation of
one or more ECM-derived proteins (e.g. collagen, laminin, elastin, fibronectin,
vitronectin), adhesive peptide sequences (e.g. arginine-glycine-aspartic acid (RGD) and
isoleucine-lysine-valine-alanine-valine (IKVAV) motifs), and/or growth factors have been
explored as approaches to tune the response of cells encapsulated within hydrogel
systems7,292–294. These modifications however, do not parallel the complexity of the ECM
in terms of composition and structure.
Tissue decellularization is a promising approach for the generation of tissue-specific
bioscaffolds that can retain biochemical and biomechanical properties of the native tissue
source13,213. A range of tissue types including small intestinal submucosa (SIS), urinary
bladder, dermal tissue, adipose tissue, and bone have been decellularized using protocols
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tailored to each tissue184,207,213–216. The resulting decellularized ECM can be enzymatically
processed using pepsin into a concentrated liquid format or milled into particulates for
incorporation within hydrogels to enhance bioactivity218,268,277. Multiple studies have
suggested that tissue-specific ECM derived from decellularized tissues can be incorporated
within a range of scaffold formats (e.g. coatings, foams, hydrogels) to enhance the lineagespecific differentiation of stem/progenitor cells233,269,297,341,349,356,416. While pepsin-digested
decellularized ECM has been successfully applied on its own as an injectable bioactive
hydrogel15,268,358, the resulting hydrogels are mechanically weak and show low stability
unless chemically crosslinked324,361. Furthermore, there is evidence to support that
strategies that minimize proteolytic digestion may be favourable for conserving bioactivity
in ECM-derived substrates270,418.
Recognizing this, a strategy adopted by our group and others has been to incorporate
processed decellularized ECM from a range of tissue types (e.g. adipose tissue, cartilage,
bone) in the form of micronized particles within naturally-derived or synthetic hydrogel
carriers to generate composite hydrogel models for investigating stem/progenitor lineage
commitment111,262,266,419–422. Overall, these studies have yielded promising results, with
ECM from tissue-specific sources promoting lineage-specific stem/progenitor cell
differentiation111,262,266,419–422. However, a key limitation is that the majority of studies to
date have focused on assessing single ECM sources111,256,262,419–422. In addition, some
comparisons have been made to control groups that have differing structural and/or
biomechanical properties in addition to composition, which makes it challenging to draw
conclusions on the mechanisms of the observed effects111,419,421,422. As such, there is a need
for more systematic comparisons between different ECM sources using well-characterized
platforms to be able to more fully interpret the tissue-specific compositional effects on the
cells.
In this context, the goal of this study was to assess the tissue-specific effects of
decellularized ECM from adipose tissue and bone on the lineage-specific differentiation of
adipose-derived stromal cells (ASCs) encapsulated within 3-D methacrylated chondroitin
sulphate (MCS) hydrogels. Chondroitin sulphate (CS) is an important ECM component
present within adipose tissue66,411,423 that also makes up the majority of the
glycosaminoglycan content in bone180,185,424. CS-based hydrogels have been shown to
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significantly enhance mesenchymal stromal cell osteogenesis in vitro and bone formation
in vivo425–428. MCS hydrogels have also previously been shown to support ASC cell
viability and adipogenic differentiation with or without the incorporation of DAT
particles261,262. The choice to focus on adipogenic and osteogenic differentiation in ASCs
was based in part on significant experimental evidence that suggests there is an inverse
relationship between adipogenesis and osteogenesis in ASCs, with adipogenic factors and
signalling pathways demonstrated to inhibit osteogenesis and vice versa87,429. Data from
Chapter 3 also indicated that the DAT and decellularized trabecular bone (DTB) were
distinct in terms of biochemical composition, allowing for the systematic evaluation of
tissue-specific ECM composition on ASC lineage commitment. The DAT contained an
abundance of basement membrane proteins that are known to play a role in
adipogenesis159,161–163, while the DTB was enriched in glycosaminoglycans (GAGs) that
may be favorable for osteogenesis403,407. Micronized particles of DAT and DTB were
incorporated along with human ASCs within the MCS hydrogels using a UV crosslinking
approach, and cell viability, adipogenesis, and osteogenesis were characterized in vitro
under culture conditions that promoted lineage-specific differentiation (induced) or
proliferation (non-induced) to probe the “conductive” and “inductive” effects of the ECM
sources respectively.

4.2 Materials and Methods
4.2.1

Materials

Unless otherwise specified, all chemicals and reagents were purchased from Sigma Aldrich
and used as received.

4.2.2

Human adipose tissue and bovine bone procurement and
decellularization

Subcutaneous adipose tissue was collected from patients undergoing lipo-reduction
surgeries at the University Hospital and St. Joseph’s Health Care Hospital in London, ON
(HREB# 105426). Samples were transported in sterile phosphate buffered saline (PBS)
supplemented with 20 mg/mL bovine serum albumin (BSA). The tissue was then was
decellularized to obtain DAT using previously published methods184.
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Bovine bone from the intervertebral bodies in the tail region of 30 month old cows was
obtained from the Mount Brydges Abattoir. Decellularized trabecular bone (DTB) was
generated using the new protocol developed in Chapter 3 (Protocol 3; Section 3.2.1.2).

4.2.3

DAT and DTB cryo-milling, characterization and staining

The human DAT (pooled from 5 donors) and bovine DTB (pooled from 3 donors) were
cryo-milled using previously established methods262. For all studies, the DAT and DTB
particles were utilized from the same batch of pooled ECM. The particles were sequentially
sieved through 125 µm and 45 µm stainless steel meshes, and those that collected on the
smaller mesh size were used in the studies. The particle size distributions of the DAT and
DTB particles were analyzed using a Malvern Mastersizer 2000 (Malvern Instruments
Ltd.,Worcestershire, United Kingdom). Prior to analysis, 1.0 g of pooled dehydrated ECM
particles was hydrated in 500 mL of PBS. The samples were then analyzed following the
manufacturer’s instructions. A Kolmogorov–Smirnov test with p < 0.05 was performed
using GraphPad Prism 6 (GraphPad Software, San Diego, CA) to assess whether the
particle size distributions for the DAT and DTB particles were statistically equivalent.
For studies requiring the visualization of the ECM particles within the hydrogels using
confocal microscopy, the DAT and DTB particles were pre-labeled with an amine reactive
AlexaFluor® 405 carboxylic acid succinimidyl ester (Life technologies). A stock solution
of 10 mg/mL was prepared by dissolving the dye in dimethyl sulfoxide (DMSO). DAT and
DTB particles were transferred to a falcon tube containing sterile 0.15 M NaHCO3 buffer
(pH 8.3) at a concentration of 60 mg of ECM particles/mL of buffer. The stock solution
was added to the solution (12.5 μL/300 mg of ECM particles), wrapped in foil and agitated
at room temperature for 1 h. The reaction was stopped using an equal volume of 1.5 M
hydroxylamine (pH 8.5) for 1 h before being rinsed in sterile PBS three times. The ECM
particles were suspended in PBS and stored at 4 °C until further use. Prior to encapsulation,
the ECM particles were decontaminated in 70 % ethanol overnight, followed by 3
successive 1 h rinses in PBS and stored at 4°C.
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4.2.4

Methacrylation of chondroitin sulphate

Methacrylated chondroitin sulphate (MCS) was synthesized using established
procedures118. Briefly, 1 g of chondroitin sulphate (LKT Technologies, St Louis) was
dissolved in 5 mL of 0.2 M sodium phosphate monobasic buffer solution. A 300 µL volume
of methacrylic anhydride (Sigma Aldrich) was added dropwise and left to react for 1 h at
room temperature with stirring. Throughout the reaction, the pH was adjusted with 2.0 M
sodium hydroxide to maintain a pH value of 8-10. Finally, the resulting solution was
precipitated in cold absolute ethanol, dissolved in deionized water (dH2O) at 50 mg/mL,
and dialyzed against 4 L of dH2O for 48 h in dialysis tubing with a molecular weight cutoff of 3.5 kDa (Fisher Scientific). The purified MCS solution was then lyophilized for 48
h and the final product was stored at -20 °C under nitrogen.
To characterize the MCS polymer, the degree of methacrylate substitution was assessed by
1

H NMR spectroscopy with a Varian Inova 400 spectrometer (Varian, USA). The MCS

was dissolved in deuterium oxide (Sigma Aldrich) at a concentration of 5 mg/mL. The
degree of methacrylate substitution was reported as the number of dimers bearing a grafted
methacrylate group per 100 dimers.

4.2.5

Composite hydrogel synthesis

Single phase (i.e. no ECM controls) and composite MCS hydrogels incorporating either
cryo-milled DAT or DTB were synthesized for characterization of gel content and
mechanical properties. In order to assess the maximum ECM concentration that could be
included within MCS hydrogels without interfering with the crosslinking, milled ECM
particles were added to the polymer solution in 2% (w/v) increments to a maximum of 10%
(w/v). The resulting hydrogels were macroscopically assessed for their stability in PBS at
37 °C over a period of 14 d, which was the standard culture period for the cell culture
studies. Based on this, a concentration of 8% (w/v) of cryo-milled ECM was chosen and
incorporated along with Irgacure 2959 photo-initiator at a final concentration of 0.05%
(w/v) within the MCS pre-polymer solution (100 mg MCS/mL of PBS). The pre-polymer
solution was transferred to a 1 mL syringe mold (Thermo Scientific), and photo-crosslinked
for 4 min (2 min on one side, followed by 2 min on the other) using long-wavelength
ultraviolet light (~365 nm) at an intensity of 12 mW/cm2.
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4.2.6
4.2.6.1

Hydrogel characterization
Gel content

Gel content indicates the relative amount of polymer that successfully integrated into the
hydrogel network and was assessed in order to confirm crosslinking efficacy (n=3 samples
per group/trial, N=3 trials). Immediately after photo-polymerization, the hydrogels were
frozen in liquid nitrogen and lyophilized for 24 h. The initial dry mass (m1) was then
recorded and each gel was incubated three times in 10 mL of dH2O water for 3 h each, to
extract the non-crosslinked polymer content from the hydrogels. After the rinses, the gels
were re-frozen in liquid nitrogen, lyophilized, and re-weighed to obtain their final dry (m2)
masses. The amount of ECM loss in the composite scaffolds during the washes was
accounted for in the mass differences by filtering the wash water through a Whatman type
I qualitative filter paper. The remaining residue was lyophilized, weighed and its weight
added to m2. The gel content was calculated using the following equation:
m+
Gel content (%) =
∗ 100
m=

4.2.6.2

Compression testing

Hydrogels for mechanical testing were prepared, swollen to equilibrium in PBS and
maintained at 37 °C prior to testing (n = 5). The height and diameter of the swollen
cylindrical hydrogels was measured using calipers immediately before testing. The
hydrogel height to diameter ratio for each sample was maintained at ~1.5 and hydrogels
were placed between sandpaper to secure them in place. Unconfined compression
measurements were conducted using a Cellscale UniVert system (Waterloo, Canada)
equipped with a 0.5 N load cell in a PBS bath maintained at 37 °C. Samples were initially
put through 2 cycles of preconditioning to a maximum of 10% strain at a rate of 0.05%/s430.
Cyclic compression testing was then performed with a 0.01 N preload applied at every
cycle and a total strain of 10 % at a rate of 0.05%/s, for a total of 4 cycles431. Nominal stress
was calculated from the applied force divided by the initial cross-sectional area of the
sample. The Young’s modulus (E) was obtained from the slope of the linear region of the
nominal stress-strain curve using the stress at 4% and 10% strain values as boundary
conditions.
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4.2.7

Human ASC isolation

Human ASCs were extracted using previously established protocols within 2 h of adipose
tissue procurement350. Fresh proliferation medium, comprised of DMEM:Ham’s F-12
medium supplemented with 10% fetal bovine serum (FBS; Thermo Scientific Hyclone,
Cat. # SH30396) and 100 U/mL penicillin and 0.1 mg/mL streptomycin (1% pen-strep),
was provided every 2-3 d, and the cells were passaged at 80% confluence. For all hydrogel
studies, passage 3 (P3) ASCs were utilized and studies were repeated on at least three
different donors. The summary of cell donor information for all in vitro studies can be
found in Appendix A (Table A.2).

4.2.8

Photo-encapsulation of hASCs within composite hydrogels

The pre-polymer solutions were made by dissolving MCS in PBS (100 mg MCS/mL of
PBS) with the addition of Irgacure 2959 photoinitiator (0.05 % (w/v)) and 8% (w/v) cryomilled DAT and DTB (decontaminated in 70% ethanol), as previously described in Section
4.2.5. ASCs were incorporated by adding P3 ASCs suspended in proliferation media, with
a final concentration of 10 x 106 ASCs/mL of final gel volume. For each group, the final
gel volume contained 80% pre-polymer and 20% cell suspension by volume was mixed
well through gentle stirring. ASCs were also encapsulated within MCS-only gels without
ECM particles for use as controls. The pre-polymer solution was transferred to 1 mL
syringe molds and photo-crosslinked for 4 min (2 min on one side followed by 2 min on
the other) using long-wavelength ultraviolet light (365 nm) at an intensity of 12 mW/cm2.
Post crosslinking, the hydrogels were cut into 50 µL gels and cultured on 12-well inserts
(Greiner Bio-one, Germany) in 3 mL of proliferation medium at 37 °C with 5% CO2.

4.2.9

Hydrogel cell culturing conditions

Hydrogels were cultured in either proliferation medium, adipogenic differentiation
medium, or osteogenic differentiation medium, as described in Table 4.1. For the cell
viability studies, all three media formulations were tested. For the studies focused on
adipogenesis, the samples were cultured in either proliferation medium or adipogenic
differentiation medium. Similarly, for the osteogenesis studies, the hydrogels were cultured
in either proliferation medium or osteogenic differentiation medium. All hydrogels were
cultured in proliferation medium for 24 h after encapsulation. To induce differentiation,
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the samples were rinsed twice with PBS and the medium was replaced with either serumfree adipogenic differentiation medium353 or osteogenic induction medium. In all cases,
fresh medium was provided to all samples every 2-3 d for up to 28 d.
Table 4.1: Formulations for the (i) proliferation medium, (ii) adipogenic
differentiation medium, and (iii) osteogenic differentiation medium used in the in vitro
culture studies. *indicates supplements included for the first 72 h of induction only.
Proliferation medium
DMEM:F12 Ham’s
10% FBS
1% Pen-strep

4.2.10

Adipogenic medium
DMEM:F12 Ham’s
1% Pen-strep
33 μM biotin
17 μM pantothenate
10 μg/mL transferrin
100 nM cortisol
66 nM insulin
1 nM triiodothryonine
0.25 mM
isobutylmethylxanthine *
1 μg/mL troglitazone *

Osteogenic medium
DMEM- Low glucose
(Gibco, Cat # 11885084)
10% FBS
1% Pen-strep
150 μM ascorbate-2phosphate
10 mM β-glycerol phosphate
10 nM dexamethasone
10 nM 1,25dihydroxyvitamin D3

Cell viability analysis of encapsulated ASCs

Cell viability in the hydrogels (MCS+DAT, MCS+DTB, MSC alone) was assessed using
the LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells (Life Technologies Inc.,
Burlington, ON) which involved staining with calcein AM and ethidium homodimer-1
(EthD-1) for live and dead cells at 7 and 14 d under proliferation, adipogenic, and
osteogenic conditions (n=3 samples per group/trial, N=3 trials with different ASC donors).
At each time point, the hydrogels were rinsed three times with PBS and stained with 2 μM
calcein AM and 4 μM EthD-1 at 37°C for 45 min, followed by two rinses in PBS to remove
excess dye. The hydrogels were imaged at 10X magnification using a Zeiss Multiphoton
LSM 510 META confocal microscope (ZEISS, Canada). To capture the entire crosssectional area of the hydrogel, a mosaic stitch technique was utilized and a total of 4-5
layers were imaged along the z-axis of the hydrogel, each layer separated by 75 μm. The
generated images were processed to quantify the calcein+ (LIVE) and EthD-1+ (DEAD)
cells using Image J analysis software. The average number of live and dead cells per plane
was counted for each sample, and the average cell viability was calculated.
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4.2.11

Adipogenic differentiation of hASCs

4.2.11.1 RT-qPCR
Quantitative RT-PCR analysis was performed to assess the expression of key adipogenic
markers (PPARg, ADIPOQ, LPL, PLIN) in ASCs encapsulated in the hydrogels
(MCS+DAT, MCS+DTB, MSC alone) at 14 d post-induction of differentiation (n=3
samples per group/trial, N=3 trials with different ASC donors). Total RNA was extracted
using the Aurum Total RNA Fatty and Fibrous Tissue kit (Bio-Rad, Cat. #7326870)
according to the manufacturer’s instructions. The concentration of RNA was assessed
using a Nanodrop 1000 spectrophotometer, and cDNA was synthesised from 250 ng of
input RNA using the iScript™ Reverse Transcription Supermix (Bio-Rad, USA). The
TaqMan® Gene Expression Assay human gene-specific primers conjugated with FAMMGB probes used in this study are presented in Table 4.2 (Invitrogen). IPO8 was selected
as the housekeeping gene based on previous validation of stability with human ASCs
cultured under both adipogenic and proliferation conditions. The samples were prepared
using the TaqMan® Fast Advanced Master Mix (Invitrogen, Cat. #4444577) in the
recommended 10 μL reaction volume for a 384-well plate. Amplification was carried out
in a CFX384 TouchTM Real-Time PCR Detection System (Bio-Rad, Cat. #1855485), with
the following cycling conditions: incubation at 50 ºC for 2 min, activation at 95 ºC for 20
s, and 40 cycles of denaturing at 95 ºC for 3 s and annealing/extension at 60 ºC for 30 s. A
comparative Ct method was used to calculate the relative fold change in gene expression
relative to the MCS only hydrogel group at 14 d under the induced conditions (i.e.
adipogenic differentiation medium). No-RT and no template controls were included on
every plate.
Table 4.2: Human gene-specific adipogenic primers used for quantitative RT-PCR.
Gene
PPARγ
LPL
ADIPOQ
PLIN1
IPO8

Description
Peroxisome proliferator-activated receptor gamma
Lipoprotein lipase
Adiponectin
Perilipin
Importin 8 (Housekeeping)

Product code
Hs00234592_m1
Hs00173425_m1
Hs00605917_m1
Hs00160173_m1
Hs00183533_m1
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4.2.11.2 Glycerol-3-phosphate enzyme (GPDH) activity
To assess the adipogenic response at the protein level, intracellular GPDH enzyme activity
was measured using a GPDH Enzyme Activity Measurement Kit (Kamiya Biomedical
Corporation, Cat. # KT-010, Seattle, WA, USA) in the hydrogels at 14 d post-induction of
adipogenic differentiation (n=3 samples per group/trial, N=3 trials with different ASC
donors). At each time point, triplicate samples from each group were rinsed in PBS and
then 1 mL of enzyme extracting reagent (pH 7.4) provided with the kit was added. The gels
were manually crushed using a plastic pestle and subsequently lysed using an ultrasonic
homogenizer (Model-100, Fisher Scientific), and centrifuged (12,800 xg, 5 min, 4 °C) to
obtain the cytosolic fraction containing the intracellular GPDH. GPDH enzyme activity
levels were normalized to the total cytosolic protein content for each sample determined
using the Pierce 660 Protein Assay Kit (Thermo Scientific) with an albumin standard. The
samples were immediately assayed for GPDH activity and total protein content according
to the manufacturers’ protocols using a CLARIOstar® spectrophotometer (BMG
LABTECH). One unit of GPDH activity was defined as the activity required to oxidize 1
μM of NADH in 1 min. For each cell donor, the data was normalized to the MCS only
hydrogel group at 14 d under non-induced conditions (i.e. proliferation medium) for
comparative purposes.

4.2.11.3 Bodipy-staining of lipids
In order to qualitatively assess ASC adipogenesis within the hydrogels, Bodipy® 493/503
staining (Thermo Scientific) was performed to visualize intracellular lipid accumulation in
the hydrogels at 14 d post-induction of differentiation (n=3 samples per group/trial, N=3
trials with different ASC donors). A stock solution of the dye was prepared in DMSO at 1
mg/mL and triplicate samples from each hydrogel group were rinsed twice in PBS before
incubation in the staining solution at a 1:500 dilution in PBS for 1 h at 37 °C. Hydrogels
were finally rinsed in PBS twice before imaging using a Zeiss Multiphoton LSM 510
META confocal microscope. Images were obtained at 25X magnification using a water
immersion objective.
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4.2.12

Osteogenic differentiation of hASCs

4.2.12.1 RT-qPCR
Quantitative RT-PCR analysis was performed to evaluate the expression of key osteogenic
markers (RUNX2, OPN, ON, OCN) in the ASCs encapsulated in the hydrogels
(MCS+DAT, MCS+DTB, MSC alone) at 14 d post-induction of differentiation (n=3
samples per group/trial, N=3 trials with different ASC donors), following the methods
described in Section 1.2.11.1. The TaqMan® Gene Expression Assay human gene-specific
primers conjugated with FAM-MGB probes used in this study are presented in Table 4.3
(Invitrogen).
Table 4.3: Human gene-specific osteogenic primers used for quantitative RT-PCR.
Gene
RUNX2
OPN
ON
OCN
UBC
PGK1

Description
Runt-related transcription factor 2
Osteopontin
Osteonectin
Osteocalcin
Ubiquitin C (Housekeeping)
Phosphoglycerate kinase 1 (Housekeeping)

Product code
Hs01047973_m1
Hs00960942_m1
Hs00234160_m1
Hs01587814_g1
Hs01871556_s1
Hs00943178_g1

4.2.12.2 Alkaline phosphatase (ALP) enzyme activity
To assess the osteogenic response at the protein level using a functional assay, the levels
of ALP enzyme activity were measured in the MCS hydrogels at 7 and 14 d post-induction
of differentiation (n=3 samples per group/trial, N=4 trials with different ASC donors). At
each time point, triplicate samples from each group were rinsed in PBS and then 1 mL of
enzyme extracting reagent (5 mM Tris, 20 mM Tricine and 1 mM EDTA, pH 7.4) was
added. The gels were manually crushed using a plastic pestle and were subsequently lysed
using an ultrasonic homogenizer (Model-100, Fisher Scientific), and centrifuged (13,000
xg, 10 min, 4 °C) to obtain the cytosolic fraction containing the intracellular ALP enzyme.
Alkaline phosphatase standards were prepared in a 96-well plate in concentrations ranging
from 0 to 200 nM of p-nitrophenol from serial dilutions of a 10 mM p-nitrophenol
standard solution (Sigma Aldrich) with 0.02 N NaOH. On the same plate, an equal
volume of sample and nitrophenyl phosphate liquid substrate (100 μL each) were mixed
thoroughly and incubated at 37 °C for 30 min. The reaction was then quenched with the
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addition of 100 μL of 3N NaOH to each well. The absorbance at 405 nm of each well
was measured using a CLARIOstar® spectrophotometer (BMG LABTECH). ALP
enzyme activity levels were normalized to the total cytosolic protein content for each
sample determined using the Pierce 660 Protein Assay Kit (Thermo Scientific) with an
albumin standard. For each cell donor, the data was normalized to the MCS only hydrogel
group at 14 d under non-induced conditions (i.e. proliferation media) for comparative
purposes.

4.2.12.3 Osteoimage staining of mineralization
In order to qualitatively assess mineralization within the MCS hydrogels, the
OsteoImageTM (Lonza, Germany) matrix mineralization fluorescent staining kit was
performed at 28 d post-induction (n=3 samples per group/trial, N=2 trials with different
ASC donors). As a control, hydrogels (MCS+DAT, MCS+DTB, MCS alone) without
ASCs were also prepared and cultured in osteogenic medium for 28 days. In brief,
triplicate samples from each hydrogel group were rinsed twice in PBS and fixed in 4%
paraformaldehyde (PFA, pH 7.4) for 30 min at room temperature. After fixation, the
hydrogels were washed two times with OsteoImageTM wash buffer (1X) and stained as per
the manufacturer’s protocol at a 1:300 dilution in the OsteoImageTM staining buffer. Each
hydrogel was incubated in 750 µL of the staining solution for 30 min in the dark. Finally,
the hydrogels were washed three times in the OsteoImageTM wash buffer (1X) and imaged
using a Zeiss Multiphoton LSM 510 META confocal microscope at a 25X magnification.

4.2.13

Statistical analysis

All numerical data are expressed as mean ± standard deviation (SD). All statistical analyses
were performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA) by oneway or two-way ANOVA with a Tukey’s post-hoc comparison of the means. Differences
were considered statistically significant at p < 0.05 unless otherwise noted.

100

4.3 Results
4.3.1

Synthesis of methacrylic chondroitin sulphate

Following established protocols, the CS was successfully functionalized with methacrylate
groups to form methacrylate chondroitin sulphate with a 20% degree of substitution (DOS)
(Fig. 4.1). The three pendant hydroxyl groups present on CS could function as nucleophiles
and attack the carbonyl groups on the methacrylic anhydride and form ester bonds, while
generating methacrylic acid as a by-product. The maintenance of pH at ~10 was necessary
to neutralize the acid formed and drive the reaction forward. Fig 4.3 illustrates the chemical
structures for both unmodified and modified chondroitin sulphate as well as the NMR
spectra for the resulting polymer.

Figure 4.1: Representative images of (A) the procedure for methacrylation of
chondroitin sulphate and (B) 1H NMR spectra confirming the presence of the
resulting methacrylated chondroitin sulphate. The peaks at 5.65, 6.1 and 1.85
correspond to the protons from the newly grafted methacrylate group, while the peak at
1.85 corresponds to the protons from the methyl group of the N-acetyl residues in native
CS.
The successful methacrylation of CS was confirmed through 1H NMR spectroscopy (Fig.
4.1). The peaks located at ~5.65 ppm and ~6.1 ppm correspond to the protons from the
vinyl group (1,2) on the grafted methacrylate. The peak at ~1.85 ppm is associated with
the protons from the methyl group (3) in the methacrylate which are absent in the native
CS, while the peak at ~1.95 ppm is due to the protons from the methyl group of the N-
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acetyl residues in native CS (4). After setting the integration of the vinyl protons to 1.0, the
integration of the peak at 1.85 is 3.0, allowing determination of the integral of the peak at
1.85 ppm, and thereby the degree of substitution.

4.3.2

Cryomilling and characterization of DAT and DBT ECM
particles

Previous studies performed in our lab on effects of DAT particle size on adipogenic
differentiation have indicated that the incorporation of smaller particles within hydrogels
was favourable for adipogenesis by promoting greater cell-cell interactions262. As such, a
45 µm to 125 µm size range was selected based on its ability to produce a high yield from
the milling process and potential to enhance adipogenesis. Mastersizer analyses of cryomilled and sieved DAT and DTB particles yielded a distribution of particle sizes between
2 μm and 200 μm (Fig. 4.2). However, the data confirmed that a majority of the particles
(~0.6 volume fraction) were in the expected size range of 45 μm to 125 μm. The presence
of smaller particles could be attributed to aggregation, which persisted during sieving and
the presence of larger particles could be attributed to the swelling or aggregation of
particles in the hydrated state during measurement, as well as potentially the irregular shape
of some of the particles. The results of the Kolmogorov–Smirnov test with p < 0.05
confirmed that the particle size distributions for the DAT and DTB particles were
statistically equivalent.

Figure 4.2: (A) Volume fraction and (B) particle size distribution of ECM particles
generated after cryo-milling and sieving between 45 µm and 125 µm stainless steel
mesh filters. ECM particles were pooled from multiple donors and the same batch was
used for all studies. Data indicated that a distribution of particle sizes between 2 μm and
200 μm was obtained, with the majority of the particles lying between the size range of
sieves used (45 μm and 125 μm). Additionally, there was no significant difference in
particle size between the DAT and the DTB. (p<0.05)
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4.3.3
4.3.3.1

Hydrogel physical characterization
Gel content

The gel content provides a measure of the amount of MCS pre-polymer that was
successfully incorporated into the hydrogel network during crosslinking, with a higher gel
content being desirable. In comparing the 3 hydrogel groups, the gel content values for the
MCS only, MCS+DAT and MCS+DTB groups were 76.7 ± 3.3%, 73.4 ± 7.2% and 80.5 ±
2.2% respectively (Fig. 4.3A), with no significant differences observed between the
groups. These findings confirm that incorporating the ECM particles at 8% (w/v)
concentration did not negatively impact the cross-linking process.

Figure 4.3: Gel content and compressive moduli of MCS, MCS+DAT and MCS+DTB
hydrogels. (A) No significant differences were observed in terms of gel content between
the three hydrogel groups. (n=3 samples per group/trial, N=3 trials) (B) The compressive
modulus of the three hydrogel groups confirmed that all hydrogels had similar mechanical
properties. (n=5)

4.3.3.2

Mechanical testing

Since the response of encapsulated ASCs can be impacted by both biochemical and
biomechanical effects, the compressive moduli of the MCS, MCS+DAT and MCS+DTB
hydrogels were quantified to gauge any differences in stiffness between the groups. The
results indicated that there were no statistically significant differences in the compressive
moduli of the hydrogels, with calculated values of 114 ± 5 kPa for the MCS group, 123 ±
17 kPa for the MCS+DAT group, and 135 ± 26 kPa for the MCS+DTB group (Fig. 4.3B).
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4.3.4

Cell viability and cellularity following hydrogel encapsulation
and culture under induced and non-induced conditions

The LIVE/DEAD® assay with confocal imaging analysis was used to assess the viability
of the encapsulated ASCs over the 14 d culture period under proliferation, adipogenic, and
osteogenic conditions (Fig. 4.4). Representative confocal images of LIVE/DEAD®-stained
hydrogels encapsulated within MCS, MCS+DAT and MCS+DTB hydrogels at 7 d can be
found in Appendix A (Fig. A.5). Quantitative analysis indicated that there was high cell
viability (>90%) over the 14 d period for all of the hydrogel groups and culture medium
conditions, confirming that the UV crosslinking approach was cytocompatible and that the
hydrogels provided a cell-supportive microenvironment. To complement the viability
analysis, the average number of live ASCs within each hydrogel cross-section was counted
for the three hydrogel groups at each time point under each media condition (Fig. 4.4).
There were no significant differences in the total number of live cells per x-y plane between
the groups for any of the media conditions at either time point. These findings suggest that
variations in cell density were not a key factor influencing the ASC differentiation response
within the various hydrogels.
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Figure 4.4: Viability and cellularity analysis of ASCs encapsulated within MCS,
MCS+DAT, MCS+DTB hydrogels cultured in (A) proliferation medium, (B)
adipogenic medium and (C) osteogenic medium. Encapsulated ASCs under all three
media conditions maintained high cell viability (> 90%) over the 14 d culture period.
Quantitative analysis of total live cells indicated no significant differences between any of
the groups under all media conditions, eliminating cell density as a factor mediating
differentiation. (n=3 samples per group/trial, N=3 trials with different ASC donors)
(*p<0.05)

105

4.3.5
4.3.5.1

Adipogenic differentiation of encapsulated ASCs
RT-qPCR

Adipogenic gene expression data obtained at 14 d demonstrated the ability of the DAT to
augment adipogenic differentiation within the MCS hydrogels under induced conditions
(Fig. 4.5). Markers from the early (PPARg), early-mid (LPL), mid-late (ADIPOQ) and late
(PLIN) stages of adipogenic differentiation were chosen to probe the progression in
differentiation towards becoming mature adipocytes76,82,429. Hydrogels cultured in
proliferation medium (i.e. non-induced conditions) exhibited significantly lower gene
expression when compared to the induced samples, with no significant differences
observed between the hydrogel groups for any of the markers studied (Fig. 4.5). In contrast,
in analyzing the master adipogenic transcription factor PPARg (Fig. 4.5A) under induced
conditions, higher expression was observed in the MCS+DAT hydrogels in comparison to
the MCS+DTB hydrogels for all three donors. Similarly, LPL (Fig. 4.5B), ADIPOQ (Fig.
4.5C) and PLIN expression (Fig. 4.5D) were significantly enhanced in the MCS+DAT
hydrogels compared to all other groups under induced conditions for all 3 ASC donors
studied, supporting that the inclusion of DAT promoted adipogenesis.
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Figure 4.5: RT-qPCR data of (A) PPARg, (B) LPL, (C) ADIPOQ and (D) PLIN
evaluated at 14 d under (left) non-induced conditions and (right) induced conditions.
For all ASC donors under non-induced conditions, no significant differences were
observed between any of the groups. For all ASC donors under induced conditions, the
DAT enhanced adipogenic gene expression in the ASCs encapsulated within the hydrogels.
ND = not detected (n=3 samples per group/trial, N=3 trials with different ASC donors)
(*p<0.05)
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4.3.5.2

Glycerol-3-phosphate enzyme (GPDH) activity

Adipogenesis was quantitatively assessed in ASCs that were encapsulated in the MCSbased hydrogels after 14 d of culture in proliferation medium (non-induced conditions) or
adipogenic differentiation medium (induced conditions) using the GPDH assay (Fig. 4.6).
Under non-induced conditions, no significant differences were observed between the
hydrogel groups for all 3 donors. Similar to the gene expression findings, significantly
higher GPDH enzyme activity was observed in the MCS+DAT hydrogels cultured in
adipogenic differentiation medium relative to all other groups, supporting that the
incorporation of the DAT enhanced ASC adipogenesis.

Figure 4.6: Adipogenesis as evaluated by GPDH Activity at 14 d in hydrogels cultured
under (A) non-induced and (B) induced conditions. While no significant differences
were observed in the non-induced conditions for all three ASC donors, under induced
conditions, the incorporation of the DAT enhanced the adipogenic differentiation of the
encapsulated ASCs. (*p<0.05) (n=3 samples per group/trial, N=3 trials with different ASC
donors)
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4.3.5.3

Bodipy-staining of intracellular lipid accumulation

BODIPY (4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene) binds to
lipid droplets and was used to visualize intracellular lipid in the encapsulated ASCs that
were differentiating into adipocytes (Fig. 4.7). During adipogenesis, differentiating ASCs
accumulate an increasing amount of triacylglycerol as adipogenesis progresses62. As such,
the presence of rounded intracellular lipid droplets is indicative of adipogenesis, with larger
droplets associated with a more mature phenotype. Under confocal microscopy, the lipid
droplets fluoresce red, while the ECM particles that were pre-stained with the aminereactive Alexa Fluor 405© succinimidyl dye, fluoresce blue. Images obtained qualitatively
suggested that there were a higher number of differentiating cells with limited regional
variability in the MCS+DAT group as compared to the other two groups under both noninduced and induced conditions, with qualitatively larger lipid droplets and an overall
higher response in the samples cultured in adipogenic differentiation medium. Overall, the
data suggest that the MCS hydrogels provided a supportive microenvironment for
adipogenesis, and that differentiation could be augmented by the combined effects of the
DAT and culturing in an inductive medium formulation.
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Figure 4.7: BODIPY© staining of lipid droplets in ASCs encapsulated in the MCS,
MCS+DAT and MCS+DTB hydrogels at 14 d post induction under non-induced
(proliferation) and induced (adipogenic) conditions. Under both non-induced and
induced conditions, incorporating the DAT qualitatively enhanced intracellular lipid
accumulation, with the cells appearing to have a more mature phenotype with larger lipid
droplets. Scale: 100 µm
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4.3.6
4.3.6.1

Osteogenic differentiation of encapsulated ASCs
RT-qPCR

Osteogenic gene expression was assessed in the hydrogels cultured in both non-induced
and induced conditions at 14 d, with genes selected from the early (RUNX2), early-mid
(OPN and ON) and late (OCN) stages of osteogenic differentiation81 (Fig. 4.8). Under noninduced conditions, there was significant upregulation of the early to mid-stage marker
OPN in the MCS+DTB hydrogels relative to all other groups for all 3 donors studied (Fig.
4.8B), suggesting a possible osteo-inductive effect of the decellularized bone matrix.
Similarly, ON expression was significantly enhanced in the MCS+DTB group for cell
donors 2 and 3, which were the highest responders in terms of OPN expression (Fig. 4.8C).
However, no significant differences or obvious trends were observed in RUNX2 and OCN
expression. In analysing the hydrogels cultured under induced conditions, no significant
differences or trends were observed between the hydrogel groups for any of the markers.
Interestingly, the gene expression levels were similar between the induced and non-induced
conditions, with the exception of OPN, which was significantly higher in the MCS+DTB
hydrogels cultured under non-induced conditions as compared to the induced conditions
for all three ASC donors studied.
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Figure 4.8: RT-qPCR data of (A) RUNX2, (B) OPN, (C) ON and (D) OCN evaluated
at 14 d under (left) non-induced conditions and (right) induced conditions. Under noninduced conditions, OPN gene expression was upregulated in all ASC donors in the
MCS+DTB hydrogels and ON expression was upregulated in ASC donors 2 and 3 in the
MCS+DTB hydrogels, suggesting a possible osteo-inductive effect of DTB. Under induced
conditions, no significant differences were observed between the groups. ND = not
detected. (*p<0.05) (n=3 samples per group/trial, N=3 trials with different ASC donors)
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4.3.6.2

Alkaline phosphatase enzyme activity

Alkaline phosphatase activity is important for the mineralization of bone and represents a
useful biochemical marker of bone formation202. During differentiation, ASCs go through
an initial proliferative phase, after which proliferation is down-regulated and the synthesis
and organization of collagen type I predominates. Finally, matrix mineralization
occurs84,429. During this process, ALP enzyme activity peaks during the initial stages of
differentiation, after which it declines before peaking again prior to matrix
mineralization84,202,429. Under non-induced conditions, the ALP activity levels were
relatively low in all of the groups at both 7 and 14 days. There were no obvious trends
between the groups, although there was a slight decline in activity from 7 to 14 d in the
MCS+DTB group for 2 of the cell donors (Donors 3 & 4). Under induced conditions, the
ALP enzyme activity levels were generally higher for all of the groups. There was notable
donor variability in the response, although a decline in activity was observed from 7 to 14
d for the MCS+DTB group for 3 of the cell donors (Donors 1, 3 & 4).

Figure 4.9: ALP enzyme activity of ASCs encapsulated in hydrogels cultured under
non-induced and induced conditions for 4 different ASC donors (A-D). ALP data from
(A) Donor 1, (B) Donor 2, (C) Donor 3 and (D) Donor 4 are presented individually. For
Donors 1, 3, & 4, a decline in ALP activity was noted from 7 to 14 days in the MCS+DTB
group cultured in osteogenic medium, potentially consistent with a progression in
differentiation (*p<0.05) (n=3 samples per group/trial, N=4 trials with different ASC
donors)
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4.3.6.3

Osteoimage staining of mineralization

Macroscopic observations of the hydrogel constructs at 14 and 28 d post-induction showed
that they grew increasingly more opaque and stiff, potentially consistent with matrix
mineralization (Fig. 4.10A). To further assess this, the hydrogels were stained at 28 d using
the OsteoImageTM kit that stains mineralized matrix and observed under the confocal
microscope (Fig 4.10B). Positive staining was evident in all three groups, with qualitatively
enhanced mineral deposition around the ECM particles in the MCS+DAT and MCS+DTB
groups. In addition, qualitatively more staining was observed in the MCS+DTB group as
compared to the other two hydrogel systems. However, in analyzing the control groups
without encapsulated ASCs that were also cultured in osteogenic medium for 28 days,
qualitatively similar levels of positive staining for matrix mineralization were observed,
indicating that there was abundant non-specific staining likely attributed to the high
phosphate concentration in the differentiation medium (Fig. 4.10C). As such, it was not
possible to assess whether any cell-induced mineralization was occurring in the system
with this assay. Hydrogels cultured under non-induced conditions showed no visible
mineralization, including within the DTB particles, indicating that all positive staining was
attributed to culturing (Appendix A, Fig. A.6).
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Figure 4.10: Representative images of (A) MCS, MCS+DAT and MCS+DTB
hydrogels at 14 and 28 d post-induction, (B) matrix mineralization within the
hydrogels incorporating ASCs using the OsteoImageTM kit at 28 d and (C) matrix
mineralization within cell-free hydrogel controls using the OsteoImageTM kit. After 28
d in culture under induced conditions, all three hydrogel groups turned opaque, suggesting
possible mineralization. The presence of positively stained regions using the
OsteoImageTM dye (Green) was consistent with matrix mineralization in the hydrogels.
However, ASC-free hydrogel controls also demonstrated positive staining for matrix
mineralization, indicating the possible precipitation of calcium phosphate from the
osteogenic differentiation medium. Scale: 50 µm.
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4.4 Discussion
A growing body of evidence has suggested that incorporating tissue-specific ECM from
various tissue sources (e.g. adipose tissue, bone, liver, lung) within a variety of bioscaffold
formats (e.g. coatings, hydrogels, foams and composites) can direct stem/progenitor cell
function

in

a

tissue-specific

manner

within

3-D

in

vitro

cell

culture

models58,261,262,296,334,338–340. Recently, in vitro cell culture models utilizing ECM-derived
hydrogels or enzyme-digested or particulate ECM as a cell-instructive component within
hydrogel phases have garnered significant attention, with studies suggesting that these
hydrogel

systems

can

be

harnessed

to

direct

stem

cell

lineage-

commitment15,111,268,340,359,421. However, a sizable number of cell culture models utilize
tissue sources that are inadequately characterized, or include simplistic controls (e.g.
purified ECM proteins, collagen type I and gelatin) that vary in composition, but are not
matched in terms of their structural and/or biomechanical properties, to be able to
methodically interpret the tissue-specific effects of the ECM on stem/progenitor lineagespecific differentiation111,262,266,419–422.
In the present study, a method was developed to homogenously incorporate a high density
of cryo-milled ECM from DAT and DTB along with human ASCs within MCS hydrogels
using a UV-initiated crosslinking approach. This method allowed for the incorporation of
tissue-specific ECM that had not been processed with proteolytic enzymes, which was
postulated to be favourable for conserving the ECM bioactivity270,297,418. Based on the data
acquired from Chapter 3 that indicated there were distinct compositional differences
between the DAT and DTB, the primary goal was to exploit this model to explore the
effects of tissue-specific ECM composition on the lineage-specific differentiation of ASCs
towards the adipogenic and osteogenic lineages, building from past work that explored
only the DAT under adipogenic conditions58,184,261,262. Although it is acknowledged that
the xenogenic sourcing of the DTB may have impacted the observed cell responses, bovine
bone is considered to have the most similar physiochemical and structural resemblance to
human bone, and ECM macromolecules are generally known to be well-conserved across
species432, suggesting that the bovine sourcing was not the predominant factor influencing
the observed effects382–385. Further, studies utilizing decellularized bovine ECM have
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demonstrated that it can promote osteogenesis in human ASCs in vitro242,256, as well as
matrix mineralization and osteointegration in vivo256.
In addition to biochemical composition, ECM biomechanical and structural properties can
play major roles in mediating cell responses within 3D culture microenvironments4.
Recognising this, initial experiments focused on characterizing the DAT and DTB particle
size, as well as the gel content and mechanical properties of the MCS, MCS+DAT and
MCS+DTB hydrogel systems. It has been previously shown that DAT particle size can
influence adipogenesis, with smaller particles augmenting adipogenesis in encapsulated
ASCs by promoting cell-cell contact262. Mastersizer analyses confirmed that the particle
size distributions between the DAT and DTB were similar, therefore eliminating this as a
potential factor for the observed responses in ASC differentiation.
The gel content was an important design consideration, to ensure that there were not high
levels of unreacted methacrylate groups that may negatively impact cell viability433 and
that the ECM particles were stably incorporated within the MCS hydrogels. Interestingly,
this system facilitated the incorporation of ECM particles at a concentration of 8% (w/v),
higher than previous studies from our lab, with no differences in crosslinking efficiency
between the groups261,262. It is postulated that the sieving of the particles into a smaller size
range, as well as differences in the crosslinking set up, may have facilitated the inclusion
of more ECM within the hydrogels.
As for the gel content, no significant differences were observed in the bulk compressive
moduli between the hydrogel groups, which was favorable for assessing the impact of the
tissue-specific ECM composition on the ASCs without potential confounding effects due
to variations in the biomechanical properties of the hydrogels. The data also indicated that
the MCS hydrogel phase was the major contributor to the stiffness of the composites. ECM
stiffness has been shown to modulate the lineage commitment of MSCs, with softer
hydrogel

substrates

promoting

adipogenesis

and

stiffer

hydrogels

promoting

osteogenesis105,106. Notably, all of the hydrogel systems exhibited stiffness values in the
range of ~114-135 kPa, significantly higher than the previously published data with
MCS+DAT composite hydrogels (40-80 kPa), possibly due to UV-crosslinking using a
different light source and performed within a different mould for a longer duration (4 mins
vs 3 mins)261. Although these stiffness values are significantly higher than native adipose
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tissue (~1-4 kPa)236, previous data has demonstrated that MCS hydrogels with a modulus
of ~35 kPa supported ASC adipogenesis261,262. In addition, mature trabecular bone is
reported to have stiffness values ranging from 1-20 GPa depending on the anatomical
location and testing method, several orders of magnitude stiffer than the hydrogels in this
study105,382,434,435. Interestingly, in the context of bone regeneration, models that are focused
on recapitulating the endochondral ossification process of bone formation have recently
gained popularity, with data suggesting this may prove favourable to facilitate bone
regeneration436–438. Further, studies measuring the mechanical properties of developing
bovine articular cartilage using compression and indentation techniques have shown
stiffness measurements in the range of 200-500 kPa439–441, suggesting that our hydrogel
model could potentially be tailored and applied to mimic this process for future studies. In
future work, it would be interesting to explore the mechanical properties of the ECM
particles, to assess whether there are biomechanical differences between the DAT and DTB
at the cellular level.
Following the physical characterization of the composite MCS hydrogels, initial in vitro
studies focused on examining the effects of the DAT and DTB particles on ASC viability
and cell density under all of the culture conditions used in the in vitro studies. Notably, cell
density is an important factor in regulating both adipogenic and osteogenic
differentiation262,442,443. High cell densities have been shown to promote adipogenesis
possibly due to the maintenance of a rounded cell morphology, while low cell densities
have been shown to promote osteogenesis by increasing cell-spreading262,442,443. Hence, the
maintained high cell viability and consistent total live cell number between the hydrogel
groups under all media formulations tested, controlled for the effects of cell death and
density as possible factors that could have impacted the cellular response. Overall, the
studies suggest that the MCS composites provided a highly cell supportive
microenvironment for the encapsulated ASCs.
The tissue-specific instructive effects of adipose tissue ECM in promoting ASC adipogenic
differentiation have been well documented in data from our lab and several other
groups266,272,358,371,416,444. Consistent with this, the current study suggested that the adipose
tissue ECM composition provided an adipo-conductive environment for human ASCs,
which was lacking in the composites incorporating ECM derived from bone and MCS

118

alone. Higher levels of adipogenic gene expression, GPDH enzyme activity, and
intracellular lipid accumulation under induced conditions, consistently confirmed that the
DAT was pro-adipogenic. The ASCs within the MCS+DAT hydrogels also displayed a
more mature phenotype as observed by the presence of larger lipid droplets. Notably, under
proliferative conditions containing serum, known to suppress adipogenic differentiation in
ASCs76,445, the intracellular lipid staining showed the presence of maturing adipocytes in
all the groups, with the MCS+DAT group showing the most consistent response with little
regional variability. This suggests that the DAT may have had an adipo-inductive effect,
although this was not evident in the gene or protein expression data. Exploring the
expression of other adipogenic markers(e.g. FABP4 and LEP, markers of mature
adipocytes) as well as including additional time points, could help to further characterize
the possible adipo-inductive effects of the adipose-derived ECM within the composites.
Previous studies have suggested that basement membrane proteins (collagen type IV and
laminin) and collagen type VI can promote adipogenesis

159,161,163,405,446,447

. For example,

studies of composite hydrogels incorporating purified laminin or laminin-derived
sequences as pro-adipogenic motifs have successfully enhanced the adipogenesis of preadipocytes and ASCs in vitro in the presence of induction media159,161,163,292,405,446–448.
Further, the use of reconstituted basement membrane (e.g. Matrigel) has also been
demonstrated to promote fat formation in vivo415,449. Collagen type VI, is secreted by
adipocytes during maturation, and adipocytes have shown enhanced growth and maturation
when cultured on collagen type VI substrates292,448. Based on this, and results from our
immunohistochemical comparison of the DAT and DTB in Chapter 3, the higher levels of
collagen type IV, VI and laminin in the DAT may have had a favorable effect on ASC
adipogenesis. Proteomic analyses of the human DAT compared to human DTB performed
in our lab also uncovered higher levels of adipogenic-specific signaling proteins in the
DAT that could have contributed in part, to the observed enhanced adipogenic response185.
The data obtained is also consistent with previous studies of other DAT formats providing
an adipo-conductive and adipo-inductive environment for ASCs58,184,261,262.
A number of studies have highlighted the ability for decellularized bone ECM to enhance
mesenchymal stromal cell (MSC) osteogenesis in the presence of exogenous
factors111,250,380,450, with some reporting enhanced early-mid osteogenic gene expression
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(RUNX2,OPN and/or ON) expression in the absence of soluble osteo-inductive
factors251,256,450. Glycosaminoglycans (GAGs), abundantly expressed in bone tissue, are
known to modulate osteoblast attachment and mineralization, possibly through GAGsequestered growth factors168–170. We postulated that the natural GAG content in the MCS,
along with elevated levels of GAG content in the DTB may be favourable for the
osteogenic differentiation of encapsulated ASCs. Under non-induced conditions, the
upregulation of the early osteogenic markers OPN and ON at 14 d in the MCS+DTB
hydrogels suggested possible osteo-inductive effects of the DTB on the encapsulated
ASCs. Under induced conditions, the peak in ALP enzyme activity at 7 d in the MCS+DTB
hydrogels for 3 out of the 4 donors studied also suggested a possible conductive effect of
the DTB. However, it is challenging to draw strong conclusions based on the single timepoint analysis in the current gene expression studies, as some osteogenic genes can be
upregulated at multiple stages throughout the differentiation process83,89. Hence, a
systematic investigation using a time-course experiment and including additional markers
at the gene and protein levels would provide better insight into the osteogenic response.
Notably, results from a recent study by Beachley et al. evaluating the effects of 7 different
types of tissue-specific ECM on the lineage commitment of human ASCs over a period of
3 weeks, indicted that inductive effects of the bone ECM on osteogenic gene expression
(RUNX2, COLL1, OCN) could not be observed until 3 weeks in culture266. A recent study
assessing the effects of the co-culture of ASCs and bone marrow MSCs (bmMSCs) on
osteogenic differentiation suggested a surprisingly rapid onset of differentiation (~48 h),
as seen by the expression of several osteogenic factors (OSX, RUNX, ALP, OPN, OCN)
at the gene and protein level compared to the typical time-frame documented for MSCs,
reiterating the importance of tracking the variations in osteogenesis over time451.
Notably, many studies have demonstrated that ASCs inherently display pronounced
adipogenic differentiation as compared to bmMSCs452–454. This is not surprising
considering ASCs are a heterogenous cell population that also includes more committed
adipocyte progenitors, which may have contributed in part to the potent adipogenic
response observed and responsiveness to the DAT38,49. Conversely, the osteogenic
potential of bmMSCs has been documented as being superior to ASCs, as evaluated by
gene expression data, ALP activity and matrix mineralization452–455. With the documented
inverse relationship between adipogenesis and osteogenesis, it is possible that a natural
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pre-disposition of the ASCs towards the adipogenic lineage may have contributed to the
lack of conclusive outcomes in the osteogenic differentiation studies89,429. In future, a
comparison of human ASCs and human bmMSCs in terms of their adipogenic and
osteogenic lineage-commitment could be assessed within the three hydrogel groups to
highlight any cell-type mediated effects.
Although it was hoped that the assessment of matrix mineralization at 28 d would provide
insight into the effects of the ECM on the terminal stages of osteogenic differentiation,
valuable information was not obtained due to the non-specific staining observed likely
resulting from calcium phosphate precipitation. Supporting this interpretation, in a study
from 1992, Chung et al. reported that media supplementation with concentrations of bglycerol phosphate (BGP) exceeding 2 mM led to non-physiological precipitation of
mineral within in vitro cell cultures456. The fact that standard osteogenic media
formulations for ASCs include high concentrations of BGP (10 mM) is a
concern111,250,256,380,457. Of note, numerous studies using these formulations have reported
positive findings in terms of matrix mineralization without showing cell-free scaffold
controls to verify the physiological origin of the mineralization250,256,380,458. The findings in
the current work emphasize the broader need in the field to include appropriate controls in
all studies to be able to accurately interpret the data. Further, it would be worthwhile in
future studies to refine the differentiation media formulation to circumvent these nonspecific effects.
Overall, a versatile method was developed and applied to encapsulate human ASCs and
tissue-specific ECM from DAT and DTB within MCS hydrogels with high cell viability in
long-term culture. Acknowledging the inherent propensity for ASCs to differentiate more
easily into adipocytes, this in vitro cell culture model could be extended to compare the
adipogenic and osteogenic response of ASCs versus bmMSCs in MCS hydrogels
incorporating DAT or DTB. This model can also be applied with other ECM sources to
further probe the effects of tissue-specific ECM on stem/progenitor cell differentiation.
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4.5

Conclusions

In the current study, a method was developed to encapsulate cryo-milled tissue-specific
ECM from two distinct ECM sources (i.e. DAT and DTB) within MCS hydrogels to assess
the lineage-specific differentiation effects on human ASCs towards the adipogenic and
osteogenic lineages. This cell culture model minimized the confounding effects associated
with ECM particle size, biomechanical properties and cell density to assess the effect of
tissue-specific ECM composition on the lineage commitment of the ASCs. Although
decellularized ECM from sources such as SIS and bladder have been utilized to assess
adipogenesis, to the best of our knowledge this is the first study to systematically compare
ECM derived from adipose tissue and bone on adipogenesis and osteogenesis. Overall, the
findings indicate that ECM derived from adipose tissue provided a pro-adipogenic
microenvironment for human ASCs, as seen by the enhanced adipogenic gene expression,
GPDH enzyme activity and intracellular lipid accumulation in the MCS+DAT hydrogels.
This was hypothesized to be the result of distinct differences in ECM composition between
the two ECM sources. While preliminary data from the osteogenic differentiation study
indicated that the DTB may have some osteo-inductive effects, a time course study
investigating changes in osteogenic gene and protein expression would help to more fully
interpret the response. A further interesting finding indicated that culturing the scaffolds in
standard osteogenic differentiation medium resulted in the precipitation of calcium
phosphate, causing false positive staining for matrix mineralization. These findings
demonstrate the need for modification of currently-used osteogenic media formulations, as
well as the importance of including appropriate controls to be able to accurately interpret
data related to matrix mineralization during osteogenesis.
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Chapter 5

5

General discussion and future work
5.1

General discussion

Acknowledging the native extracellular matrix (ECM) composition as a key player in
mediating cellular responses322,459, there is a compelling need to develop high fidelity twodimensional (2-D) and three-dimensional (3-D) in vitro cell culture models that can
replicate this tissue-specific ECM composition. These models can be applied to clarify the
effects of tissue-specific ECM composition on stem/progenitor cell lineage-commitment,
and assess the utility of this approach in designing cell-delivery strategies. With the advent
of decellularization, extensive research has focused on the development of
decellularization protocols that can retain the complex ECM composition, as well as
subsequent ECM processing methods that conserve ECM bioactivity184,215,232,254,264,297,393.
Indeed, decellularized ECM processed into a variety of formats (e.g. coatings, hydrogels,
foams and composites) have been used within in vitro models, and shown to direct
stem/progenitor cell differentiation in a tissue-specific manner, providing a rationale for
further exploring this approach58,261,262,296,334,338–340.
However, a major limitation in interpreting whether there are tissue-specific effects of the
ECM on stem/progenitor cell lineage commitment include that past studies have often
focused on studying single ECM sources111,256,262,419–422. Further, commonly implemented
controls used for comparison include substrates such as collagen gels that have different
structural and/or biomechanical properties, making it challenging to draw any definitive
conclusions on the effects of ECM composition111,419,421,422. In addition, there is a growing
body of evidence suggesting that strategies which avoid or minimize proteolytic digestion
may be favourable for conserving ECM bioactivity and stability264,270,297,418. This
necessitates the development of alternative ECM processing methods that can retain the
ECM ultrastructure and remain stable throughout the cell culture period to accurately
assess the effect of the substrates on stem/progenitor cell lineage-commitment.
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With regards to the challenges described above, this thesis focused on developing 2-D and
3-D ECM-derived scaffolding platforms, processed using methods that avoided proteolytic
digestion and proved favourable for conserving ECM bioactivity. Further, incorporating
these platforms in a tissue-specific manner within well-characterized in vitro cell culture
models enabled the systematic assessment of tissue-specific ECM composition on the
lineage-specific differentiation of human adipose-derived stromal cells (ASCs).
Adipose tissue represents an abundant source of ECM that is enriched in adipogenic
structural and signalling proteins184,185,239. Employing strategies that minimise or avoid
proteolytic digestion, decellularized adipose tissue (DAT) has previously been shown have
adipo-conductive and adipo-inductive capabilities when cryo-milled into particles or
digested using α-amylase to fabricate foams58,261,262. ASCs cultured within these scaffold
formats have demonstrated elevated levels of adipogenic gene expression and glycerol-3phosphate dehydrogenase (GPDH) activity with or without the provision of exogenous
differentiation factors58,261,262. While these pro-adipogenic effects were typically highly
pronounced within induced conditions, the effects under non-induced (proliferative)
conditions were subtle, including the enhanced expression of early-stage adipogenic genes,
a slight upregulation of GPDH enzyme activity within some scaffold formats and lower
levels of intracellular lipid accumulation. On the other hand, ASCs cultured on
microcarriers fabricated from DAT digested using pepsin also showed enhanced
adipogenesis relative to gelatin microcarrier and tissue culture polystyrene controls,
although these DAT microcarriers required chemical crosslinking to enable synthesis361.
Recent evidence has suggested that the choice of ECM processing method can highly
modify ECM physical and bioactive properties, consequently impacting their cellular
response264,297,336. A comprehensive study by Kusuma et al. compared pepsin digestion,
urea extraction and acetic acid homogenization as methods to process decellularized ECM
secreted by placental MSCs to fabricate ECM-derived coatings264. Each method retained
proteins of differing molecular weights, and also resulted in a unique cell response, with
pepsin-digested ECM enhancing metabolic activity, urea extracted ECM enhancing
osteogenesis, and acetic acid homogenization producing negligible bioactive effects when
compared to tissue culture plastic264. Recognizing this, the body of work in this thesis
incorporated tissue-specific ECM using methods that avoided proteolytic digestion, such
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as α-amylase digestion and cryo-milling, which were predicted to be more favourable for
ECM bioactivity and generating substrates that were stable in long-term culture.
The structure of the ECM plays a significant role in mediating cell-attachment460,461, cellshape462,463 and even differentiation460. The α–amylase-digestion of DAT used in Chapter
2 resulted in better conservation of the fibrillar structure of the native ECM and retained a
more complex range of high molecular weight proteins. Similarly, previous scanning
electron microscopy characterizations of cryo-milled DAT particles processed using
similar methods as in Chapter 4, have also shown the retention of a fibrous
microarchitecture, closely resembling intact DAT scaffolds184,262. Therefore, both methods
of processing allowed for the incorporation of tissue-specific fibrous ECM into
macroscopically homogeneous and robust 2-D or 3-D platforms without the need for
proteolytic

digestion,

which

may

be

favourable

for

conserving

the

ECM

bioactivity264,270,297,418. Notably, the ASCs cultured on both the α–amylase-digested DAT
and collagen coatings showed a more spindle-like morphology characteristic of multipotent
ASCs, possibly due to the thicker, softer and fibrous nature of these substrates.
Homogeneity and stability are acknowledged as being important design considerations
when designing substrates for long-term cell culture. The two processing methods applied
in the cell culture models developed, α–amylase-digestion and cryo-milling, produced
substrates that were stable in long term culture. The Alexafluor© 405 staining and
visualization of cryo-milled ECM particles verified their stability up to 28 d in culture, as
well as their uniform distribution throughout the hydrogel phase. Further, the coatings
fabricated with α–amylase-digested ECM were structurally robust, macroscopically
homogenous and exhibited markedly higher stability than the pepsin-digested coatings.
Since several other groups have reported the ability for pepsin-digested ECM coatings and
hydrogels to promote MSC proliferation and differentiation, the lack in cellular response
observed in this study may have been due to substrate instability. Indeed, previous work
has shown the long term stability of microcarriers and foams fabricated from α–amylase
digested DAT16,58,239, while microcarriers fabricated from pepsin-digested DAT required
chemical crosslinking to enable synthesis361. The new method of fabricating ECM-derived
coatings developed in this thesis contributes to the growing body of evidence that the
methods of ECM processing are a critical design consideration, and emphasizes the
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importance of characterizing coating structure and stability to be able to reliably harness
their instructive effects within cell culture models. Since the α–amylase digestion method
has also been previously used in our group to fabricate 3D foams and microcarriers from
other tissue types such as porcine decellularized myocardium273 and porcine decellularized
dermis16, this platform represents a versatile method that can be extended to generate α–
amylase ECM coatings from a range of tissue types.
As indicated previously, a major limitation in the interpretation of current studies assessing
the effects of ECM composition on stem/progenitor cell lineage-commitment is the use of
single ECM sources. In our lab, the α–amylase-digested human DAT fabricated into porous
foams and bead-foams, displayed both adipo-conductive and adipo-inductive properties
when compared to tissue culture polystyrene and intact DAT, shown through enhanced
ASC gene expression and GPDH activity58. Similarly, DAT in the form of cryo-milled
ECM particles within methacrylated chondroitin sulphate and methacrylated glycol
chitosan hydrogels enhanced adipogenesis as compared to single phase hydrogels261,262.
While these studies conclusively indicated the pro-adipogenic properties of the DAT,
exploring the effects of ECM from other tissue sources is required to more fully understand
the benefits of applying a tissue-specific approach in ECM-derived bioscaffold design.
Hence, the in vitro cell culture models utilized in this thesis, evaluated the tissue-specificity
of the DAT in mediating ASC differentiation when compared to compositionally distinct
matrix sources, bovine tendon collagen (COL) and bovine decellularized trabecular bone
(DTB).
A recent novel multi-enzyme digestion approach developed and utilized in our lab enabled
the characterization of the proteome of human DAT, human DTB, and bovine COL using
high-throughput mass spectrometry techniques185. This study highlighted distinct
differences with respect to structural and signaling proteins between these ECM sources185,
rationalizing their choice as control sources within the experiments performed in this thesis.
While it is acknowledged the bovine sourcing of the bone and collagen may have
influenced the observed ASC responses, bovine bone is considered to have the most similar
physiochemical resemblance to human bone, and ECM macromolecules are generally
known to be well-conserved across species382–385,432. Further, the comprehensive
characterization of bovine DTB in comparison to human DAT using immunohistochemical
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techniques and biochemical assays in Chapter 3, aided in identifying key differences
between the sources in the relative abundance and distribution of some selected ECM
structural constituents. More specifically, higher levels of sulphated glycosaminoglycans
were found in the DTB, while the DAT contained higher levels of basement membrane
proteins. These tissue-specific differences further supported the application of the bovine
DTB within the 3-D composite hydrogel system to probe ECM compositional effects on
ASC adipogenesis and osteogenesis. In the future, characterization of the bovine DTB
using established mass spectrometry methods185 could ascertain further differences in the
types and abundance of glycoproteins, proteoglycans, growth factors and matricellular
proteins between the ECM sources.
Variations in structural and/or biomechanical properties between ECM sources studied can
create an added layer of complexity that is difficult to decouple from the effects of
composition, making the results challenging to interpret334,338–340,356. Within each of our
two cell culture platforms, the substrates were evaluated to have similar starting properties,
suggesting that ECM composition was the predominant factor contributing to the enhanced
adipogenesis observed with the DAT-based coatings and hydrogel composites. Within the
3-D hydrogel platforms, additional possible confounding effects associated with ECM
particle size and cell density were also considered, to have a controlled platform for
assessing the effects of the DAT versus DTB particles.
Overall, this thesis developed processing methods that conserved ECM bioactivity and
generated well-characterized 2-D and 3-D culture platforms that facilitated the systematic
evaluation of ECM composition on the adipogenic and osteogenic differentiation of ASCs.
The tissue-specific instructive effects of adipose tissue ECM in promoting ASC adipogenic
differentiation have been well documented in data from our lab and several other
groups266,272,358,371,416,444. Consistent with this, the results from this thesis supported the
ability for adipose-derived ECM to provide a pro-adipogenic microenvironment for human
ASCs when integrated into 2-D coatings or 3-D hydrogel composites, which was not
observed in the compositionally distinct tissue-type controls. The enhanced adipogenesis
on the DAT-based platforms was evident based on enhanced adipogenic gene expression
(PPARg, LPL, ADIPOQ and PLIN), glycerol-3-phosphatedehydrogenase (GPDH) enzyme
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activity and intracellular lipid accumulation under differentiation conditions. The
uniformity of the adipogenic response on α–amylase-digested DAT coatings and within
MCS+DAT hydrogels under adipogenic conditions was particularly notable, with a larger
fraction of ASCs accumulating intracellular lipid. The ASCs also displayed a more mature
phenotype observed by the presence of larger lipid droplets. Within the 3-D hydrogel
model, under proliferative conditions known to suppress adipogenic differentiation76,445,
the incorporation of the DAT increasing the presence of maturing adipocytes containing
intracellular lipid, with the most consistent response of the three hydrogel groups tested,
and limited regional variability. This suggests that the DAT may have had an adipoinductive effect, although this was not evident in the gene or protein expression data.
Interestingly, the results from Chapter 2 indicated that tissue-specific ECM (i.e. DAT)
when processed using methods avoiding proteolytic digestion were more favourable for
adipogenesis. The differences in the cell response relative to the coatings synthesized from
pepsin-digested ECM may have been due to a combination of factors such as
biomechanical properties, cell-ECM interactions and substrate stability.
The assessment of ASC osteogenic differentiation in the 3-D hydrogel model however, did
not provide any strong conclusions, potentially due to the fact that some osteogenic genes
can be upregulated at multiple stages throughout the differentiation process83,89.
Preliminary data in terms of the upregulation of the early osteogenic markers OPN and ON
in the non-induced MCS+DTB composites, as well as a peak in ALP enzyme activity at 7
days in the induced samples from this group for most of the ASC donors suggested that the
DTB may have subtle pro-osteogenic effects. Supporting this hypothesis, a number of
studies have highlighted the ability for decellularized bone ECM to enhance mesenchymal
stromal cell (MSC) osteogenesis in the presence of exogenous factors111,250,380,450, with
some reporting enhanced early-mid osteogenic gene expression (RUNX2,OPN and/or ON)
expression in the absence of soluble osteo-inductive factors251,256,450. These studies provide
a concrete rationale to systematically explore the osteo-inductive capacity of the DTB
further using a time-course experiment and including additional markers at the gene and
protein levels111,256,464–466. Although the adipo- and osteo-inductive effects of adipose tissue
ECM and bone ECM on MSCs have been individually studied, this thesis represents the
first comparison of these two sources on adipogenesis and osteogenesis within a single 3D hydrogel cell culture model.
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Notably, the extensive precipitation of calcium phosphate observed within the cell-free
control MCS hydrogels indicated that the high concentration of phosphates within the
osteogenic media was causing non-physiological mineralization that confounded
interpretation of the late-stages of osteogenesis. Since standard osteogenic media for ASCs
employ high concentrations of phosphates111,250,256,380,457 (~10 mM) in the form of bglycerol phosphate (BGP) and ascorbate-2-phosphate (A2P), this suggested the need to
improve the current media formulations. Indeed it has been shown that an increasing
concentration of phosphates in the induction media can promote the elevated expression of
genes such as OPN, also warranting the modification of media formulations to provide a
less artificial microenvironment and facilitate accurate interpretations of the observed cell
responses467. In addition the findings emphasize the critical importance of the inclusion of
cell-free controls to be able to accurately interpret the data.

5.2

Future recommendations

The body of work documented in this thesis reinforced that ECM from adipose tissue
incorporated within both 2-D and 3-D in vitro cell culture models can provide a proadipogenic microenvironment enhancing the adipogenic differentiation of human ASCs
when compared to compositionally distinct tissue sources (DTB and COL).
The results from Chapter 2 demonstrated the cell-supportive and pro-adipogenic
microenvironment provided by α–amylase-digested DAT coatings in terms of enhancing
ASC proliferation and adipogenic differentiation. In light of the proliferation data, these
coatings could be investigated as a platform for ASC expansion, with validation performed
downstream in terms of maintaining the ASC immunophenotype and multilineage
differentiation capacity post-expansion. In extension to our observed differentiation data,
and evidence indicating the ability for MSCs to exhibit markers of tenocyte differentiation
within decellularized tendon ECM scaffolds in vitro360,468,469, it would be worthwhile to
extend and apply this model to assess the tissue-specificity of DAT and COL to express in
vitro markers of this lineage. Interestingly, Zhang et al. found that tissue-specific ECM
coatings prepared from decellularized skin, liver, and muscle tissues were able to promote
lineage-specific differentiation of tissue-matched cell types336. Another possible avenue to
explore could be the culture of tissue-matched cell types (ASCs vs tendon stem/progenitor
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cells) used in combination with DAT and COL ECM coatings to further examine the
inductive effects of ECM in maintaining cell phenotype and regulating differentiation.
Despite improvements in terms of grafting adhesive sequences to encourage cell
attachment and coating with purified or complex ECM-derived proteins, 2-D culture
systems lack the complexities in terms of cell-cell and cell-ECM interactions in vivo and
have been associated with altered cell behaviour and differentiation capacity8,355. Further,
with the long-term goal of designing tissue-specific carriers for stromal cell-based
therapies, it is imperative that the results from the 2-D perspective can be effectively
translated into 3-D platforms. Hence, Chapter 4 supported that the tissue-specific effects
of the DAT observed in the coatings in Chapter 2 could be harnessed within a 3-D hydrogel
cell culture model. Indeed, the data indicated the ability for cryo-milled DAT to enhance
the adipogenic differentiation of ASCs in the MCS hydrogels, although the interpretation
of the effects of incorporating the DTB on osteogenesis was more challenging. In terms of
short term future goals related to the work presented in Chapter 4, it would be worthwhile
to explore a time course for gene expression as early as 24 h to capture differences in terms
of the initiation of osteogenesis and as late as 4 weeks post-induction to highlight any
differences in gene expression by mature osteoblasts. Notably, results from a recent study
evaluating the lineage commitment of human ASCs over a period of 3 weeks, indicted that
inductive effects of the bone ECM on osteogenic gene expression (RUNX2, COLL1, OCN)
were not observed until 3 weeks in culture266, while in another study was observed as early
as 48 h451, reiterating the importance of tracking the variations in osteogenesis over time.
To further support the findings in Chapter 4, the inclusion of additional gene markers of
osteogenic differentiation such as OSX and BSP could be explored, complemented by the
assessment of these markers at the protein level using methods such as
immunohistochemical and western blotting techniques. OSX is an early osteogenic
differentiation marker downstream of RUNX2 and BSP is a late-stage differentiation
marker involved in osteoid matrix secretion and mineralization83. In assessing transcription
factors, activation is often more important than expression levels. With the translocation of
transcription factors to the nucleus indicative of their activation, immunohistochemical
techniques could potentially be utilized to localize the expression of the master regulators
of osteogenesis (RUNX2 and OSX) at the earlier stages of osteogenic differentiation.
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An important issue to explore in the future is the precipitation of calcium phosphate as a
result of the high b-glycerol phosphate content (~10 mM) that becomes hydrolysed even
under cell-free conditions in the differentiation media, causing precipitation. This issue
demands the development of alternative media formulations that can provide favourable
conditions for ASC osteogenic differentiation, while not artificially skewing the
differentiation process. The inclusion of phosphates are important as they serve as a source
for the phosphate portion in hydroxyapatite during the secretion of mineralized matrix and
act as intracellular signaling molecules to regulate the expression of many of the osteogenic
genes including OPN85. To reduce overall concentration of phosphates in the
differentiation media, ascorbic acid can be supplemented in place of A2P due to the similar
roles played by both constituents, although ascorbic acid is known to be a less stable analog
under aqueous conditions. Furthermore, the limited supplementation of phosphates through
inorganic means (e.g. sodium dihydrogen phosphate) has also been explored and
demonstrated to be more effective in promoting bone marrow-derived mesenchymal stem
cells MSC osteogenesis and matrix mineralization despite use at lower concentrations467.
Finally, an interesting alternative could be to use an induction media to initiate the
differentiation process, followed by longer-term culture in a more minimalistic cellsupportive medium to assess the capacity of the tissue-specific ECM-derived substrates to
support ongoing differentiation in the absence of high concentrations of soluble factors.
This may circumvent the requirement for long-term culture in differentiation media, allow
the more accurate interpretation of inductive effects of the ECM, and could also mitigate
the precipitation effects observed with high phosphate concentrations.
Notably, many studies have demonstrated that ASCs display pronounced adipogenic
differentiation452–454, while displaying inferior osteogenic differential potential as
compared to bmMSCs based on gene expression data, ALP enzyme activity and matrix
mineralization452–455. In addition, with the well-established and intricately controlled
inverse relationship between adipogenesis and osteogenesis, it is possible that the natural
pre-disposition of the ASCs towards the adipogenic lineage may have influenced the
observed osteogenic response89,429. Hence, a comparison of human ASCs and human
bmMSCs in terms of their adipogenic and osteogenic lineage commitment could be
assessed within the three hydrogel groups to explore possible cell-type mediated effects.
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Recently, several studies have documented the positive effect of mineral content on the
osteogenesis of MSCs, which was postulated to be due to a stiffening effect470–472. Hence,
a valuable strategy could be to incorporate an external mineral source in the form of
commonly used tri-calcium phosphate473–475 to assess the inductive effects of DTB with or
without added mineral content in influencing the osteogenic differentiation of ASCs.
Finally, ECM stiffness has also been shown to play a crucial role in modulating the lineage
commitment of stem cells, when mimicked using hydrogels with tunable mechanical
properties104. Given that our hydrogel systems did not match the stiffness values of either
native adipose184,236 (1-4 kPa) or bone (1-20 GPa)435,476, altering the mechanical properties
of the system to fabricate either softer gels or stiffer gels, could allow for the exploration
of hydrogel stiffness and ECM composition simultaneously on ASC differentiation. Given
the versatility of this model, effects of other parameters such as ECM concentration and
ASC cell density on ASC lineage-commitment could also be easily assessed.

5.3

Summary

This thesis developed 2-D and 3-D cell culture platforms that incorporated tissue-specific
ECM processed using methods that were favourable for conserving the ECM bioactivity.
Furthermore, the cell culture models designed and utilized facilitated the evaluation of
ECM composition on the adipogenic and osteogenic differentiation of human ASCs. First,
an α-amylase digestion method was developed to fabricate stable and bioactive ECM
coatings from DAT and COL, as an alternative to proteolytic digestion with pepsin. The αamylase-digested coatings were softer and more stable, with a complex composition and
fibrillar architecture. Within this 2-D platform, the α-amylase DAT enhanced ASC
proliferation and provided a pro-adipogenic microenvironment compared to COL,
signifying its ability to promote the tissue-specific differentiation of ASCs. To further
evaluate the effects of tissue-specific ECM composition on ASC differentiation, bovine
trabecular bone was explored as a compositionally distinct matrix source. The DTB was
decellularized using a detergent-free approach and characterized compared to DAT in
terms of composition using immunohistochemical and biochemical techniques. Higher
levels of glycosaminoglycans were expressed in the DTB and higher levels of basement
membrane proteins were expressed in the DAT. Finally, cryo-milled DTB and DAT were
incorporated within a 3-D hydrogel platform to assess the effect of ECM composition on
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the lineage-specific differentiation of ASCs. The results convincingly demonstrated the
adipo-conductive effects of incorporating DAT within MCS hydrogels on ASCs, which
were not observed in the composites incorporating DTB. Preliminary osteogenic data
suggested the possibility of an inductive effect of DTB on ASCs, which requires further
exploration through time-course studies under refined culture conditions.
Overall, this body of work supports the rationale of applying a tissue-specific approach in
the development of in vitro cell culture models to promote the lineage-specific
differentiation of ASCs.
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Appendix A: Supplementary figures
Table A.1: Immunophenotype of P2 human ASCs
Marker

Mean ± Standard deviation (%)
(n=3, N=3)

CD90
CD29
CD44
CD73
CD105
CD34
CD146
CD31
CD45

99.98 ± 0.03
99.92 ± 0.02
99.99 ± 0.02
99.94 ± 0.08
99.84 ± 0.19
13.67 ± 9.70
5.32 ± 4.94
0.19 ± 0.16
1.04 ± 0.33
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Figure A.1: (A) Macroscopic images of pepsin-digested DAT and a-amylase DAT,
showing that pepsin digestion produces a clear solution while a-amylase digestion
generates a viscous cloudy suspension. (B) Macroscopic images of well plates coated with
the respective ECM suspensions after overnight drying (top) and representative image of
an a-amylase-digested DAT coating extracted from the plate following rehydration in PBS
using forceps (bottom). (C) SDS-Page highlighting the size distribution of ECM proteins.
The ECM digested with α-amylase showed bands at higher molecular weights, while
pepsin-digested ECM showed faint bands at lower molecular weights. (D) SEM image of
a-amylase-digested DAT showing the retention of the D-banding structure characteristic
of collagen. Scale: 500 nm.
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Figure A.2: Scanning electron microscopy (SEM) images of the pepsin-digested DAT
and COL coatings before and after the rinses in cell culture medium, prior to cell
seeding. Images support that the pepsin-digested coatings were retained following rinsing.
Scale: 100 µm.
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Figure A.3: Representative images of ASCs cultured on the different coatings at 4 h,
24 h, 72 h and 7 d, showing distinct differences in ASC morphology and cell density.
ASCs cultured on the a-amylase-digested coatings had a more spindle-shaped
morphology, while cells cultured on pepsin-digested coatings and uncoated controls
showed enhanced cell spreading over time. Scale:10 µm.
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Figure A.4: Representative images of positive tissue type controls for
immunohistochemical staining. Mouse skin was used as a tissue type control for collagen
type I, IV, laminin and fibronectin, while adipose tissue was used as a tissue type control
for collagen type V and VI. Scale:100 µm.
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Table A.2: Summary of cell donor information for all in vitro studies.
Study
Viability

Adipogenic
Differentiation

Osteogenic
Differentiation

Donor information
Donor 1: 62 yr, BMI=30.1
LIVE/DEAD®
Donor 2: 37 yr,BMI=29
Donor 3: 39 yr, BMI=30
Donor 1: 59 yr, BMI=26
RT-qPCR
Donor 2: 37 yr, BMI = 32.3
Donor 3: 66 yr, BMI=25.8
Donor 1: 59 yr, BMI=26
GPDH/BODIPY
Donor 2: 59 yr, BMI=29
Donor 3: 58 yr, BMI=30.4
Donor 1: 57 yr, BMI=31.4
RT-qPCR
Donor 2: 58 yr, BMI=25.6
Donor 3: 35 yr, BMI=21.8
Donor 1: 66 yr, BMI=25.8
ALP
Donor 2: 57 yr, BMI=31.4
Donor 3: 58 yr, BMI=25.6
Donor 4: 35 yr, BMI=21.8
Matrix mineralization Donor 1: 66 yr, BMI=22.2
Donor 2: 66 yr, BMI=22.8
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Figure A.5: Representative confocal microscopy images of LIVE/DEAD®-stained
ASCs encapsulated within an MCS, MCS+DAT and MCS+DTB hydrogel at 7 d. Live
cells are shown at the top in green and dead cells at the bottom in red.

Figure A.6: Representative confocal microscopy photomicrographs of OsteoImageTM
stained MCS, MCS+DAT and MCS+DTB hydrogels cultured under proliferative
(non-induced) conditions at 28 d post induction. The data indicated that no matrix
mineralization was observed when hydrogels were cultured in proliferation medium and
no visible differences were observed between the groups.
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